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Abstract
Increasing evidence suggests that an adverse in utero environment can result in
disease later in life. Diseases such as hypertension and type 2 diabetes have recently,
in epidemiological studies, been linked to low birth weight. This link has also been
found in animal studies, and has led to the suggestion that factors acting very early in
life may 'program' the setpoint of certain physiological systems. The brain is
particularly sensitive to early environmental manipulations. Prenatal stress, maternal
deprivation, and neonatal handling have long-term effects on brain functioning such
as regulation of the hypothalamic-pituitary-adrenal (HPA) axis and stress-induced
behaviour. The factor(s) underlying the link between low birth weight and later
disease is unknown, but glucocorticoids have been implicated. Whereas low
glucocorticoid levels are important for normal development, exposure to excessive
levels can have deleterious effects. To maintain this critical balance
11 P-hydroxysteroid dehydrogenase (lip-HSD) type 2 normally rapidly inactivates
glucocorticoids in placenta and many fetal tissues, thus acting as a 'barrier' to
maternal steroids.
We investigated the effect of bypassing (using dexamethasone, DEX) or inhibiting
(using carbenoxolone, CBX) feto-placental 1 lp-HSD in rats, on subsequent offspring
HPA axis regulation and stress-induced behaviour. Pregnant Wistar rats were
injected with CBX, DEX or vehicle daily throughout pregnancy. A separate group
received DEX injections in the last week of pregnancy only (DEX3), as this had
previously been shown to contain the critical time window for programming of
hypertension and hyperglycaemia. All treatments reduced birth weight (CBX 12%,
DEX1-3 15%, DEX3 7%). This was reversed by 4 and 6 weeks of life in DEX3 and
CBX offspring, respectively, while offspring of dams treated with DEX throughout
pregnancy had reduced body weight throughout life (7% at 5 months of age).
Prenatal exposure to glucocorticoids resulted in increased basal corticosterone
(CORT) levels (CBX 0.70 pg/dl, DEX 1-3 0.76 ug/dl, control 0.40 pg/dl) and a trend
(p=0.07) towards increased corticotropin-releasing hormone (CRH) in the
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hypothalamic paraventricular nucleus (PVN) in adult offspring. In addition, CBX
offspring had reduced PVN glucocorticoid receptor (GR) mRNA and a prolonged
stress response. Hippocampal GR and mineralocorticoid receptor (MR) mRNA
expression was reduced only in DEX3 offspring, which also showed increased CRH
mRNA levels in PVN. CBX and DEX3 rats displayed impaired non-spatial learning.
In addition, exploratory behaviour in an open field was affected by prenatal
glucocorticoid exposure, especially in DEX3 offspring, which showed reduced
locomotion and rearing. The behavioural alterations are associated with increased
expression of MR, GR and CRH mRNAs in the amygdala, a structure implicated in
the expression of fear and anxiety. These data suggest that disturbance of the feto¬
placental enzymatic barrier to maternal glucocorticoids, or in utero exposure to DEX,
reduces birth weight and produces permanent subtle alterations of the HPA axis
combined with behavioural inhibition or impaired coping in aversive situations.
Furthermore, the similar but not identical effects resulting from CBX. DEX1-3 and
DEX3 administration suggest the existence of critical time windows for
glucocorticoid programming, different programming mechanisms for CBX and
DEX, or exposure to different concentrations of glucocorticoid in utero. The
behavioural and HPA effects may reflect corticosteroid receptor and CRH gene
programming in amygdala and hypothalamus, respectively. In conclusion, fetal
overexposure to endogenous (reduced activity of feto-placental 11 (3-HSD) or
exogenous (prenatal DEX therapy) glucocorticoids may represent a common link
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Preface
Increasing evidence suggests that an adverse in utero environment can result in
disease later in life. Diseases such as hypertension and type 2 diabetes, generally
assumed to result from a combination of genetic predisposition and life style factors
in adult life (smoking, lack of exercise, diet), have recently, in epidemiological
studies, been linked to low birth weight. This link has also been found in animal
studies, and has led to the suggestion that factors acting very early in life may
'program' the setpoint of certain physiological systems, in order to prepare the
organism for life under sub-optimal conditions.
A system that has long been shown to be programmable is the central nervous system
(CNS). Early environmental manipulations (e.g. prenatal stress, maternal deprivation,
neonatal handling) alter brain development and have long-term effects on brain
functioning. For example, prenatal stress induces permanent changes in offspring
sexual behaviour (Holson et al., 1995), hormonal and behavioural responses to stress
(Fride et al., 1986; Henry et al., 1994; Takahashi et al., 1988; Vallee et al., 1997;
Weinstock et al., 1992) and brain monoamine systems (Day et al., 1998; Peters,
1984; Peters, 1990; Takahashi et al., 1992a). Disturbances in hypothalamic-pituitary-
adrenal (HPA) regulation and brain monoamine levels are associated with affective
and anxiety disorders in humans (Holsboer and Barden. 1996; Lopez et al., 1998).
Thus, the majority of depressed patients display increased levels of corticotrophin
releasing hormone (CRH) in CSF, elevated plasma levels of adrenocorticotrophic
hormone (ACTH) and Cortisol and an attenuated diurnal variation in HPA activity.
This suggests that such conditions may be, in part, prenatally programmed. Indeed,
several behavioural abnormalities have been reported in children exposed to 'prenatal
stress' (Weinstock, 1997). Interestingly, prenatal stress also results in low birth
weight offspring in rats (Kinley and Svare, 1986; Takahashi et al., 1988) and humans
(Rothberg and Lits, 1991; Sandman et al., 1997; Wadhwa et al., 1993).
In the search for a mechanism underlying prenatal programming, fetal exposure to
glucocorticoids has been implicated. Glucocorticoids are necessary for normal
development [for review see (Meyer, 1985)]. They affect mitosis, myelination and
differentiation in the CNS and have many other key regulatory functions during
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development. However, excess exposure to glucocorticoids can have deleterious
effects, inhibiting fetal body and brain as well as placental growth. For example,
exposure to high levels of glucocorticoids inhibits neurogenesis, gliogenesis and
dendrite and myelin formation in the CNS (Bohn et al., 1994; Cotterrell, 1972;
Meyer, 1985). Thus, the inhibiting effects of high doses and the permissive effects of
physiological low doses of glucocorticoids indicate the importance of keeping
glucocorticoid concentrations within limits for normal development. It has recently
become apparent that even moderate-dose glucocorticoid administration to pregnant
rats has long-lasting effects and results in low birth weight offspring that develop
hypertension and hyperglycaemia in adulthood (Lindsay et al., 1996a, 1996b;
Nyirenda et al., 1998). The long-term effects of low levels of glucocorticoids
administered prenatally on brain functioning have received little attention. It is
important that these effects are established, since glucocorticoids are commonly
administered in pregnancies where the fetus is potentially affected with congenital
adrenal hyperplasia. Moreover, they are used in cases of threatened prematurity to
prevent neonatal respiratory distress syndrome by promoting lung maturation.
Because glucocorticoids are lipophilic, they are assumed to readily pass the placenta
from mother to fetus (Zarrow et al., 1972). However, a high-affinity glucocorticoid-
inactivating enzyme 11 P-hvdroxysteroid dehydrogenase (11(3-HSD) is present in
both placenta and fetus (Brown et al., 1996; Stewart et al., 1994) and may function as
a barrier protecting the ferns from high levels of maternal glucocorticoids. Synthetic
glucocorticoids such as dexamethasone (DEX) are poor substrates for this enzyme.
Inhibiting this barrier has been shown to program low birth weight and hypertension
and hyperglycaemia later in life (Lindsay et al., 1996a; Lindsay et al., 1996b), similar
to the effects of low-dose prenatal synthetic glucocorticoid administration.
This thesis aims to increase understanding of the effects of prenatal glucocorticoid
exposure on HPA regulation and stress-induced behaviour. Furthermore, the role of
feto-placental lip-HSD was investigated in protecting the fetus from the effects of
maternal glucocorticoids on these parameters. The findings may have important
implications for prenatal glucocorticoid treatment in humans.
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Chapter 1. Introduction
A. Glucocorticoids, their regulation and actions
A.l. Glucocorticoids
An organism responds to change in environmental or physiological circumstances in
both a reactive and an anticipatory mode. Whereas a reactive response is set out in
order to restore homeostasis, an anticipatory response is the result of a process called
allostasis. Allostasis has been defined as 'the regulation ofmany variables over time
in maintaining stability to meet changing circumstances' (Schulkin et ah, 1994) or in
short 'maintaining stability through change' (De Kloet, 1991). The physiological
endpoint of both types of response is known as the 'stress response'. This reaction
involves activation of the sympathetic nervous system as well as the release of
glucocorticoid hormones.
Glucocorticoids have a wide range of actions in the body, and several theories have
been put forward to explain the role of glucocorticoids in the stress response [for
review see de Kloet, 1991]. Thus, it has been proposed that their main goal is to
mobilise energy and suppress systems that are not essential in an emergency
situation. Alternatively, they may have a permissive role in the actions of
neurotransmitters released in reponse to stress. A third hypothesis postulates that
glucocorticoids prevent damage to the organism caused by primary stress reactions
by inhibiting these reactions (Munck et al., 1984). In metaphorical terms, they
'prevent water damage caused by the fire brigade'.
Among the effects of glucocorticoids are suppression of growth, bone production,
immune- and reproductive functions, and increased glucose levels, blood pressure
and cardiovascular tone. Obviously, these effects can all be considered adaptive in an
acutely stressful situation. However, as all the above mentioned actions are
potentially damaging, chronic elevation of glucocorticoid levels can have deleterious
results. It is important that glucocorticoid levels are tightly regulated, so that they
return to basal levels once the stressor has disappeared. Therefore, glucocorticoids
are subject to homeostatic, negative-feedback control acting at several levels of the
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system that mediates glucocorticoid release: the hypothalamic-pituitary-adrenal
(HPA)-axis.
A. 2. The hypothalamus-pituitary-adrenal axis
The HPA-axis regulates the release of glucocorticoids. The hypothalamus receives
direct or indirect input from virtually all areas of the brain (Herman and Cullinan,
1997a) and thereby acts as the regulatory centre of the stress response. Thus, a
variety of central inputs can trigger the hypothalamus to release CRH, arginine
vasopressin (AVP) and several other peptides from its parvocellular paraventricular
(PVN) neurones (Figure 1.1). Together these peptides are released into the
hypophyseal portal circulation of the median eminence and trigger anterior pituitary
corticotrophs to stimulate the release of proopiomelanocortin (POMC), the precursor
molecule for ACTH and several other peptides. The effect of CRH is potentiated by
AVP, which is colocalised with CRH in PVN neurones. Once released into the
circulation, ACTH triggers the adrenal cortex to synthesise and secrete
glucocorticoids (O'Riordan et al., 1988). In humans, the main glucocorticoid is
Cortisol, whereas in rats and mice it is corticosterone (CORT).
In addition to stress-induced release, CORT levels follow a diurnal variation, with
peak levels occuring toward the start of the active period. This endogenous circadian
rhythm is generated by the suprachiasmatic nucleus of the hypothalamus, which has
projections to the hypothalamus, but variations in pituitary and adrenal
responsiveness and splanchnic nerve activity also play a role (De Kloet, 1991;
Dijkstra et al., 1996).
Glucocorticoids, via binding to their specific receptors, regulate their own secretion
by negative feedback actions at the level of the hypothalamus and the pituitary,
inhibiting the synthesis and release of CRH, AVP, POMC and ACTH, thus
terminating the stress response (Figure 1.1). This is referred to as 'slow feedback'
and its effects may last several days (de Kloet, 1991). There are also two non-
genomic mechanisms of feedback. Fast feedback is thought to take place at the level
of the cell membrane, while intermediate feedback may be underlain by steroid











Figure 1.1 Schematic representation of the HPA axis.
-> stimulating effect; —> inhibiting effect
A. 3. Corticosteroid receptors
Corticosteroids exert most of their actions via binding to their intracellular receptors
(De Kloet et al., 1998). Molecular and biochemical studies have revealed two
receptor subtypes: the mineralocorticoid receptor (MR) and the glucocorticoid
receptor (GR) (Reul and de Kloet, 1985). GRs are found in practically every tissue in
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the body, whereas the distribution of MRs is restricted to specific mineralocorticoid
target tissues such as kidney, skin and intestines. Within the brain, a widespread
distribution of GR in neurones and glial cells is observed but MRs are found in
relatively few areas, mainly in the limbic system. Thus, autoradiography,
immunocvtochemistry and in situ hybridisation studies have revealed that GRs are
concentrated in hippocampus, septum, amygdala. PVN, supraoptic nucleus and
arcuate nucleus of the hypothalamus, cerebral cortex, cerebellum and ascending
monoaminergic neurones of the brainstem. High MR densities have been shown in
neurones in hippocampus, septum, amygdala, olfactory nucleus, and brainstem
sensory and motor neurones (De Kloet, 1991).
The physiological ligands for MR are aldosterone (ALDO) and CORT, for which
MR has equal affinities (Kd ~ 0.5 nM). GR binds its natural ligand CORT with a ten
times lesser affinity (Kd « 5.0 nM) (De Kloet et al., 1998), while it has a slightly













HC C = 0
Dexamethasone Aldosterone
Figure 1,2 Structures of IVIR and GR ligands.
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Corticosteroid receptors belong to a family of nuclear steroid hormone receptors,
acting as transcription factors, which are characterised by three regions: a DNA-
binding domain, a C-terminal ligand-binding domain and an N-terminal domain
involved in transcriptional regulation or modulation (Evans and Arriza, 1989). The
ligand-binding domain is associated with heatshock proteins. Upon binding of the
receptor to its ligand, the hormone-receptor complex dissociates from the heatshock
protein complex, the receptor becomes phosphorylated and translocates to the
nucleus. There it forms homo- or heterodimers (Trapp et al., 1994) and binds to
glucocorticoid response elements (GREs) on the DNA of target genes in order to
regulate their transcription (Evans and Arriza, 1989). In addition to transcriptional
regulation via steroid receptor-DNA interaction, activated steroid receptors may
influence transcription by interaction with other transcription factors such as AP-1,
NF-kB or CREBP (Pfahl, 1993).
Access of CORT to its receptors is regulated on three levels: 1) CBG and albumin in
plasma bind > 95% of circulating CORT, rendering it biologically unavailable (De
Kloet et ah, 1998); 2) in- and reactivation of CORT by the enzyme 11 (3-HSD, types 1
and 2 (see section C of this chapter); 3) metabolism of CORT by 5a- and 5(3-
reductase (fi/2 ~ 6 h).
Brain corticosteroid receptors are subject to autoregulation in a cell- and region-
specific fashion (Herman, 1993): adrenalectomy (ADX) results in increased MR and
GR mRNA (Herman, 1993; Herman and Spencer, 1998; Pfeiffer et ah, 1991) and
MR and GR binding (Reul et ah, 1987) in the hippocampus, but not PVN (Peiffer et
ah, 1991). In contrast, high doses of dexamethasone or stress decrease hippocampal
GR numbers (Herman, 1993; McEwen et ah, 1986; Sapolsky et ah, 1984), while high
glucocorticoid levels decrease MR binding in some studies (Herman et ah, 1995;
Herman and Watson, 1995), but increase them (De Kloet, 1991) or leave them
unaffected (Makino et ah, 1995a; Reul et ah, 1987) in others. The mechanisms
underlying the specificity of corticosteroid receptor expression and regulation may
involve transcriptional control via specific promoters as well as posttranscriptional
and -translational control.
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There is also evidence for neural control of brain corticosteroid receptors. Thus,
alterations in noradrenergic (Kabbaj et al., 1995; Kabbaj et al., 1996; Maccari et al.,
1992a; Maccari et al., 1992b; Yau and Seckl, 1992), serotonergic (Seckl et al., 1990;
Weidenfeld and Feldman. 1991) or cholinergic (Yau et al., 1992) neurotransmission
induce changes in brain MR and GR expression.
In addition to their genomic actions, steroids exert rapid non-genomic effects on
neurotransmission and behaviour (Schumacher, 1990), perhaps via binding to
membrane receptors (Orchinik et al., 1991). Proposed mechanisms include binding
of steroid metabolites to neurotransmitter receptors on the neuronal membrane such
as the GABAa receptor (Paul and Purdy, 1992; Puia et al., 1990).
A.4.1. Central corticosteroid action: hippocampus
A. 4.1.1 .Neuroendocrine regulation
There is considerable evidence that the hippocampus plays a role in regulating both
stress-induced and circadian HPA-activity (Jacobson and Sapolsky, 1991), stemming
from lesion studies, electrical stimulation of the hippocampus and administration of
receptor agonists and antagonists.
Because of the abundant levels of MR and GR in this structure, hippocampal
modulation of HPA-activity is likely to be influenced by occupation of these
receptors. The different affinities of MR and GR for CORT imply that under basal
resting conditions, when CORT levels are low, mainly MRs are occupied in the
hippocampus, whereas at high CORT levels, such as during stress or at the circadian
peak, MRs and GRs are simultaneously activated (Reul et al., 1987). In fact, the
hippocampus is itself thought to play a role in the regulation of circadian HPA-
activity, mainly through MR occupation (Bradbury et al., 1994; Levin et al., 1987).
Electrophysiological studies have shown that in the hippocampal CA1 area MR and
GR activation interact and antagonise each other in the control of neuronal
excitability (De Kloet et al., 1998; Joels and de Kloet, 1992). Similarly, MR and GR
appear to have opposing effects on hippocampal cholinergic theta-activity (Murphy
et al., 1998). The same might be true in complex spatial memory tasks associated
with the hippocampus such as the Morris watermaze task (Oitzl et al., 1998). It has
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recently been suggested that, similar to their effects on cell activity and behaviour,
hippocampal MR and GR co-ordinately mediate hippocampal regulation of HPA-
activity (De Kloet. 1991; De Kloet et al., 1998). Thus, activation of hippocampal MR
mediates a tonic inhibitory control over basal HPA-activity. At higher CORT levels,
hippocampal GRs are also activated and override the MR-mediated action, thereby
disinhibiting HPA-activity. GR-mediated negative feedback on stress-induced HPA-
activity would primarily take place at the levels of the PVN (Feldman et al., 1992;
Feldman and Weidenfeld, 1995), and pituitary (De Kloet et al., 1988; Young et al.,
1995), although hippocampal MRs may also play a role in glucocorticoid negative
feedback (Dallman et al., 1992; Ratka et al., 1989; Spencer et al., 1998). Indeed, van
Haarst et al. showed that intrahippocampal administration of the GR antagonist
RU38486 decreased basal ACTH levels in the afternoon, whereas RU38486 given
i.c.v. increased basal HPA-activity in the afternoon and in response to stress (van
Haarst et al., 1996; van Haarst et al., 1997), suggesting that the effect of the GR
antagonist in the PVN overrides the effect of hippocampal GR blockade. In addition.
Feldman et al. showed that intrahippocampal high concentration CORT implants
failed to decrease the HPA-response following neural stimuli (Feldman et al., 1992).
Taken together, it appears as though hippocampal GRs are not involved in
glucocorticoid negative feedback of the HPA axis, and may even underlie stress-
induced facilitation ofHPA-activity.
However, early life manipulations that alter hippocampal, but not PVN or pituitary,
GR levels affect glucocorticoid negative feedback (Henry et al., 1994; Meaney et al.,
1989). Similarly, other correlative evidence as well as lesion studies suggest that
hippocampal GRs mediate stress-induced corticosteroid negative feedback (Feldman
and Weidenfeld, 1995; Herman et al., 1989; Jacobson and Sapolsky, 1991; Makino et
al., 1995a; Sapolsky et al., 1984; Sapolsky et al., 1986). In these studies, elevated or
decreased plasma CORT levels are consistently associated with respectively
decreased or increased hippocampal GR levels, but whether altered CORT levels are
cause or consequence of altered hippocampal GR levels is unclear. In a more direct
study, Feldman et al showed that intrahippocampal high concentration CORT
implants failed to decrease the HPA-response following neural stimuli (Feldman et
al., 1992).
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Thus, the role of hippocampal GR in mediating HPA-activity remains somewhat
controversial. In any case, the hippocampus is certainly not the only site regulating
HPA-activity. It has been suggested that although the hippocampus, via its GRs, may
be involved in the behavioural response to stress, its role in corticosteroid feedback
may only be modulatory (De Kloet et al., 1998).
A.4.1.2. Behaviour
The hippocampus has been shown to be a critical site in the regulation of learning
and memory and in the behavioural response to novelty. The 'Porsolf or 'forced
swim' test (for details see Materials & Methods section) is an example of tests that
involve activation of hippocampal MR and/or GR. The increased immobility rats
acquire upon exposure to forced swimming has been interpreted as 'learned
helplessness', but also as a successful means of passive 'behavioural adaptation'
aimed to conserve energy in an inescapable situation. I.e.v. or intrahippocampal
treatment with antiglucocorticoids or with antisense directed against GR mRNA as
well as ADX reduces the time spent immobile (De Kloet et al., 1988; Korte et al.,
1996; Mitchell and Meaney, 1991), and reduced immobility in ADX rats is restored
by CORT-injections, suggesting a role for hippocampal corticosteroid receptors in
this form of acquired behaviour.
The watermaze (for details see Materials & Methods section) is a spatial ability test
that relies on hippocampal integrity (Morris et al., 1982) and activation of
hippocampal MR and GR, although the exact roles ofMR and GR in spatial memory
are still a matter of debate. The implications of hippocampal corticosteroid receptor
number for watermaze performance depend on the strain and the age of the rats used
(Yau et al., 1994; Yau et al., 1995), but in general reduced corticosteroid receptor
levels correlate with impaired spatial memory [e.g. (Issa et al., 1990)]. Accordingly,
blockade of central GRs impairs spatial memory (Conrad et al., 1997; Oitzl and de
Kloet, 1992).
However, not only receptor number but also levels of available ligand may be crucial
in (especially) GR-mediated effects on watermaze performance. Thus, at low levels
of plasma CORT, a lower percentage of GRs will be activated than at high plasma
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CORT concentrations (Reul and Dekloet, 1985). Very low (ADX) as well as very
high GR occupation impairs spatial memory measured in a Y-maze (Conrad et al.,
1997), suggesting an inverted U-shape relationship between hippocampal GR
occupation and spatial memory (Conrad et al., 1997). Accordingly, in a watermaze
task acute posttraining intrahippocampal administration of antiglucocorticoids,
imposing a reduction in GR occupation possibly to a level corresponding with the
'top' of the inverted U-shape, improves spatial memory (Oitzl et al.. 1998), although
these data were originally interpreted as GR occupation interfering with memory
consolidation. Interestingly, a similar concentration-dependent biphasic influence of
CORT levels has been found for the mechanisms thought to underlie learning and
memory, namely hippocampal long-term potentiation (LTP) and primed-burst
potentiation (PBP) (Diamond et al., 1992).
In contrast to hippocampal GRs, hippocampal MRs appear to play a less specific role
in memory formation. Central injection ofMR antagonists in Wistar rats only altered
search strategy and not spatial memory (Oitzl and de Kloet, 1992), suggesting
distinctly different functions for hippocampal MR and GR in this task, possibly
through nonspecific effects such as increased arousal (Conrad et al., 1997; Oitzl and
de Kloet, 1992; Sandi, 1998). Indeed, the function of hippocampal MR has been
studied in a number of other behavioural tasks, such as an open field (De Kloet et al.,
1993; Oitzl et al., 1994), forced swim test (Mitchell and Meaney, 1991), black-white
box (Smythe et al., 1997), and elevated plusmaze (Bitran et al., 1998; Korte et al.,
1996). They appear to facilitate memory formation by mediating adaptive
behavioural responses to stressful challenges, through evaluation of the situation and
selection of an appropriate strategy, a process called 'sensory integration' (Lupien
and McEwen, 1997).
A. 4.2. Central corticosteroid action: amygdala
A.4.2.1. Neuroendocrine regulation
Electrical stimulation and lesion studies have led to the hypothesis that the amygdala
may have a facilitatory influence on HPA-activity. Stimulation of the central
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amygdaloid nucleus (CEA) depletes the ME of CRH and increases plasma CORT
and ACTH concentrations. Recent data suggest that hypothalamic 5-HT and NA
mediate these effects via S-HT? and ai receptors, respectively (Feldman and
Weidenfeld, 1998) and that they are sensitive to inhibition by i.p. injections of
dexamethasone (Weidenfeld et al., 1997). Furthermore, lesions of the CEA before a
single learning trial of fear of inescapable footshock, abolish the CORT response to
stress (Roozendaal et al., 1992). These amygdaloid influences on HPA-activity may
be mediated by projections from the CEA to the PVN, both direct and indirect via the
BNST and POA [for review see (Davis, 1992)]. It has been suggested that the
inhibitory GABA-ergic tone in the PVN is inhibited by GABA-ergic neurones from
the CEA, thus having a net stimulatory result on HPA-activity (de Kloet et al., 1998;
Herman and Cullinan, 1997). Recently, evidence has emerged for a reciprocal
influence between CEA and PVN, as direct innervations from PVN neurones were
traced to CRH-producing CEA cells through the ST and through the lateral
hypothalamus (Palkovits et al., 1998).
A. 4.2.2. Fear & anxiety
The amygdala also plays a major role in the behavioural expression of fear and
anxiety. Electrical stimulation of the amygdala results in fear-associated responses
[see (Applegate et al., 1982; Davis et al., 1994)], whereas amygdaloid lesions
attenuate fear-related behavioural responses (Kopchia et al., 1992). Furthermore,
i.c.v. or intra-amygdaloid injections of CRH generally have anxiogenic effects
(Dunne and Berridge, 1990), suggesting that CRH may be a mediator of anxiety.
Since the amygdaloid complex contains both CRH and CRH receptors (Owens and
Nemeroff, 1991; Potter et al., 1994), it may be the site of action for CRH-induced
behavioural responses [for review see (Gray and Bingaman, 1996)]. CRH mRNA
expression in CEA is facilitated by corticosteroids: chronic or acutely elevated
CORT levels or chronic stress increased CRH mRNA in CEA (Albeck et al., 1997;
Hatalski et al., 1998; Hsu et al., 1998; Makino et al., 1994a), whereas ADX caused a
decrease of CRH mRNA in CEA (Makino et al., 1994b; Palkovits et al., 1998)
(although CRH binding in whole amygdala did not alter after 4 days of CORT
treatment (Hauger et al., 1987)). CRH receptor mRNA expression in the amygdala is
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not affected by alterations in CORT levels (Makino et al., 1995b). Thus, CORT
appears to increase the CRH signal in the CEA. thereby augmenting amygdala-
modulated fear.
The presence of corticosteroid receptors in CRH-positive neurones in the CEA
(Honkaniemi et al., 1992) suggests that CORT may directly regulate the level of
CRH gene transcription through MR and/or GR in the amygdala. Additionally, there
may be an indirect effect of CORT: the recent discovery of direct innervations from
PVN to CEA (Palkovits et al., 1998), in combination with the opposite effect of
plasma CORT manipulations on CRH mRNA expression observed in the PVN and
CEA, respectively (Makino et al., 1994b; Palkovits et al., 1998), have led to
speculations that this PVN input into the CEA has an inhibitory influence upon CEA
CRH expression.
The CEA also receives input from the BLA. Whereas the BLA is involved in
conditioned fear behaviour (Goldstein et al., 1996), this is probably not the case in
innate fear, which in fact appears to be regulated by an activated CEA (Moller et al..
1997).
A. 4.2.3. 'Emotional memory'
Increasing evidence suggests a role for the amygdala in the formation of 'emotional
memory'. PET-scans of human subjects watching 'emotionally arousing' films reveal
heightened activity in the amygdala. Moreover, three weeks later, a higher number of
'emotionally arousing' films was recollected than of neutral films, and these numbers
correlated positively with PET-scan activity in the amygdala during the viewings
(Cahill et al., 1996). A possible mechanism underlying this correlation is that
glucocorticoids, secreted in response to a stressful, 'emotionally loaded' event,
activate the amygdala, resulting in modulation of memory formation. Indeed,
numerous animal studies by Roozendaal et al have shown that GR agonists
administered systemically (Roozendaal and McGaugh, 1996), intrahippocampally
(Roozendaal and McGaugh, 1997a) or into the BLA (Roozendaal and McGaugh,
1997b) immediately posttraining in an inhibitory-avoidance task enhance memory,
and that this effect requires an intact BLA (Roozendaal and McGaugh, 1996).
Similarly, BLA-lesions block learning deficits in a water maze task resulting from
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pretraining i.e.v. administration of antiglucocorticoids or as a consequence of ADX
(Roozendaal et al., 1996). BLA-lesions alone however, do not impair memory
retention (Roozendaal and McGaugh, 1996), suggesting that the BLA modulates
memory consolidation in other brain regions, such as the hippocampus (Quirarte et
al., 1997). Indeed, although BLA-lesions block the memory-impairing effects of
ADX in a spatial watermaze task, they do not affect ADX-induced dentate gyrus
damage in the same animals (Roozendaal et al., 1998).
Summarising, increasing evidence suggests that the amygdala, via the CEA.
modulates neuroendocrine as well as behavioural responses to stress, and, through
the BLA. also plays a role in glucocorticoid-induced memory modulation. Taken
together, it can be postulated that the amygdala is a critical site for integrating and
interpreting incoming sensory signals, thus playing a role in the perception of fear
and in modulation ofmemory storage of aversive events. This continuous evaluation
of incoming information by the amygdala and the concomitant anticipatory
behavioural and endocrine responses can be considered an allostatic mechanism
(Schulkin et al., 1994).
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B. Development and programming of HPA-axis, brain
corticosteroid receptors and behaviour
B.l. Introduction
The components of the fetal HPA-axis are functional during late gestation, although
developmental changes still take place in the postnatal period (Grino et ah, 1995;
Sapolsky and Meaney, 1986). HPA-activity during late gestation is represented by a
gradual increase in fetal plasma ACTH levels, stimulated by signals from pituitary
and placenta as well as from intrahypothalamic excitatory amino acids. This rise in
plasma ACTH is followed by an increase in CORT concentrations (Brooks et al.,
1996). The concomitant rise in ACTH and CORT during this period indicates the
absence of negative feedback regulation at this time. The sensitivity to negative
feedback regulation by circulating glucocorticoids develops postnatally, increasing
with age (McEwen et al., 1986; Meaney et al., 1985). Relatively high HPA-activation
during the late fetal period is followed by reduced activity after birth, resulting in a
marked suppression from around postnatal day 4 until postnatal day 14. This period
is known as the stress hyporesponsive period (SHRP) (Goldman et al., 1973;
Sapolsky and Meaney, 1986; Walker et al., 1986). During the SHRP, most stressors
evoke only a blunted HPA response, although the HPA axis is capable of eliciting an
adult-like response to specific stressors (Walker et al., 1991). It was thought that this
intriguing phenomenon might serve to protect the neonate from anti-proliferative
effects of high levels of glucocorticoids during a critical time in development.
The physiological relevance of low HPA-activity during development has become
clear from studies that investigated the effects of corticosteroids on neural
development. Exposure to high levels of glucocorticoids in particular can have
catabolic effects that interfere with brain growth and cell proliferation (Cotterrell,
1972; Weichsel, 1974)[for review see (Meyer, 1985)]. On the other hand, they are
known to play an organisational role in neuronal development by acting as a
differentiating signal as well as by stimulating synaptogenesis and regulating cell
signalling (Slotkin et al., 1993; Slotkin et al., 1998; Takahashi and Goh, 1998)[for
review see (Meyer, 1985)]. Thus, the inhibiting effects of high doses and the
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permissive effects of moderate doses of glucocorticoids indicate the importance for
normal neuronal development of keeping glucocorticoid concentrations within
closely regulated limits.
Brain MR and GR levels, important in the regulation ofHPA-activity, follow distinct
developmental patterns. In early gestation both types of corticosteroid receptors are
not expressed. Increases in receptor levels from midgestation onwards are the result
of both an increase in the number of expressing cells and an increased expression per
cell (Bohn et al., 1994; Rosenfeld et ah, 1988a).
MR mRNA has not been detected until the last week of gestation (Brown et ah, 1996;
Diaz et al., 1998), with high levels at birth (Bohn et al., 1994). Immunocytochemistrv
studies showed that the high perinatal levels of MR immunoreactivity are followed
by a sharp decline around pnd 10, after which immunoreactivity gradually increases
until adult levels are reached around the time of weaning (Lawson et al., 1991). MR
binding however is only detectable from pnd 8 (Rosenfeld et al., 1988b) at which
time it has adult characteristics regarding affinity and capacity. The discrepancy
between binding studies and mRNA expression can be explained by the fact that
binding studies require prior ADX, which may influence receptor levels.
Furthermore, binding studies measure functional receptors, whereas mRNA
expression studies do not take into account possible posttranscriptional and
posttranslational mechanisms that may determine the number of functional receptors.
GR mRNA expression has been demonstrated in rat brain from midgestation onwards
(Diaz et ah, 1998; Kitraki et al., 1996). GR immunoreactivity develops 1 or 2 days
later (Cintra et al., 1993). The signal increases to high levels perinatally (Bohn et al.,
1994), and a drop in GR mRNA expression and immunoreactivity is noted around
pnd 10-12 (Lawson et al., 1991; Rosenfeld et al., 1988b; Rosenfeld et al., 1988c),
although not in every study (Kalinyak et al., 1989). GR binding and
immunoreactivity then gradually increase until adult levels have been reached around
pnd 21 (Rosenfeld et al., 1988b; Rosenfeld et al., 1988a). Unlike in the adult animal,
GR expression during development does not seem to be subject to autoregulation.
For example, DEX-binding at pnd 10 is not altered by five days of either ADX or
CORT-treatment (Meaney et al., 1985), and DEX failed to regulate GR mRNA
expression in the early neonate (Kalinyak et al., 1989). Furthermore, after the SHRP
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both GR number and circulating CORT levels increase in parallel. Thus, the potential
for autoregulation seems to develop gradually with age.
In conclusion, the brain and the components of the HPA-axis are developing in utero
until weeks after birth. The plasticity of these developing systems becomes evident
when investigating the effect of environmental events that take place during these
periods on their physiological or behavioural endpoints. How early life events,
especially the intensively-studied prenatal stress paradigm, alter the development of
the HPA- and behavioural responses to stress is described in the following
paragraphs.
B.2. Prenatalprogramming ofHPA axis and behaviour
B.2.1. Introduction
Developing physiological systems are sensitive to outside influences. The androgenic
hormonal status in utero for example, can determine within a specific developmental
stage or 'time window' the development of brain and body in a 'male' or a 'female'
direction (O'Riordan et al., 1988).
The HPA-axis is another well-known example of systems of which the 'setpoint' can
be altered by early life events. One of the most intensively investigated early life
manipulations of this system is prenatal stress. In this paradigm, a pregnant dam is
exposed to stress, and effects of this manipulation are studied in the offspring. These
effects are described in the next paragraphs. In short, prenatal stress has been shown
to have profound effects on offspring sexual development and behaviour, hormonal
and behavioural responses to stress and brain development, although results of
different studies can be variable or even contradictory. This is probably due to high
variability between studies in timing, duration and type of stressor applied during
pregnancy (Fride and Weinstock, 1984). Many behavioural abnormalities associated
with prenatal stress are also seen in humans [see (Weinstock et al., 1988; Weinstock,
1997)], although these studies are mostly retrospective.
In many studies birthweight of prenatally stressed rats was lower than that of control
offspring (Kinsley and Svare, 1986; Peters, 1982; Takahashi et al., 1988; Williams et
al., 1998), and in humans, maternal stress during the third trimester of pregnancy was
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associated with a decrease in infant birthweight (Sandman et al., 1997). Low
birthweight has been linked with an increased risk of hypertension, coronary heart
disease, glucose intolerance and non-insulin-dependent diabetes mellitus. in
epidemiological human studies (Barker, 1995; Fall et al., 1995; Hales et al., 1991;
Stein et al., 1996) as well as in animal models (Langley and Jackson, 1994; Levitt et
al., 1996; Lindsay et al., 1996a, 1996b; Nyirenda et al., 1998). It is unlikely that low
birthweight per se causes this increased risk. Rather, there may be a common factor
that influences birthweight as well as the setpoint of other physiological systems (see
section B.3). The concept of a (non-genetic) factor early in life imprinting on
physiological systems, such as in prenatal stress, is known as 'prenatal
programming'.
The biological relevance of prenatal programming appears to be that plasticity of a
physiological system allows environmental factors to 'hard-wire' that system in
order to prepare the unborn animal for unfavourable environmental conditions in
which it will grow up and spend its adult life. Thus, prenatal programming can be
considered to be an allostatic mechanism. However, if the environmental
circumstances in later life are not as anticipated, programming can have adverse
effects and ultimately even lead to disease.
B.2.2. Prenatal stress: effects on HPA-activity
B.2.2.1. During pregnancy
Few studies have investigated the fetal and maternal HPA-responses to maternal
stress, but most (Barbazanges et al., 1996; Holson et al., 1995; Ohkawa et al., 1991;
Takahashi, 1998; Williams et al., 1999) found that maternal CORT levels remain
elevated after repeated stress, suggesting that the HPA-axis of pregnant rats did not
adapt to chronic stress in these experiments. Furthermore, fetal and maternal plasma
CORT levels were positively correlated (Takahashi, 1998). Importantly, ACTH
levels were also elevated in fetuses exposed to maternal stress. Because maternal
ACTH cannot pass the placenta (Dupouy et al., 1980), ACTH measured in fetal
plasma must be of fetal origin. Indeed, the same study found a decrease in fetal
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pituitary ACTH-content (Ohkawa et al., 1991). This implies that the fetal HPA-axis
is actually capable of responding to maternal stress, although different stress
paradigms may result in different response patterns in the fetus (Weinstock et al.,
1988). However, although the fetal HPA-axis is active by the end of gestation
(Brooks et al., 1996) and capable of secreting CORT, a substantial part of CORT
measured in fetal plasma is likely to be of maternal origin (Beitins et al., 1973;
Zarrow et al., 1970).
Considering the elevated plasma CORT levels in maternally stressed fetuses, a
possible mechanism for the decreased hippocampal corticosteroid receptor binding
capacity often observed in adult prenatally stressed rats could be a permanent
downregulation of those receptors (Sapolsky et al., 1984), initiated by elevated
CORT levels during a critical period in development. Whether this is CORT of
mainly maternal or fetal origin remains to be investigated, although an important
study has revealed that the effects of prenatal stress on offspring HPA-activity and
hippocampal MR binding are dependent upon the stress-induced increase in maternal
CORT levels (Barbazanges et al., 1996).
B.2.2.2. During postnatal development
Studies into the effects of prenatal stress on HPA-activity during the first weeks of
life have shown variable results, depending on the type and timing of the maternal
stress. In some cases, male prenatally stressed rats have elevated basal CORT levels
(Takahashi et al., 1988; Takahashi and Kalin, 1991) up until weaning, whereas in
other cases, no effect of prenatal stress on basal CORT (Fride et al., 1986; Peters,
1982; Henry et al., 1994) or ACTH (Takahashi et al., 1990) was found. Stress-
induced rises in CORT and ACTH are generally found to be higher in prenatally
stressed animals throughout the preweaning period (Fride et al., 1986; Peters, 1982;
Takahashi and Kalin, 1991), thus interfering with the SHRP normally seen in rats
roughly between pnd 4 and pnd 14. Young prenatally stressed animals typically also
have higher post-stress CORT levels compared to control animals (Henry et al.,
1994; Takahashi and Kalin, 1991; Weinstock, 1997).
Hippocampal MR and GR binding is lower compared to controls in prenatally
stressed rats at the time of weaning, but not on pnd 3 (Henry et al., 1994). Thus, the
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increase in plasma CORT levels (already observed on pnd 3) in this study preceded
the changes in hippocampal MR and GR binding. It is possible that the apparent
absence of an SHRP, and thus elevated HPA activity in neonatal life, in these
prenatally stressed rats in some way underlies the altered development of
hippocampal MR and GR numbers, although (negative) autoregulation of GR does
not appear to take place until after weaning (Kalinyak et al., 1989; Meaney et ah,
1985).
B.2.2.3. In adult rats
Prenatal stress has long-lasting effects on offspring's HPA-axis. These effects are
more marked in females than in males (McCormick et ah, 1995; Weinstock et ah,
1992). For example, basal CORT or ACTH levels in adult prenatally stressed male
rats are unchanged compared to control rats in many studies (Barbazanges et ah,
1996; McCormick et ah, 1995; Stobr et ah, 1998; Takahashi et ah, 1992a; Vallee et
ah, 1996; Vallee et ah, 1997; Weinstock et ah, 1992), but increased in females
(McCormick et ah, 1995; Weinstock et ah, 1992). Stress-induced CORT levels
however, are elevated in both male and female prenatally stressed rats in most
studies (Henry et ah, 1994; Weinstock et ah, 1992), especially in post-stress samples
(Barbazanges et ah, 1996; Maccari et ah, 1995; Vallee et ah, 1996; Vallee et ah,
1997; Weinstock et ah, 1998), indicating an impaired negative-feedback regulation.
Although the effect of prenatal stress in rats is generally a hyperactive HPA-system,
inconsistencies between studies investigating prenatally stressed effects on HPA-
activity can be explained in terms of type, timing and predictability of the prenatal
stress, as well as the stress paradigm and timing of the bloodsampling used when
testing the offspring.
Several groups have shown that prenatal stress causes alterations in hippocampal
corticosteroid binding sites: permanently decreased MR capacity in prenatally
stressed males (Barbazanges et ah, 1996; Henry et ah, 1994; Maccari et ah, 1995;
Vallee et ah, 1997), and decreased DEX-binding in females (Weinstock et ah, 1992)
have been observed. Hippocampal MR are involved in the control of basal HPA-
activity and possibly also in the negative feedback regulation after stress (Dallman et
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al., 1992; Ratka et al., 1989). Thus, a permanently reduced number of hippocampal
MRs could be responsible for the increased poststress CORT levels observed in adult
prenatally stressed animais. However, because corticosteroid receptors in adult rats
are subject to autoregulation (Sapolsky et al., 1984), it is unclear whether increased
CORT levels in prenatally stressed rats are actually the cause or the consequence of
decreased hippocampal corticosteroid receptor levels. Moreover, the mechanism
behind the decreased hippocampal receptor levels in prenatally stressed rats remains
unclear. As mentioned earlier, increased CORT levels in utero could permanently
alter the transcriptional level of corticosteroid receptors. Alternatively, they may
influence developing monoaminergic systems which in turn regulate brain MR and
GR expression [see (Kabbaj et al., 1995; Kabbaj et al., 1996; Maccari et al., 1992b;
Seckl et al., 1990; Yau et al., 1992; Yau and Seckl, 1992)].
B.2.3. Prenatal stress: effects on behaviour
Prenatally stressed rats have often been described as having 'higher emotionality'
(Fride et al., 1986). This conclusion stems from early open-field studies, where
prenatally stressed rats typically show decreased locomotion and increased
defecation (Fride et al., 1986; Pfister and Muir, 1992; Wakshlak and Weinstock,
1990)[see also (Weinstock et al., 1988)]. However, higher initial open-field activity
has also been observed (Vallee et al., 1997), and this was explained as prenatally
stressed rats having a higher level of escape behaviour, thus underlining the difficulty
in interpreting animal behaviour. Furthermore, Vallee et al. showed avoidance of
anxiogenic places in prenatally stressed animals, indicated by a low number of visits
to the open arms on an elevated plusmaze (Vallee et al., 1997). Both types of
behaviour were positively correlated with plasma CORT levels. These data, in
combination with a reduced propensity to play and an increase in defensive freezing
(Takahashi et al., 1992a; Takahashi et al., 1992b), reduced activity in an activity
wheel (Lambert et al., 1995), and increased ultrasonic vocalisations in an open field
(Williams et al., 1998b), led to the conclusion that prenatal stress causes behavioural
suppression or increased anxiety in aversive situations. Interestingly, central CRH
administration causes hyperanxiety-like behaviour similar to that seen in prenatally
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stressed rats (Dunn and Berridge, 1990). Considering the role of the amygdala in this
type of behaviour, it is tempting to speculate that the level of or sensitivity to CRH in
the amygdala may be increased in prenatally stressed rats, resulting in a
'hyperemotional' state and reduced coping ability.
Cognitive abilities are also affected by prenatal stress. Acute and repeated prenatal
stress reduced memory in an operant discrimination task (Grimm and Frieder, 1987).
Furthermore, prenatal stress alters behaviour in a watermaze test: prenatally stressed
rats spend more time looking for the platform in a reversal task in a watermaze-test
in two studies (Hayashi et ah, 1998; Szuran et ah, 1994), indicating improved
memory or altered search strategy. However, a third study failed to find a prenatal-
stress effect on watermaze performance (Vallee et ah, 1997). The amount of CORT
secreted during the learning phase of this test may be of influence on retention
expression, as only training in cold water (12°C) revealed differences between
prenatally stressed and control rats (Szuran et al., 1994).
Because brain neurotransmitter systems and glucocorticoids interact to modulate
both behaviour and HPA-activity (McEwen, 1987), it is possible that the effects of
prenatal stress on these two parameters are mediated by prenatal stress-induced
alterations in these systems. Indeed, prenatal stress alters brain 5-HT, NE and DA
levels and turnover (Hayashi et ah, 1998; Peters, 1982; Takahashi et ah, 1992a),
stress-induced hippocampal ACh levels (Day et ah, 1998), and decreases synaptic
density in the hippocampus, which is known to be regulated by 5-HT (Hayashi et ah,
1998). Furthermore, in humans prenatal stress has been suggested to increase the risk
of developing schizophrenia (van Os and Selten, 1998), a putative
neurodevelopmental disorder that is associated with alterations in brain monoamine
levels.
In conclusion, there is accumulating evidence to suggest that prenatal stress
programs the HPA-axis as well as behaviour, and that plasticity of developing brain
monoamine systems may underlie these changes. Ultimately, prenatal stress results
in impaired coping and increased anxiety. Disturbances in HPA-regulation and brain
monoamine levels have been associated with affective and anxiety disorders in
humans (Holsbor and Barden, 1996; Lopez et ah, 1998), suggesting that such
conditions may be (partially) prenatally programmed. The mechanism underlying the
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changes resulting from prenatal stress has not been convincingly established. In the
search for a 'programming factor' imprinting on the development of fetal tissues, two
major hypotheses have arisen which will be discussed in the next paragraphs.
B.3. Mechanisms ofprogramming
B.3.1. Glucocorticoids
Because an important feature of the stress response is the secretion of high levels of
CORT, this steroid has become an obvious candidate for the role of 'programming
factor' in the prenatal stress paradigm. Moreover, prenatal glucocorticoid exposure
has recently been implicated in the development of hyperglycaemia and
hypertension, and may represent the epidemiological link observed between these
disorders and low birth weight. Experiments describing the effects of injecting
pregnant rats with dexamethasone (DEX), corticosterone (CORT) or ACTH have
shed some light on the involvement of prenatal glucocorticoid exposure in fetal
programming.
Daily administration of ACTH in the last week of pregnancy resulted in altered brain
monoaminergic activity, reduced adrenal weight in combination with elevated basal
CORT but reduced stress-induced CORT levels in plasma (Fameli et al., 1994).
Similar to prenatal stress, prenatal ACTH injections had stronger effects in female
than in male rats and caused an inability to adapt appropriately to stressful situations.
Because ACTH does not pass the placental barrier (Dupouy et al., 1980), prenatal
ACTH probably acts by increasing maternal CORT production. This has been tested
by studying the effects of CORT administration to pregnant rats on their offspring. In
two studies rats were injected with 21-28 mg CORT daily in the second (Lee and
Rivier, 1992) or third (Holson et al., 1995) week of pregnancy, but in neither study
was offspring HPA activity affected. In contrast, a third study administered a much
lower dose of CORT (9 mg/day) to adrenalectomised dams following daily restraint
procedures and observed effects identical to those of prenatal stress (Barbazanges et
al., 1996).
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Many more studies have been performed looking at the effects of prenatal exposure
to the synthetic glucocorticoid DEX. A large number of animal studies have
described the effects of DEX on normal growth and proliferation. Decreased brain
weight is a well-established consequence of perinatal DEX administration (Benesova
and Pavlik, 1989; DeKosky et al., 1982; Ferguson and Holson, 1999; Slotkin et al.,
1993; but also Holson et al., 1995), and prenatal DEX administration on GD 17, 18
and 19 has been shown to influence brain development by altering the induction of
nuclear transcription factors such as c-fos and AP-1 (Slotkin et al., 1998). Brain or
hippocampal weights are rarely measured in prenatal stress studies, but Szuran et al
showed decreased hippocampal wet weight in prenatally stressed males and females
(Szuran et al., 1994). Furthermore, prenatal DEX-administration consistently reduces
birth weight (Benediktsson et al., 1993; Celsi et al., 1998; Holson et al., 1995; Levitt
et al., 1996; Muneoka et al., 1997; Slotkin et al., 1993), and perinatal DEX exposure
is associated with (mostly transiently) reduced body weight (Dekosky et al., 1982;
Ferguson and Holson, 1999, Muneoka et al., 1997; Slotkin et al., 1993). In addition,
prenatal exposure to DEX increases blood pressure (Benediktsson et al., 1993; Celsi
et al., 1998) and exposure only in the last week of pregnancy programs glucose
intolerance (Nyirenda et al., 1998). This has led to the suggestion (Edwards et al.,
1993) that prenatal glucocorticoid exposure may explain the link between low
birthweight and later hypertension and diabetes found in epidemiologial studies [e.g.
(Barker, 1995; Hales et al., 1991)].
A preliminary human study showed that prolonged prenatal low-dose DEX exposure
did not affect cognition scores, but increased scores for shyness, internalising,
avoidance, emotionality and decreased scores for sociability (Trautman et al., 1995).
The similarities with prenatal stress-effects in rats are striking (Takahashi et al.,
1992a; Takahashi et al., 1992b; Vallee et al., 1997; Weinstock, 1997). Alterations in
brain monoamine systems may play a role in these effects on emotion. Indeed, late
gestational DEX administration reduces brain 5-HT and DA turnover and elevates
NA contents (Muneoka et al., 1997).
Behaviour in an open field was unaltered in offspring from mothers treated with
DEX in the last week of pregnancy compared to offspring of untreated dams (Hoison
et al., 1995). In a different study however, DEX was only administered on GD
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(gestational day) 17, 18 and 19 and offspring was compared to offspring of vehicle-
treated dams. Here, an increased activity in an open field was observed in
combination with reduced defecation, suggesting specific time windows for the
effects of prenatal treatments as seen previously in prenatal stress procedures
(Muneoka et ah, 1997). However, this altered behaviour in an open field-test is
actually opposite to what is usually observed in prenatally stressed rats (Fride et ah,
1986; Wakshlak and Weinstock, 1990)[see also (Weinstock et al., 1988)]. In
contrast, the effects of prenatal stress on male sexual behaviour could be imitated by
injections with DEX in the last week of pregnancy, but not with CORT or ACTH
(Holson et al., 1995). In the few studies investigating the effects of DEX-injections
on HPA-activity, basal (Levitt et al., 1996; Muneoka et al., 1997), but not stress-
induced (Holson et al., 1995) plasma CORT levels appear to be increased as a result
of DEX-administration in the last week of pregnancy.
Summarising, prenatal DEX exposure clearly has programming capacities, acting
centrally as well as peripherally. The effects of prenatal high endogenous
glucocorticoid levels are less clear-cut and this raises the question whether maternal
glucocorticoids reach the fetus to the same extent as DEX does. This question will be
discussed in more detail in part C of this chapter.
B.3.2. Prenatalfood restriction
The hypothesis of fetal (or maternal) undernutrition is based on the rationale that the
fetus adapts to poor in utero energy availability by changing the set point of systems
involved in metabolism. However, these permanent changes may be
counterproductive if nutrition in the postnatal environment is normal and may
ultimately even lead to disease. The relevance of this theory for HPA programming
may lie in the capacity of glucocorticoids to regulate body weight and food intake
(Spinedi and Gaillard, 1998; Tempel and Leibowitz, 1994), and effects of altered
glucocorticoid levels due to nutritional programming on other parameters such as
behaviour and learning may occur as a 'side effect'.
Food restriction or reduced protein intake during pregnancy programs offspring birth
weight and blood pressure (Langley and Jackson, 1994; LangleyEvans, 1997;
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Woodall et al., 1996). A correlation between maternal nutritional status during
pregnancy and childhood blood pressure has also been observed in humans (Godfrey
et ah, 1994). Moreover, there is epidemiological evidence from persons conceived
during the Dutch Hunger Winter of 1944-1945 that prenatal food restriction may be
involved in obesity (Susser and Stein, 1994), glucose intolerance (Ravelli et al.,
1998) and even in the origin of (some cases of) schizophrenia (Susser et al., 1996).
Furthermore, early malnutrition reduces brain DNA content in children (Winick,
1971). Only one study has investigated stress-induced behaviour in prenatally
protein-restricted rats, and found decreased anxiety or altered behavioural inhibition
(Almeida et al., 1996). Interestingly, changes in behavioural suppression are also
found in prenatally stressed rats (Weinstock, 1997), and stressed pregnant rats have
been shown to eat and drink less than unstressed pregnant rats (Kinsley and Svare,
1986).
B. 3.3. A common mechanism?
The similarities between the effects of prenatal DEX-injections and prenatal
malnutrition or protein restriction, especially peripherally, suggest a common
mechanism underlying these effects. One possibility is that DEX-injections reduce
food intake in pregnant rats. Alternatively, food- or protein restriction could activate
the dam's HPA-axis, thereby increasing CORT levels, as has been shown in primates
(Recabarren et al., 1998), which in turn affect fetal development. In rats, HPA
activation by undernutrition occurs at least in non-pregnant animals (Jacobson et al.,
1997). A mutual interaction is not unlikely, since endogenous CORT is known to
modulate food intake through its receptors, and increased energy requirement results
in increased CORT levels (Tempel and Leibowitz, 1994). Accordingly, prenatally
stressed rats, which have increased stress-induced HPA-activity (Henry et al., 1994),
are lighter than control rats at 5 months of age and have reduced food intake (Vallee
et al., 1996).
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B. 4. Interactions with the postnatal environment
It has been suggested that postnatal and later environmental events might modulate
the effects of prenatal programming. Lifestyle factors such as smoking, exercise and
diet clearly influence blood pressure and blood glucose levels. Where brain and HPA
axis are concerned, early manipulations such as handling (Smythe et al., 1994;
Wakshlak and Weinstock. 1990) and adoption (Maccari et al., 1995) reverse at least
some of the effects of prenatal stress. This implies that postnatal manipulations and
prenatal stress have at least some common neural targets on which they have
opposite effects at different timepoints. Alternatively, it is possible that the effects of
prenatal stress extend into the postnatal period and thus can be prevented or
modulated by events within that same period. Interesting in this respect is the
observation that an estimated 80% of hippocampal DG cells are formed in the first
postnatal week (Takahashi and Goh, 1998).
Maternal behaviour is known to influence offspring HPA-activity and anxiety levels
(Caldji et al., 1998; D'Amato et al., 1998). In fact, the effects on offspring of
neonatal handling are due to increased licking/grooming of pups by the dam, initiated
by the short daily separations that characterise the neonatal handling procedure (Lee
and Williams, 1974), since the offspring of undisturbed mothers that have a naturally
high licking/grooming behaviour are indistinguishable from handled rats (Liu et al.,
1997). Moreover, stroking pups during a maternal deprivation procedure can abolish
the effects of long-term maternal deprivation (van Oers et al., 1998), whereas
maternal treatment with anxiolytics upon daily neonatal handling of the pups
reverses the effects of the handling procedure on offspring emotionality (D'Amato et
al., 1998). Thus, it may be possible that maternal stress during pregnancy has its
effects through altered maternal behaviour in the early neonatal period, and that
environmental manipulations during that period also influence maternal behaviour.
At present it is not known whether stress during pregnancy does alter maternal
behavioural patterns, although one paper suggested that at least the duration of
anogenital licking of pups does not differ between previously stressed and unstressed
mothers (Melniczek and Ward, 1994). Interestingly however, early adoption
increases maternal licking behaviour and its effects on offspring HPA-activity are
irrespective of the dams' experiences during pregnancy (Maccari et al., 1995),
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indicating that possible stress effects on maternal licking behaviour are reversed by
cross fostering of offspring at birth.
Additionally, stress during pregnancy and/or postpartum manipulations could alter
the hormonal status of the dam's milk, and this in turn might influence the offspring's
HPA-axis. Unpredictable stress to dams has been shown to increase plasma CORT
levels up to 3 weeks after parturition [see (Weinstock, 1997)], which may be
reflected in high levels of CORT in milk. However, when lactating dams are
administered CORT through drinking water, their offspring's basal and stress-
induced CORT levels are actually lower than those of control offspring from pnd 16
onwards, rendering it unlikely that prenatal stress effects on plasma CORT levels are
indirectly caused by increased CORT levels in the mothers' milk (Catalani et al.,
1993).
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C. The feto-placental barrier
C.l. 11 j3-Hydroxysteroid dehydrogenase
As discussed earlier, maternal glucocorticoids are thought to, at least partly, underlie
the effects of prenatal stress on the fetus (Barbazanges et al., 1996). The fact that
glucocorticoids are highly lipophilic and therefore easily cross the placenta has
contributed to this hypothesis. Indeed, many studies into the consequences of
prenatal glucocorticoid exposure refer to a 1970 study by Zarrow (Zarrow et al.,
1970), which claims to show the passage of uC-CORT from the rat mother to the
fetus. However, this study, in which mothers were injected with 14C-CORT, only
measured the amount of radioactivity that had passed from mother to fetus, assuming
it was still incorporated into CORT. The possibility that part of the radiolabel might
have been incorporated into CORT-metabolites was not considered.
It is now well established that a CORT-metabolising enzyme is in fact found in the
placenta (Brown et al., 1993, 1996; Lakshmi et al., 1993), as well as in many other
organs (Monder, 1991; Walker et al., 1992). This 11 (3-hydroxysteroid dehydrogenase
(lip-HSD) protein catalyses the interconversion of CORT and Cortisol into 11-
dehydroCORT and cortisone, respectively (Figure 1.2). These metabolites have very
low affinity for corticosteroid receptors and can thus be considered to be 'inert'. In
this way, lip-HSD is thought to regulate corticosteroid access to its receptors. Two
distinct isozymes of lip-HSD have been characterised: the type 1 enzyme (lip-
HSD1) is a widespread NADP(H)-dependent enzyme (Agarwal et al., 1989; Lakshmi
and Monder, 1988) with relatively low affinity for CORT (Km in low micromolar
range), that catalyses in intact cells mainly the reductase reaction (Low et al., 1994a;
Rajan et al., 1996) or is bi-directional (Agarwal et al., 1989). On the other hand, the
type 2 enzyme (11P-HSD2) is an NAD-dependent exclusive dehydrogenase with a






Figure 1.3 Conversion of corticosterone and 11-dehydrocorticosterone by 11(3-HSD.
The crucial role of 11P-HSD in regulating corticosteroid access to MR and GR was
discovered in ALDO-target tissues such as the distal nephron. Plasma levels of active
CORT far exceed those of ALDO, even allowing for the majority of CORT being
bound (and therefore presumed inactive) to CBG and other plasma proteins. In spite
of these differences in concentration and their equal affinity for MR, ALDO and not
CORT binds to MRs in certain tissues. It was revealed that 11P-HSD2 present in
those tissues protects MRs from CORT by inactivating it, thus allowing ALDO
access to the receptor (Edwards et al., 1988). ALDO is itself not a substrate for 11 p-
HSD due to its [1 l-18]hemiacetal bridge. When renal llp-HSD2 is inhibited by
liquorice or its derivatives (Stewart et al., 1987), or in case of a congenital absence of
the enzyme (a syndrome called 'apparent mineralocorticoid excess') (DaveSharma et
al., 1998), CORT is not inactivated and occupies renal MRs, causing overstimulation
of these receptors which results in chronic hypertension (Edwards et al., 1988).
Clearly, MR specificity in vivo is enzyme- and not receptor-mediated (Funder et al.,
1988).
C.2. Placental 11 fi-HSD
The placenta is not an ALDO-target tissue, but placental 11P-HSD2 is thought to
protect the fetus from excessive maternal CORT which, as described earlier, may
have deleterious effects on normal growth and development. Consequently, in human
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term fetuses. 75% of Cortisol is of fetal origin, whereas cortisone is mainly of
maternal origin (Beitins et al., 1973). The fetus itself also expresses 11P-HSD2 in a
region- and time-specific manner (Brown et al., 1996). In addition to its protective
role, feto-placental 11P-HSD2 is thought to locally regulate CORT access to GR in
the developing fetus. A role for this enzyme in regulating CORT access to MR is
unlikely as it is only expressed in high levels until midgestation, whereas MR do not
appear in the fetus until the last few days of gestation (Brown et al., 1996).
Placental lip-HSD activity has been shown to vary greatly between individuals
(Benediktsson et al., 1993), possibly due to differences in the levels of local or
circulating natural regulators of lip-HSD activity (Buhler et al., 1994; Seckl, 1997;
Soilness et al., 1995). Interestingly, activity of placental lip-HSD correlates
positively with birth weight in rats (Benediktsson et al., 1993) and humans (Stewart
et al., 1995) and humans with defective 11P-HSD2 often have low birth weight
(Kitanaka et al., 1996; White et al., 1997). Indeed, inhibition of feto-placental 11P-
HSD by administration of carbenoxolone (CBX) to pregnant rats decreases
birthweight in the offspring, and programs hypertension and hyperglycaemia later in
life (Lindsay et al., 1996a; Lindsay et al., 1996b).
The synthetic glucocorticoid DEX is relatively poorly metabolised by 11P-HSD2
(Kream et al., 1983; Siebe et al., 1993) and as mentioned before, when administered
to pregnant rats it affects a range of developmental processes, resulting in growth
retardation, hypertension, glucose intolerance and HPA-dysregulation (Benediktsson
et al., 1993; Levitt et al., 1996; Nyirenda et al., 1998; Slotkin et al., 1993). Taken
together, this suggests that feto-placental 11P-HSD2 may play an important role in
modulating the programming effects of prenatal glucocorticoid exposure (Edwards et
al, 1993; Seckl, 1997).
C.3. Ontogeny of 11J3-HSD
High levels of 11P-HSD2 mRNA expression have been found in the fetal portion of
mouse placenta until GDI6.5 (Brown et al., 1996). Although residual 11P-HSD2
protein may continue to inactivate CORT in the last few days of gestation, it is likely
that expression of the enzyme is reduced to allow glucocorticoids to act on
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developing fetal tissues. Diaz et al (Diaz et al., 1998) described the expression of
11P-HSD types 1 and 2 in rat brain during fetal development. The type 1 enzyme
mRNA is not expressed until the last week of gestation and activity is very low or
undetectable, whereas high levels of type 2 enzyme mRNA and activity are
expressed from midgestation onwards, reducing strongly in the last week of
gestation, with exception of the thalamus and cerebellum. These patterns of
expression suggest specific time-windows for glucocorticoid effects on the
developing fetus. During midgestation 11P-HSD2 in fetus and placenta could be
protecting the fetus from the growth-limiting effects of maternal CORT by
inactivating it. Indeed, humans with defects in 11P-HSD2 have low birthweight
(White et al., 1997), a feature often seen in animals that have been prenatally
exposed to high glucocorticoid levels. By the end of gestation, when the fetal HPA-
axis is active, glucocorticoids produced by the fetus are essential for differentiational
and maturational processes. During this time window 11 P-HSD 1, the expression of
which may be induced by rising CORT levels (Low et al., 1994b) may ensure the
presence of active glucocorticoids, while discrete localisation of 11P-HSD2
postnatally (Robson et al., 1998) probably acts to restrict glucocorticoid access to
specific brain areas.
The time- and tissue-specific expression of 11 P-HSD during development may, in
addition to different stages of maturity of the fetal target tissues, account for the
variability of prenatal stress effects between studies in which maternal stress is often
applied at different times during pregnancy.
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D. Aim of the study
Numerous studies have described the epidemiological link that exists between birth
weight and later hypertension (Leon et al., 1996), coronary heart disease (Barker,
1995) and glucose intolerance (Leon et al., 1996). This link has been confirmed in
animal studies and can be induced by prenatally exposing animals to the synthetic
glucocorticoid DEX (Levitt et al., 1996; Nyirenda et al., 1998), suggesting that
glucocorticoids in utero may program birthweight and later cardiovascular disease
and glucose intolerance. An alternative hypothesis proposes a role for prenatal
undernutrition or protein restriction in fetal programming (Langley and Jackson.
1994).
The system that controls release of endogenous corticosteroids is the HPA axis and
the activity of this axis is in turn (partly) controlled by the hippocampus. The HPA
axis itself is perinatallv programmable (Henry et al., 1994; Meaney et al, 1989;
Weinstock et al., 1992; Rots et al., 1996), and the hippocampus is particularly
sensitive to perinatal manipulations (Takahashi, 1998). Prenatal stress and maternal
deprivation result in HPA hyperactivity in response to stress, whereas short-term
daily neonatal handling has the opposite effect. These alterations in HPA
responsiveness appear to be associated with alterations in hippocampal corticosteroid
receptor levels. Therefore, the first aim of this thesis was to establish the long-term
effects of prenatal exposure to the synthetic glucocorticoid DEX (figure 1.4) on HPA
activity and regulation. Furthermore, because DEX has been shown to act in a
specific time window on blood pressure and glucose metabolism (Levitt et al., 1996;
Nyirenda et al., 1998), we also investigated whether a similar critical window was
applicable here.
Glucocorticoids play an important role in CNS development: low levels promote
mitosis, myelination and differentiation [for review see (Meyer, 1985)], but the
catabolic actions of high glucocorticoid levels have deleterious effects on normal
neural development. Therefore, it is important that corticosterone levels in utero are
tightly regulated. The CORT-metabolising enzyme 11P-HSD2 present in both
placenta and a range of fetal tissues may act to protect the fetus from adverse effects
by high levels of maternal corticosterone. Inhibition of this barrier results in
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hypertension and glucose intolerance in a similar way to DEX administration in
pregnancy (Lindsay et al., 1996a; Lindsay et al., 1996b). The second aim of this
thesis was therefore to investigate whether inhibition of the enzymatic barrier to
maternal glucocorticoids using carbenoxolone (figure 1.4) has permanent effects on




Figure 1.4. Structures of carbenoxolone (CBX) and dexamethasone (DEX).
Corticosteroids play an important role in cognition and behaviour by binding to their
receptors in specific regions in the brain. The limbic system contains high levels of
receptors and the hippocampus in particular is critically involved in learning and
memory. Thus, corticosteroid modulation of hippocampal activity is thought to
underlie some cognitive processes. The third aim of this thesis was to see if an
altered HPA activity and hippocampal receptor expression resulting from prenatal
glucocorticoid exposure had behavioural consequences. Firstly, the effect of the
prenatal treatments on spatial (watermaze) and non-spatial (forced swim-test)
learning and memory was investigated. Secondly, the animals' behaviour in adverse
environments (open field, elevated plus-maze) was studied. Because the amygdala is
involved in the expression of anxiety and also contains corticosteroid receptors,
changes in this structure resulting from prenatal glucocorticoid exposure may be








This study has important clinical relevance. Long-term DEX therapy is not
uncommon in pregnancies where congenital adrenal hyperplasia is suspected.
Furthermore, short-term administration of DEX is often used perinatally in order to
promote lung maturation in premature babies. Additionally, glucocorticoids are used
as immunosuppressants for a number of maternal inflammatory diseases. The long-
term consequences of maternal or fetal glucocorticoid therapy on the offspring have
received little or no attention. Even subtle alterations in HPA activity and regulation
resulting from prenatal exposure to glucocorticoids may have consequences for
vulnerability to a number of affective disorders. For example, HPA abnormalities
have been observed in depression (Holsboer and Barden, 1996b), schizophrenia
(Jansen et al., 1998) and chronic fatigue syndrome (Demitrack et ah, 1991).
E. Outline of the thesis
Chapter 3 describes the effects of prenatal exposure to glucocorticoids throughout
pregnancy, either by administration of DEX or by inhibition of feto-placental 110-
HSD with CBX, on offspring HPA activity and regulation. In addition, maternal food
intake and weight gain during pregnancy as well as offspring body weight gain were
monitored. In order to establish whether cognitive function of these animals was
affected as a result of the prenatal treatments they were tested for spatial ability in a
Morris watermaze, as described in chapter 4. Because DEX has been shown to act in
a specific time window on blood pressure and glucose metabolism, we investigated
in chapter 5 whether a similar critical window was applicable here. Finally, in
chapter 6, stress-induced behaviour was studied in a number of tests. The
involvement of the amygdala in possible behavioural alterations resulting from
prenatal glucocorticoid exposure was investigated by measuring the expression of
mRNAs for corticosteroid receptors and CRH.
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Chapter 2. Materials and methods
A. Materials
I. Chemicals
Acetic anhydride Sigma-Aldrich Company Ltd., UK
Acetone BDH [Merck Ltd.], UK
Amberlite resin BDH [Merck Ltd.], UK
Amfix fixative H.A. West Ltd., UK
Ammonium acetate Sigma-Aldrich Company Ltd., UK
Ammonium persulphate Sigma-Aldrich Company Ltd., UK
Boric acid Sigma-Aldrich Company Ltd., UK
Bovine serum albumin Sigma-Aldrich Company Ltd., UK
Calcium chloride (CaC12) Sigma-Aldrich Company Ltd., UK
Carbenoxolone Sigma-Aldrich Company Ltd., UK
Cocktail T Sigma-Aldrich Company Ltd., UK
Chloroform/isoamyl (24:1) Sigma-Aldrich Company Ltd., UK
Citric acid Sigma-Aldrich Company Ltd., UK
Corticosterone Sigma-Aldrich Company Ltd., UK
D19 developer Ilford Ltd., UK
Denhardt's 50x Sigma-Aldrich Company Ltd., UK
DEPC Sigma-Aldrich Company Ltd., UK
Dexamethasone Sigma-Aldrich Company Ltd., UK










BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
Sigma-Aldrich Company Ltd., UK
Sigma-Aldrich Company Ltd., UK
Sigma-Aldrich Company Ltd., UK
































BDH, Merck Ltd., UK
Sigma-Aldrich Company Ltd., UK
Sigma-Aldrich Company Ltd., UK
BDH, Merck Ltd., UK
Amersham Pharmacia Biotech UK
Amersham Pharmacia Biotech UK
Kodak
Life Sciences International. UK
Fisher Scientific, UK
Sigma-Aldrich Company Ltd., UK
Sigma-Aldrich Company Ltd., UK
BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
Sigma-Aldrich Company
Promega UK Ltd., UK
Sigma-Aldrich Company
Sigma-Aldrich Company
BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
Sigma-Aldrich Company Ltd., UK
Amersham Pharmacia Biotech UK
Sigma-Aldrich Company Ltd., UK
Promega UK Ltd., UK
Sigma-Aldrich Company Ltd., UK
BDH [Merck Ltd.], UK
BDH [Merck Ltd.], UK
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NICK columns, Sephadex G50
Razorblades
BDH [Merck Ltd.], UK
Bright Instruments Ltd., UK
Whatman Labsales Ltd., UK
BDH [Merck Ltd.], UK
Sarstedt Ltd., UK
Amersham Pharmacia Biotech UK










Adult Wistar rats were obtained from Charles River UK Ltd. All experimental rats
were housed in same-sex groups of 2-4. Animals had ad libitum access to food
(standard rat chow: 56.3% carbohydrate, 18.3% protein, 0.7% NaCl; BS&S Scotland
Ltd. Edinburgh). Rats were maintained under conditions of controlled temperature
(22°C) and lighting (lights on 7:00 h, lights off 19:00 h). All experiments were
performed in accordance with the Animals (Scientific Procedures) Act 1986.
II. Prenatal treatments
Virgin female rats (225 g) were housed with adult male rats. Pregnancy was
confirmed by the presence of a vaginal plug, checked every morning. Pregnant
females were housed individually and randomly assigned to one of four treatment
groups. In each experiment, pregnant rats received daily subcutaneous injections
with 200 pi vehicle solution (4% ethanol in 0.9% saline), 12.5 mg/200 pi
carbenoxolone (CBX), or 100 pg/kg dexamethasone (DEX1-3), respectively,
throughout pregnancy. An additional treatment group received 200 pi vehicle during
the first 2 weeks of pregnancy and 100 pg/kg dexamethasone during the last week of
pregnancy (DEX3).
Body weight and food intake of pregnant rats were measured daily until the day
before expected delivery. A single blood sample was taken from the tail vein (see
below) on day 20 of pregnancy for determination of plasma CORT levels.
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III. Litters
On the day of birth litters were weighed, sexed and culled to 8 pups per litter with a
preference for male pups. Remaining pups were sacrificed by decapitation, their
brains removed and quickly frozen on powdered dry ice and their blood collected for
CORT measurement. Only litters containing 8 pups or more were selected for the
studies. Unless stated otherwise, litters were then left undisturbed until weaning apart
from routine maintenance. After weaning, pups from each litter were housed in
same-sex groups of 2-4 animals and left undisturbed until the time of testing. In a
separate experiment following the same prenatal- and birth protocol, one pup from
each litter was sacrificed at 1 and 2 weeks of age and trunk blood was collected for
determination of plasma CORT concentrations.
IV. Blood sampling
When repeated blood samples were required, rats were handled regularly during the
week before the experiment by the experimenter and habituated to being held inside
a folded tea towel. For blood sampling, rats were taken out of their home cage by the
experimenter, quickly placed inside the folded tea towel and loosely restrained by a
second experimenter. When only one blood sample per rat was required, a second
experimenter held the rats while the first experimenter carried out the sampling
procedure. A small cut was made approximately 1 cm from the tip of the tail, using a
razorblade. Blood was gently pushed out of the tail vein by stroking the tail from the
base to the tip and pressing it slightly just above the cut. Blood was collected in
Microvette tubes, stored on ice until centrifuged at 4°C. Subsequently, plasma was
stored at -20°C until assayed. The complete procedure took place within 2 minutes of
removing the rat from its home cage. Using this method, low unstressed basal CORT
levels could be obtained (0.5-1.5 pg/dl), and the effect of making the first cut on
plasma CORT levels generally disappeared after 90 minutes (Figure 2.1).
Unfortunately however, the volume of plasma obtained using this method was not
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Figure 2.1 Effect of single tail cut on plasma CORT levels.
Plasma CORT levels are back to basal 90 minutes after the cut was made (squares). The effect of a
single tail cut plus 20 minutes restraint is also shown (triangles). Blood samples were taken from a
tail cut, made at time point t=-90.
V. HPA axis activity
To assess circadian variation in basal plasma CORT concentrations, 6 month-old rats
were handled regularly during the week before the experiment. Using the method
described above, blood samples were taken at 08:00 h, 14:00 h and 20:00 h in all
rats. In order to avoid stress induced by making more than one tail cut on one day,
sampling was spread out over several days for each rat. Evening samples were taken
under red-light illumination.
Stress-induced activation of the HPA axis in adult rats was determined using a
restraint procedure. Two versions of this procedure were used. In the first version, a
blood sample was taken at 8:00 h for determination of basal CORT levels ('t=-120').
Rats were then left undisturbed in their home cages for 2 h. A second plasma sample
was taken ('t=0'), immediately after which rats were placed in a Perspex cylinder for
20 minutes. Upon termination of the restraint procedure, rats were placed back in
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their home cages. Further plasma samples were taken at the following time points:
t=15, t=30, t=45, t=60, t=90, t-120, t=150.
In a second stress-experiment, a blood sample was taken at 9:00 h for determination
of basal CORT levels. Rats were then left undisturbed for 3 hours, after which they
were restrained in Perspex cylinders for 20 minutes. A second plasma sample was
taken 10 minutes into the restraint procedure. Upon removal from the tube, rats were
placed back in their home cages and were not disturbed until a third blood sample
was taken 90 minutes after the restraint, to measure post-stress CORT levels.
In a separate experiment, we determined the sensitivity to the suppressive effects of
DEX on stress-induced CORT secretion. Thus, rats were given a single bolus of
DEX (40 pg/kg) s.c. before the first blood sample was drawn, using the procedure
described above. This dose was chosen because it has been shown not to suppress the
HPA axis completely and was thought to be suitable for detecting subtle changes in
sensitivity to DEX (Meaney et al., 1989).
VI. Corticosterone assay
Plasma aliquots were freshly thawed for the analysis of corticosterone, using an in-
house specific radioimmunoassay as described previously (MacPhee et al, 1989), and
modified for microtiter plate scintillation proximity assay. Plasma samples were
diluted in borate buffer (135 mM sodium borate (pH 7.4), 0.5% bovine serum
albumin, 1% methanol, 0.1% ethylene glycol, pH 7.4) and heated to 70°C in order to
inactivate plasma proteins. 3H-CORT (s.a. 84 Ci/mmol) and rabbit antirat-CORT
antiserum (kindly donated by Dr C. Kenyon; final antibody dilution 1:10000 in
borate buffer containing 0.01% Na azide) were added to each sample. After a 1-h
incubation at room temperature, a secondary antibody bound to fluomicrospheres
(anti-rabbit SPA reagent) was added. [JH-CORT]-labelled antibody bound to the
secondary antibody is immobilised by the fluomicrospheres, which then emit light as
detected by a p-scintillation counter 24 h later. Samples were assayed in duplicate
and their CORT concentrations estimated by comparison to serial dilutions of CORT
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in duplicate, ranging from 320 to 0.613 nM. using the 1224 Multicalc Software
program. Results are presented as pg/dl plasma. The inter- and intra-assay
coefficients of variation were <10% and <5 %, respectively, whilst the detection
limit was 0.15 ,ug/dl.
VII. In situ hybridisation histochemistry
This technique allows visualisation of the exact cellular and/or structural location of
specific mRNAs (indicating transcription of the corresponding genes) by
hybridisation of a radiolabeled 'antisense' RNA probe to the mRNA of interest.
Labelled RNA 'sense' probes of similar length, nucleotide content and specific
activity were included in each experiment in order to asses the specificity of the
probe and the hybridisation reaction.
Probes
RNA probes for mineralocorticoid receptor (MR), glucocorticoid receptor (GR) and
corticotropin-releasing hormone (CRH) mRNAs were produced in vitro using T3, T7
or SP6 phage polymerase systems. The templates used in this study were a kind gift
from Dr Arriza, San Diego (MR), Dr Miesfeld, San Francisco (GR), and Dr.
Thompson, Portland (CRH), were contained in plasmids (listed in table 2.1) and
where necessary subcloned by June Noble and Karen French. The cDNA fragments
of interest, flanked by T3, T7 or SP6 promoter sequences (table 2.1), were linearised
with the appropriate restriction enzymes (table 2.1). After phenol/chloroform
extraction and ethanol precipitation, 0.5-1.0 pg of linear DNA template was
transcribed by incubation with a ribonucleotide mix (ATP, CTP, GTP, UTP), J5S-
UTP (s.a. 800 Ci/mmol), 6.7 mM DTT, 0.5 pi RNase inhibitor and 1 pi of the
appropriate polymerase (see table 2.1) in a total volume of 10 pi in transcription
buffer (see table 2.1) for 1 h at 37°C (T3, T7) or 40°C (SP6). The proportions of
labelled and cold UTP were adjusted to yield probes of the specific activity required.
Adding 1 pi DNase I for 10 minutes at 37°C degraded the DNA templates, after
which probes were purified using NICK columns (Sephadex G50). For each probe,
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the total activity was estimated by counting 1 jj.1 in a p-counter (minimum activity
• 8
required 2.5x10 cpm/ml), and purity was determined by running 1 pi on a
polyacrylamide gel and exposing the gel to Hyperfilm P-max, which should produce
a single black band on the film. Finally, probes were stored at -20°C for a maximum
of 4 days.










673 Eco RI SP6 40
GR as pGEM3 Pstl-
EcoRI
673 Ava I T7 37
MRs pGEM4 EcoRI 513 Eco RI T7 37
MR as pGEM4 EcoRI 513 Hind III SP6 40
CRHs Bluescript Ks PvuII-
BamHI
518 Hind III T7 37
CRH as Bluescript Ks PvuII-
BamHI
518 Xba I T3 37
Table 2.1 Characteristics of rat GR, MR and CRH riboprobe generation.
s sense; as antisense.
Slide preparation
Before use, glass microscope slides were washed in 0.2 M HC1, DEPC-treated water
(0.1% DEPC in ultrapure water) and acetone for 3 minutes each. Slides were then
subbed in a solution containing 0.03% Na-azide and 15% gelatine and left to dry o/n
at 50°C. The following day, slides were subbed in poly-L-lysine solution (100 mg in
500 ml DEPC-water) for 20 seconds, twice washed in DEPC-water for 10 minutes
and left to dry at 50°C. Dried slides were wrapped in aluminium foil until further use.
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Tissue preparation
Rats were decapitated between 09:00 h and 12:00 h. Brains were removed, rapidly
frozen on powdered dry ice and stored at -80°C. Coronal cryosections (10 pm) were
cut at a temperature of -18°C at the level of the PVN, hippocampus and amygdala
(approx. bregma -2.00 mm, -2.80 mm, -2.30 mm, respectively (Paxinos and Watson.
1986)). Sections were immediately thaw-mounted onto gelatine-subbed, poly-L-
lysine-coated slides and stored at -80°C until further use.
Post-fixation
Slides were kept on dry ice until the start of the post-fixation procedure. Sections
were post-fixed for 10 minutes in pre-chilled 4% paraformaldehyde/0.1 M phosphate
buffer (3.12 g NaH2P04, 11.28 g Na2HP04 in 1 1 DEPC-water, with 40 g
paraformaldehyde added at 80°C), rinsed twice in lx phosphate buffered saline
(PBS, lOx diluted from lOx PBS (80 g NaCl, 29 g Na2HP04.2H2o, 2 g KH2HP04, 2
g KC1 in 1 1 DEPC-water)), acetylated for 10 minutes in 0.1 M triethanolamine (13.3
ml triethanolamine in 1 1 DECP-water, pH 8.0, 0.75 ml acetic anhydride added prior
to transfer of slides), rinsed in lx PBS and dehydrated in 70-95% ethanol solutions.
Pre-hybridisation
For CRH mRNA detection, sections were pre-hybridised with 200 ul/slide buffer (2x
pre-hybridisation buffer consisting of 0.6 M NaCl, lOmM Tris-HCl pH 7.5, lmM
EDTA pH 7.5, lx Denhardt's solution, 0.5 mg/ml denatured salmon sperm DNA and
0.1 mg/ml yeast tRNA diluted 1:1 with formamide (deionised using 10% amberlite
resin) for 3 h at 50°C in humidified boxes (box buffer, 50% deionised formamide,
20% 20x SSC, 30% DEPC-water).
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Hybridisation
Sense and antisense riboprobes were defrosted, added to hybridisation solution
consisting of 50% deionised formamide and 50% 2x hybridisation buffer (10%
dextran sulphate, 0.6 M NaCl, 10 mM Tris-Cl pH 7.5, ImM EDTA pH 7.5. lx
Denhardt's solution, 0.1 mg/ml denatured salmon sperm DNA and 0.1 mg/ml yeast
tRNA), and denatured at 75 °C. Pre-hybridisation buffer was drained from the slides
and probes (10-15 x 10° cpm/ml, 200 pl/slide) were applied to sections and
hybridised overnight at 50°C in humidified chambers (box buffer as above).
RNAse digestion ofunboundprobes
Slides were washed 3 times 5 minutes in 2xSSC and carefully wiped dry around the
sections with lens tissue. RNase A (200 pi/slide, 30 mg/ml in RNase buffer,
consisting of lOmM Tris-Cl pH 7.5, ImM EDTA pH 7.5 and 0.5 M NaCl in
ultrapure water) was applied to the sections and left to incubate for 1 h at 37°C in
humidified (RNase buffer as above) boxes.
Washes and dehydration ofsections
Slides were washed for 15-30 minutes in 2xSSC at room temperature, then twice in
O.lx SSC at 60°C and left to cool down to room temperature. Sections were then
dehydrated through 50%, 70% and 90% ethanol in 0.3 M ammonium sulphate
solutions for 2 minutes each and left to dry.
Visualisation ofpositive areas
Sections were exposed to autoradiographic film (Hyperfilm (3-max) for 7-10 days.
Afterwards, they were individually dipped in NTB-2 photographic emulsion (diluted
1:1 with ultrapure water at 40°C) and exposed in light-tight boxes at 4°C for 21-28
days. They were then developed in D19 solution (diluted 1:1 with water), fixed in
Amfix solution (diluted 1:5 with water) and counterstained with 1% w/v pyronin Y.
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Cellular MR, GR and CRH mRNA expression was quantified by blindly counting
silver grains overlying identified neurones (~10 measurements per subfield in two
replicate sections from each brain area) under bright-field illumination using an
automatic image-analysis system (Seescan). Results were calculated as mean number
of grains/cell area for each subregion after subtraction of background (counted over
areas of white matter), which was always low, so that the number of grains in
expressing cells was higher than 10x background expression. Alternatively, total
mRNA expression per region was determined by measuring optical density (O.D.) of
the relevant area on autoradiograms using a PC-based image analysis package
(MCID, Research Imaging, Canada). Typical expression patterns for MR and GR
mRNA in brain sections taken at the level of the hippocampus are shown in figure
2.2. The advantages and disadvantages of using in situ hybridisation analysis are
discussed in the general discussion (chapter 7).
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Figure 2.2 Typical MR and GR mRNA expression patterns in rat brain at the level of the
hippocampus.
These autoradiographic images show the restricted distribution of MR mRNA when hybridised with
antisense (A) and sense (B) probes. GR mRNA is more widely expressed, as shown by the strong





Rats were tested for their exploratory and anxiety-like behaviour in a large novel
environment. The apparatus consists of an octagonal field with a diameter of 1 m
surrounded by 31-cm high walls. The field was divided into 16 parts: 4 central and
12 peripheral segments. Testing took place in an air-conditioned, reasonably
soundproof, brightly lit room between 9:00 h and 15:00 h. Sixteen hours before
testing, paired-housed animals were transferred in their home cages to a room
adjacent to the testing room. All rats were weighed, as an indicator of their
dominance or subordinance and immediately put in the centre of the open field.
Animals were allowed to explore the field freely for 12 minutes, during which their
behaviour was monitored by a video camera. Following each 12-minute session the
field was thoroughly wiped with ethanol to remove any olfactory cues. The recorded
behaviour was analysed by an experimenter blind to treatment conditions. The
following parameters were considered: (1) total ambulation (expressed as the number
of grids crossed), (2) number of centre entries, (3) time spent grooming, (4) number
of rears and (5) defecation.
VIII2 Elevatedplus-maze test
This test is a common test often used to assess anxiety. It evokes an approach-
avoidance response in rats, based on their natural exploratory drive and their innate
fear of open spaces. Thus, a highly anxious animal will tend to avoid the open arms
on an elevated plus-maze and spend the majority of time on the closed arms (Pellow
and File, 1985, 1986). The elevated plus-maze is a plus-shaped platform made of
black plastic. It consists of two opposing open arms (50 cm x 10 cm) and two arms
of the same size but enclosed by 40-cm high walls. A central area of 10 cm2 connects
all 4 arms. The maze is elevated 64 cm from the floor.
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At the start of the test, a rat was placed in the central area facing one of the open
arms and allowed to explore the maze freely for 10 minutes. During this time, the
following number of open- and closed-arm entries and the time spent on open and
closed arms were determined. This was achieved by computer-controlled (MazeSoft
software, Panlab, Spain) recording of the interruptions of infrared photo beams that
were located at the beginning and halfway each arm. All rats were tested between
9:00 hand 12:00 h.
VIII. 3 Forced-swim test
This test is used to obtain an indication of 'behavioural adaptation' and is regarded as
a test for nonspatial learning. It is based on the fact that a rat will recognise the
inescapability of a situation upon second exposure. A cylindrical bucket (height 40
cm, diameter 35 cm) was filled with 21°C water to a level of 25 cm. In two sessions,
called 'acquisition' and 'retention test', respectively, 24 h apart, rats were placed in
the water and remained there for 10 minutes. During this time, the duration of active
escape behaviour (swimming, diving, climbing) and passive behaviour (floating or
'acquired immobility') was measured. Immobility typically shows after an initial
period of escape behaviour (climbing, struggling, diving) and is thought to reflect the
rats' ability to learn that escape is impossible. When the procedure is repeated 24 h
later (retention test), rats will have retained the acquired immobility and show
passive behaviour earlier than on the first exposure. After the second exposure, a
blood sample was taken from the tail vein to measure corticosterone levels. After
testing animals were thoroughly dried off with a towel and put back in their home
cages. Between six and ten paired-housed rats from each treatment group were
tested, but rats housed together were tested 4 days apart. All testing was carried out
between 9:00 h and 12:00 h.
Villi. 4 Neophagia test
This test is a conflict-based test in which a food-deprived rat has to overcome its
aversion of novel spaces in order to approach food (Britton and Britton, 1981).
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Longer latencies to approach food and start eating reflect increased anxiety. Thus,
rats were deprived of food for 18 hours. Subsequently they were placed in a novel
environment, consisting of a large cage with Perspex walls and no bedding. Around
10 pellets of rat chow were placed in the centre of the cage and animals were allowed
to freely explore the cage and eat the food for 5 minutes. This induced a conflict in
rats between their appetite and novelty-induced fear, such that more fearful rats were
expected to wait longer before moving to the centre of the cage to eat. In order to
control for possible differences in basal appetite between the treatment groups,
separate numbers of rats from each treatment group were provided with the same
amount of food in their home cage. The experimenter observing the animals was
unaware of their prenatal treatments. The following parameters were recorded:
latency to approach the food, number of approaches, eating latency and time spent
eating. All testing was carried out between 9:00 h and 12:00 h.
VIII. 5 Watermaze test
Spatial learning and memory is often assessed in a watermaze test, introduced by Dr
R. Morris (Morris, 1984). In this test, rats are trained in a circular pool to find a
platform submerged under the water surface on 4 consecutive days (the
acquisition/consolidation compound of the test). On the fifth day, the platform is
removed and the amount of time spent around the former platform location is
recorded (the memory/strategy compound of the test).
Apparatus
The watermaze consisted of a circular pool (0 2 m) filled with water of 26 ± 1°C,
made opaque with latex, that was arbitrarily divided into four quadrants. An escape
platform (0 10 cm), submerged 1.5 cm, was located in the middle of one of the
quadrants. Visual cues (posters) were placed on the walls of the testing room and
remained there for the duration of the test. The rats' behaviour was recorded using a
video camera, connected to a computer analysis system, that was fixed above the
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centre of the pool. Three days before the test started, rats were allowed to habituate
to the water for a period of 2 minutes.
Acquisition procedure
During the acquisition phase of the test, rats were trained to locate the submerged
platform, which was located at the 'north-east' (NE) position for 50% of rats, and
located at 'south-west' (SW) for the other 50%, using visual cues. For each rat, the
platform remained in the same position across trials. Each trial started with the rat
placed into the pool facing the wall of the pool at one of four starting positions. It
was then given 2 minutes to locate the platform. If a rat failed to find it within 120
seconds, the experimenter placed the rat on the platform manually. The rat was left
there for 30 seconds before the next trial began. Each rat was subjected to four trials
per day. The latency to find the platform ('escape latency') was monitored for each
trial as an indicator of spatial learning. At the end of a daily session, the rats were
dried off thoroughly and put back into their home cage. This procedure was repeated
the following 3 days, during which the platform remained in the same position. The
starting position of the rats however, was changed between trials so that each starting
position was used once every day.
Retention test
On the fifth day of the test, the platform was removed and the animals' behaviour
was recorded during a 1-minute free-swim trial (probe test). The following
parameters were recorded: a) latency until the former platform location was reached;
b) number of crossings of the former platform location; c) percentage of time spent
swimming in the quadrant where the platform had been located; d) swim speed; e)




Image analysis: Seescan pic., Cambridge, UK
Image analysis: MCID, Research Imaging, Canada
Elevated Plus-maze: MAZE, Panlab, s.L, Barcelona, Spain
CORT-assay: 1224 Multicalc Software v2.0 (Wallac Software)
Watermaze: HVS image analyser, Acorn Archimedes computer
X. Statistics
Data are presented as mean value per group ± s.e.m. Normally distributed data from
two treatment groups were compared using Student's t-test, data from three or more
treatment groups were compared using ANOVA followed by an LSD test, where
appropriate. Where the normality tests on data failed, an ANOVA on ranks was
performed.
The combined behavioural data from chapter 6 were analysed by multivariate
(factor) analysis using Statistica 5.1 package. This is a statistical approach that
analyses the correlations between variables and tries to detect structure in them by
identifying common underlying dimensions (factors). Thus, factor analysis aims to
reduce the number of variables for a number of new indices that are linear
combinations of the original variables. These indices are then independent from each
other and represent the underlying dimensions of the data.
The principal factors were selected according to an eigenvalue > 1, which means that
factors that accounted for only a small proportion of the total variability were
ignored. The remaining factors were then subjected to a varimax rotation (so that the
relative locations of the factors to each other remained unchanged), in order for their
significance to be interpreted more easily.
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Chapter 3. Effects of prenatal glucocorticoid exposure on
offspring HPA activity (studies with CBX and DEX)
Introduction
Prenatal stress reduces birthweight in rats (Kinsley and Svare, 1986; Takahashi et al.,
1988), and induces permanent effects on offspring sexual behaviour (Holson et al.,
1995), hormonal and behavioural responses to stress (Fride et al., 1986; Henry et al.,
1994; Takahashi et al., 1988; Vallee et al., 1997; Weinstock et al., 1992) and brain
monoamine systems (Day et al., 1998; Peters, 1984; Peters, 1990; Takahashi et al.,
1992a). In general, prenatal stress impairs coping and alters the HPA response in
aversive situations.
The mechanisms underlying the effects of prenatal stress have not yet been
convincingly established. Prenatal undernutrition clearly has programming capacities
(Almeida et al., 1996; LangleyEvans et al., 1996; Woodall et al., 1996), and stressed
pregnant rats eat and drink less than unstressed rats (Kinsley and Svare, 1986).
According to an alternative theory, high levels of the glucocorticoid CORT secreted
in response to stress render maternal CORT an obvious candidate 'programming
factor' in this paradigm. In rats, prenatal exposure to the synthetic glucocorticoid
dexamethasone (DEX) reduces birthweight, affects brain development (Slotkin et al.,
1993) and programs hypertension and hyperglycaemia in adult offspring
(Benediktsson et al., 1993; Nyirenda et al., 1998). Moreover, prenatal glucocorticoid
exposure reduces birth weight in humans [see (Seckl, 1994)] and some preliminary
studies have indicated that even small doses of DEX given prenatally alter
neuropsychological parameters such as emotionality in humans (Lajic et al., 1998;
Trautman et al., 1995).
The fetus is normally thought to be protected from the relatively high levels of
maternal physiological glucocorticoids by llp-HSD2, which catalyses the
conversion of active CORT (Cortisol in humans) into inert 11-dehydroCORT
(cortisone), whereas DEX is a poor substrate for this enzyme (Siebe et al., 1993).
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11 (3-HSD2 is highly expressed in the placenta, as well as in many fetal tissues
(Brown et al., 1996; Stewart et al., 1994). Interestingly, placental 11P-HSD2 activity
correlates positively with birthweight in rats (Benediktsson et al., 1993) and in some
human studies (Stewart et al., 1995). Moreover, humans with mutations of the lip-
HSD2 gene have low birth weight (DaveSharma et al., 1998; Kitanaka et al., 1996;
White et al., 1997). Inhibition of feto-placental lip-HSD by administration of
carbenoxolone (CBX) to pregnant rats decreases offspring birthweight and programs
hypertension and hyperglycaemia later in life (Lindsay et al., 1996a; Lindsay et al.,
1996b) in a similar way to DEX administration.
These data raise the hypothesis that when the feto-placental barrier to maternal
CORT is defective, inhibited or bypassed, the resulting prenatal exposure to
glucocorticoids may cause alterations in HPA activity similar to those seen in
prenatally stressed rats. This hypothesis was tested by injecting pregnant females
with the 11P-HSD inhibitor CBX and investigating the effects of this inhibition on
offspring HPA activity and -regulation. Moreover, in order to establish whether the
effects of CBX were due to overexposure to glucocorticoids, the effect of prenatal




As described in chapter 2. In short, pregnant females injected daily throughout
pregnancy with carbenoxolone (CBX, 12.5 mg/200 pi) or dexamethasone (DEX, 100
pg/kg), dissolved in 4% ethanol-0.9% saline (n=6-8 per group in each of two
separate experiments), or the vehicle solution (controls). Body weight and food
intake of pregnant rats were measured daily. On day 20 of pregnancy a blood sample
was taken from the tail vein (see below) for determination of plasma CORT levels.
Litters
As described in chapter 2. In short, on the day of birth, litters were weighed, sexed
and culled to 8 pups per litter. Remaining pups were sacrificed by decapitation, their
brains were removed and quickly frozen on powdered dry ice and their blood
collected for CORT measurement. Offspring were weighed regularly, starting 4
weeks after birth. In a separate experiment with identical prenatal- and birth
protocols, one pup from each litter was sacrificed at 1 and 2 weeks of age and blood
was collected for determination of plasma CORT concentrations. In addition, brains
from the 1 week-old sacrificed pups were removed and quickly frozen on dry ice.
Blood sampling
As described in Chapter 2. Pilot experiments (chapter 2) showed that using this
method, very low (0.5-1.5 pg/dl) basal morning CORT levels can be obtained.
HPA axis activity
As described in chapter 2. In short, 6 month-old rats were handled regularly during
the week before the experiment. Blood samples were taken at 08:00 h, 14:00 h and
20:00 h, but in order to avoid possible stress induced by making more than one tail
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cut on one day, sampling was spread out over several days for each rat. Evening
samples were taken under red-light illumination.
Stress-induced activation of the HPA axis was determined using a procedure in
which adult rats were restrained in Perspex cylinders for 20 minutes. Plasma CORT
levels were measured in blood samples taken from the tail vein at several times
before, during and after termination of the restraint procedure
In a separate experiment, we determined the sensitivity to the suppressive effects of
DEX on CORT secretion in the rats. Thus, rats were given a single bolus ofDEX (40
pg/kg) s.c., after which the restraint procedure described above was performed.
Corticosterone assay
As described in Chapter 2.
In situ hybridisation histochemistry
In situ hybridisation was performed as described in Chapter 2 on sections taken at the
level of the PVN (adult rats; GR and CRH riboprobes) and hippocampus (pups and
adult rats; MR and GR riboprobes). Equivalent 'sense' probes were included as
controls. MR, GR and CRH mRNA expression was quantified by counting silver
grains overlying identified neurones under bright-field illumination using an
automatic image-analysis system. Results were calculated as mean number of
grains/cell area for each subregion after subtraction of background (counted over
areas of white matter), which was always low.
Statistics
Data are presented as mean value per group ± s.e.m. Data from the three treatment
groups were compared using a one-way or two-way ANOVA followed by an LSD
test, where appropriate. Significance was set at p< 0.05.
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Results
Effects ofdaily injections with CBX or DEX on pregnant rats
Vehicle and DEX treatment were tolerated well. In contrast, multiple CBX injections
in the same region caused sores at the site of injection, but not to a similar extent in
all CBX-injected rats. Thus, in order to avoid distress and possible infection as much
as possible, injection sites were varied daily for CBX rats.
Weight gain as well as food intake during pregnancy were different between the
three groups (weight gain: F2,19=48.98, pO.OOOl; food intake: F2,19=17.02,
pO.OOOl). Both parameters were lower in rats that received daily injections with
CBX or with DEX (Table 3.1). The amount of food eaten per g weight gain during
pregnancy also differed between groups (F2,19=22.97, pO.OOOl), with DEX- but not
CBX- injected rats eating more food per g weight they gained, compared to control
mums. Maternal plasma CORT levels on day 20 of pregnancy were influenced by the
prenatal treatments (H2,i4=12.36, p<0.002) and varied highly in CBX-treated mums.
Levels were higher in CBX-mums than in DEX-injected animals, but neither differed
from concentrations in control dams (Table 3.1).
Total food Total weight Food intake (g) per Plasma [CORTJ
intake (g) gain (g) g weight gain day 20 (pg/dl)
control 483 + 11 128 + 5 3.8 ±0.1 16.6 ±2.5
CBX 421 ± 18** 103 ±7** 4.2 ±0.2 40.0 ± 10.4*
DEX1-3 377 ± 13*** _ _ .***D7±4 6.8 ±0.5*** 3.7 ±0.7
Table 3.1 Effect of treatment on pregnant rats.
Food intake and weight gain were measured daily from day 2 of pregnancy until the day before
delivery. Note the high variation in CORT levels in CBX rats. *p<0.05, versus DEX1-3,** p<0.01,
*** p<0.001, **** pO.OOOl versus control; n=7-8/group for weight gain and food intake; n=5-
6/group for plasma [CORT].
Effects ofprenatal injections with CBX or DEX on offspring
Prenatal injections with CBX or DEX had no effect on gestation length (F2,32=0.51,
p=0.61) or litter size (F2,32=0.72, p=0.49). On the day of birth, plasma CORT
concentrations were different between the three groups (F2,16=13.34, p<0.001): CBX-
offspring had higher plasma CORT concentrations than control pups. However,
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plasma CORT levels taken during the SHRP (see Chapter 1) on pnd 7 and pnd 14 did
not differ between groups (Table 3.2). Furthermore, prenatal treatment with CBX or
with DEX affected birth weight (F2.g2=15.24, p<0.0001). Birth weights were reduced
by 12% and 15%, respectively (Table 3.3). Reduced body weight persisted in DEX
offspring until at least 5 months of age, whereas CBX rats showed catch-up growth





















6.7 ±1.5 1.4 ±0.2
13.1 ± 1.1* 1.4 ±0.3




Table 3.2 Effect of Drenatal injections on gestation length, litter size and Dlasma CORT levels in
pups.
*p<0.01 versus control; n=l 1-12/group for gestation length and litter size, n=6-7/group for plasma
CORT levels.










153 ± 2 261 ± 2 319 ± 4
150 ± 2 255 ± 3 314 ± 4




Table 3.3 Effect of prenatal injections on body weight.
Results are expressed as g bodyweight. *p<0.01; **p<0.005 versus control; n= 18-47/group.
Brain MR, GR and CRHmRNA expression in 1 day and 1 week-old offspring
Slides containing sections of both ages were processed together in two in situ
hybridisation procedures for MR mRNA and two for GR mRNA. Therefore, the
measured expression per neurone is in figure 3.1 expressed as % expression in
control rats.
Hippocampal GR mRNA levels increased by 2-3 fold during the first week of life.
However, prenatal exposure to glucocorticoids had no effect on GR mRNA
expression in male rats of either age (Figure 3.1, top panel).
Hippocampal MR mRNA expression was relatively high in newborn rats and was
decreased slightly in 1 week-old pups. Prenatal treatments had no effect on neuronal
MR mRNA levels in 1 day-old rats' hippocampi, but at 1 week of age a significant
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treatment effect occurred in CA2 (F2.i4=7.58, p<0.05). Post-hoc analysis revealed
that in this region, CBX offspring have higher MR mRNA expression than DEX
offspring (p<0.01), but there are no significant differences compared with control
offspring (Figure 3.1, bottom panel).
Figure 3.1 Hippocampal GR and MR mRNA expression in 1 day-oid and 1 week-old pups.
Data are expressed as % expression in control pups. Open bars control rats, striped bars CBX rats,
closed bars DEX 1-3 rats * p<0.05 versus DEX 1-3 pups; n=5-7/group.
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Brain MR, GR and CRHmRNA expression in adult offspring
Prenatal exposure to glucocorticoids altered GR mRNA expression in PVN of 6
month-old rats (F2,ir=9.73, p<0.01), and post-hoc analysis revealed that prenatal
CBX- but not DEX- injections were associated with a significant decrease in GR
mRNA expression in the PVN (Figure 3.2, left panel; Figure 3.3). ANOVA for CRH
mRNA expression in PVN approached significance (F2.i6=3.00, P=0.07), and figure
3.2 (Figure 3.2, right panel; Figure 3.4) shows a trend in both CBX and DEX
offspring towards increased CRH mRNA expression in PVN that becomes
significant when CBX- and DEX rats are compared to controls separately. Daily
injections with either CBX or DEX had no effect on MR or GR mRNA expression in
any of the hippocampal subfields in 6 month-old rats (Table 3.4).
PVN GR mRNA expression PVN CRH mRNA expression
Figure 3.2 GR and CRH mRNA expression in PVN of 6-month old rats.
Left panel GR mRNA expression; right panel CRH mRNA expression. **p<0.01, n=6-7/group.
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Figure 3.3 Photomicrographs of GR mRNA expression in PVN of 6 month-old rats.
Images show typical sections from animals in each treatment group. A-control, B-CBX, C-DEX1
D-sense. Scale bar represents 200pm.
A B
Figure 3.4 Photomicrographs of CRH mRNA expression in PVN of 6 month-oid rats.
Pictures show typical sections from animals in each treatment group. /1-control, fi-CBX, C-DEX1
D-sense. Scale bar represents 200 pm.
MR mRNA DG CA1 CA2 CA3-4
control 127.9 ± 8.2 103.4 ±3.9 143.7 ±3.7 83.7 ± 3.0
CBX 124.9 ± 10.5 99.1 ±4.7 139.1 ± 1.9 79.9 ±2.2
DEX1-3 124.5 ± 9.5 100.8 ± 1.4 136.3 ±2.5 81.3 ±1.9
GR mRNA DG CA1 CA3 CA4
control 111.3 ±2.9 111.0±3.3 43.0±2.2 33.8 ±1.6
CBX 108.8 ±1.7 103.7 ±4.9 41.6 ± 1.4 34.3 ± 0.7
DEX1-3 109.2 ±2.1 104.9 ± 3.8 43.1 ±2.2 35.0 ±2.2
Table 3.4 Hippocampal MR and GR mRNA expression.
Results are expressed as mean number of grains/cell area ± s.e.m. for each subregion after subtraction
of background; n=7-8/group.
HPA axis activity in adult offspring
a. Circadian variation in plasma CORT levels
A number of samples taken at 14:00 h had CORT levels exceeding those of evening
samples. Further investigation revealed that on some days rats had been fed and
watered shortly before afternoon blood samples were taken. As values resulting from
these particular samples did not reflect basal afternoon CORT levels, they were
excluded from the analysis. Thus, samples sizes being different and multiple plasma
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samples having been taken over several days, an ANOVA for repeated measures
would not be the appropriate statistical method of analysis to use. One-way
ANOVAs for each time point separately showed significant differences in CORT
concentrations measured in morning (8:00 h) (F2,49=3.33, p<0.05) and evening
(20:00 h) (F2.24=7.87, p<0.01) plasma samples, but not in afternoon (14:00 h)
samples (F2,i2=0.07, p=0.93). Post-hoc analysis revealed that both CBX- and DEX-
offspring have elevated basal morning CORT levels, at 0.70 ± 0.13 pg/dl and 0.76 ±
0.10 pg/dl, respectively, compared to controls (0.40 ± 0.07 pg/d0. In contrast, basal
evening CORT levels are lower in DEX rats compared to controls, whereas CBX











Figure 3.5 Circadian variation in plasma CORT concentrations.
Plasma CORT levels, expressed as ug/dl in adult rats prenatally exposed to
CBX (striped bars), DEX (filled bars), or control rats (open bars). *p<0.05,
**p<0.01, n=16-18/group for 8:00 levels, n=5/group for 14:00 and 20:00
levels, n=9/group for 20:00 levels.
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b. CORT response to restraint
Figure 3.6 shows the CORT concentrations in plasma samples taken before, during
and after 20 minutes restraint. Rats prenatally treated with CBX or DEX did not
respond to restraint differently from control rats. However, the maximum CORT
levels measured were high in all groups (55-70 ug/dl), suggesting that ceiling levels
of CORT output may have been reached. Furthermore, 90-150 minutes after
initiation of the restraint procedure, none of the rats' plasma CORT concentrations
had returned to basal levels, indicating that they may have been re-stressed.
Therefore, a simplified version of this test was performed, and the results are shown
in figure 3.7.
Figure 3.6 Plasma CORT response to 20 minutes restraint.
CORT concentrations measured in plasma samples taken before (t=-120; t=0), 15 minutes into
(t=15), and at several time points after (t=30-/50) 20 minutes restraint. n=9/group.
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Figure 3.7 shows the CORT response to 20 minutes of restraint. An ANOVA for
repeated measures revealed a time effect (F2.3o-33.02, p< 0.001), but no group effect,
(F2,15=1 -09, p=0.36). There was a significant groupxtime interaction (F4.3o-3.2,
p<0.05), and post-hoc analysis revealed that post-stress plasma CORT concentrations
were elevated in CBX- but not DEX- offspring compared to control rats (Figure 3.7,
top panel).
c. DEX-suypression ofstress-induced CORT levels
A single bolus of DEX (40 pg/kg) given s.c. 3 hours before start of the restraint
procedure, suppressed the CORT response to a similar extent in the three groups.
ANOVA showed no group effect or groupxtime interaction (Figure 3.7, bottom
panel), although there was a time effect (F?,30-4.66, p<0.05), showing that the dose








Figure 3.7 Plasma CORT response to 20 minutes restraint.
CORT concentrations measured in plasma samples taken before (basal), 5 minutes into (stress), and
90 minutes after (post) 20 minutes restraint (top graph). The bottom graph shows the effect of a single




Prenatal administration of CBX, an inhibitor of 11P-HSD, reduced birth weight and
elevated basal and post-stress HPA activity. These findings are in accord with studies
of prenatal stress, which causes persisting effects in adult life including reduced body
weight and increased HPA activity (Fride et ah, 1986; Takahashi and Kalin, 1991);
(Vallee et ah, 1996; Vallee et ah, 1997), suggesting that a common mechanism may
underlie these effects. Furthermore, prenatal exposure to DEX caused similar
(although not identical) alterations. This indicates that glucocorticoid exposure in
utero may be, at least partly, responsible for the changes observed in CBX offspring.
CBX is a potent inhibitor of 11P-HSD2, which rapidly converts CORT to inert 11-
dehydroCORT (Brown et ah, 1993) and is highly expressed in placenta and ferns
(Brown et ah, 1996). Previous experiments conducted in our laboratory showed that
CBX treatment reduced placental 11 p-HSD activity and increased JH-CORT levels
in fetal tissues (Lindsay et ah, 1996a). Thus, administration of CBX to pregnant
animals is predicted to increase fetal exposure to CORT. Accordingly, in the present
study plasma CORT levels were higher in newborn pups measured within 24 h of the
last CBX-injection than in controls.
Previous studies showed that the effects of prenatal administration of CBX on blood
pressure and blood glucose levels require intact maternal adrenal glands (Lindsay et
al., 1996a, 1996b), and that they can be simulated by prenatal exposure to the
synthetic glucocorticoid DEX (Benediktsson et al., 1993; Levitt et al., 1996;
Nyirenda et al., 1998). This indicates that fetal exposure to maternal glucocorticoids
underlies the changes observed in CBX offspring, as far as blood pressure and blood
glucose levels are concerned. However, because adrenalectomy studies were not
performed, it cannot be excluded that, in the present study, other factors than
increased exposure to maternal glucocorticoids may have contributed to the effects of
prenatal CBX described here. Indeed, prenatal administration of the synthetic
glucocorticoid DEX did not result in identical changes in the parameters studied
here. Several explanations are possible. Firstly, CBX is not an exclusive 11 P-HSD
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inhibitor and therefore may have affected other enzymes such as 3a-HSD (Baker,
1994). The 3a-HSD isozymes are involved in the production of neurosteroids, which
influence brain functioning via interaction with the neurotransmitter GABAa- and
NMDA receptors (Paul and Purdy, 1992; Puia et al., 1990; Schumacher, 1990).
Secondly, it is not unlikely that the CBX-paradigm may have acted not only to
inhibit 11 P-HSD activity in mother, placenta and fetus, but also as a maternal stress.
CORT levels in CBX-injected rats varied greatly and may be related to the fact that
most pregnant rats did not tolerate CBX injections well and that some developed
sores at the site of injection. Consequently, factors released in response to infection
or stress may underlie the alterations seen in CBX offspring. Stress-induced release
of CORT in addition to inhibition of 11 [3-HSD may have exposed CBX-fetuses to
much higher (endogenous) levels of glucocorticoids than the relatively low doses that
DEX-fetuses were exposed to. Moreover, other factors associated with the possibly
stressful CBX injections such as neurotransmitters or opioids may have played a role
in programming CBX offspring. This possibility is supported by studies showing that
the effects of prenatal stress on growth and behaviour in rats could be completely
normalised by simultaneous benzodiazepine injections (Drago et al., 1999) and partly
by blocking opiate receptors with naltrexone (Keshet and Weinstock, 1995).
Thirdly, although CBX and DEX were both administered daily throughout
pregnancy, they may have acted at different times. Most fetal tissues show a rapid
decline in 11P-HSD2 expression at the end of mid-gestation and even placental 11P-
HSD2 mRNA begins to decline during the last week of pregnancy (Brown et al.,
1996; Waddell et al., 1998). Thus, fetal tissue glucocorticoid exposure resulting from
CBX-induced inhibition of fetal and placental 11P-HSD2 probably occurs mainly
during the second week of pregnancy, whereas DEX may have acted for a longer
period, GRs being expressed at least from midgestation onwards and increasing
towards delivery (Bohn et ai., 1994; Diaz et al., 1998; Kitraki et al., 1996).
Lastly, prenatal DEX only has a high affinity for GR, whereas increased CORT
levels in the fetal circulation as a consequence of CBX administration may exert
effects via both MR and GR, which have distinct and specific developmental
expression [see chapter 1 and (Bohn et al., 1994; Diaz et al., 1998; Kitraki et al.,
1996)] and gene targets. Thus, the patterns of lip-HSD expression during
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development, the stages of maturity of the fetal target tissues and the differential
expression of corticosteroid receptors may underlie the time windows for specific
effects of prenatal glucocorticoid exposure. This, in combination with the
stressfulness of CBX injections may account for differential effects of prenatal DEX
and CBX.
CBX and DEX treatment reduced body weight at birth and in DEX rats this effect
persisted into adulthood. Insulin-like growth factors (IGFs) are important mediators
of fetal growth, and the IGF system in turn is regulated by glucocorticoids (Li et al.,
1993; Price et al., 1992). Indeed, IGF binding protein-1 (IGFBP-1), which inhibits
the actions of IGF, was increased in fetuses that had been exposed to DEX (Price et
al., 1992).
The mechanism underlying the persistence of the body weight reduction in DEX
offspring may involve altered food intake and body weight regulation by
glucocorticoids (Tempel and Leibowitz, 1994), possibly via modulation of leptin
action (Inui, 1999; Spinedi and Gaillard, 1998). Further studies are needed to
establish whether food intake is altered in DEX offspring, but interestingly,
prenatally stressed rats, which in some studies also have permanently reduced body
weight and increased HPA activity, show reduced food and water intake (Vallee et
al., 1996).
An alternative hypothesis of prenatal programming has implicated undernutrition
during pregnancy, in particular reduced protein intake (Almeida et al., 1996; Godfrey
et al., 1994; Hales et al., 1991; Langley and Jackson, 1994; LangleyEvans et al.,
1996a). The finding that daily CBX- and DEX injections throughout pregnancy
reduced maternal food intake and body weight gain, similar to maternal stress during
pregnancy (Kinsley and Svare, 1986), was therefore intriguing. It had already been
shown that maternal protein restriction attenuates placental 11 (3-HSD2 activity in rats
(LangleyEvans et al., 1996b) and increases maternal plasma Cortisol levels in
primates (Recabarren et al., 1998), suggesting that excessive exposure to maternal
glucocorticoids may mediate, at least in part, the effects of prenatal undernutrition.
The present study, however, shows that the opposite is also true: exposure to
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glucocorticoids reduces maternal food intake. This indicates a reciprocal relationship
between food intake and glucocorticoid levels during pregnancy, and the two
hypotheses may not be mutually exclusive.
Prenatal CBX- and DEX administration increased basal CORT concentrations,
indicating an increased central drive or reduced negative feedback of the HPA axis in
the offspring. In addition, DEX rats had reduced evening CORT levels. Interestingly,
subtle elevation of basal morning CORT concentrations has been shown to decrease
evening CORT levels, thus ensuring that the mean daily output of CORT remained
unaltered (Akana et ah, 1992). The trend towards increased PVN CRH levels
observed in both CBX- and DEX rats could indicate a slightly higher basal
transcription rate of the CRH gene, resulting in greater release of CRH and
concomitant elevation of basal CORT concentrations. However, ACTH levels in
plasma and adrenal weights were not measured in this study. These would have
provided important additional information regarding differences in HPA activity and
adrenal sensitivity to ACTH in the three treatment groups.
Hippocampal corticosteroid receptors are involved in the regulation of basal HPA
activity (De Kloet, 1991), but their mRNA levels were unaltered in CBX- and DEX
rats compared to controls. This lack of effect was somewhat surprising, as DEX
administration in the third week of pregnancy has been shown to reduce hippocampal
MR and GR gene expression (Levitt et ah, 1996). However, the hippocampus is not
the only brain structure that mediates HPA activity. The prefrontal cortex (Herman
and Cullinan, 1997; Sullivan and Gratton, 1999) and the amygdala (Weidenfeld et
al., 1997) have also been implicated in the central control of HPA activity. Both
structures contain moderate to high levels of corticosteroid receptors (De Kloet,
1991; McEwen et al., 1986). Thus, further studies are needed to establish whether
inhibition of feto-placental 11P-HSD increases the central drive of the HPA axis by
altering corticosteroid receptor expression in these areas.
In CBX offspring, levels of GR mRNA in the PVN were reduced. The PVN is
considered to be one of the major sites for glucocorticoid negative feedback. Thus, it
would not have been unlikely for CBX-rats to be less sensitive to DEX inhibition of
stress-induced CORT secretion. However, sensitivity to the suppressive effects of a
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single DEX-injection sufficiently low not to completely suppress the animals' HPA-
axis, was similar in all groups. This discrepancy may be explained by the recent
finding that DEX in low doses only poorly penetrates the brain (Meijer et ah, 1998).
If this was the case in our paradigm, then the DEX administered may have inhibited
the HPA axis mainly at the pituitary level. Whether pituitary GR levels in CBX-
DEX- and control offspring are similar has yet to be verified.
In contrast, post-stress plasma CORT levels were elevated in CBX offspring,
indicating a reduced sensitivity to glucocorticoid negative-feedback that did not
show up in the DEX-suppression test. This may be explained by the fact that in the
stress test, endogenous CORT feeds back on GRs in pituitary and PVN, where a
lower level of GR may be responsible for reduced negative-feedback sensitivity and
thus elevated post-stress CORT levels.
The mechanisms whereby prenatal exposure to high levels of corticosterone alter
corticosteroid receptor gene expression in the PVN have yet to be determined.
Increased CORT levels in utero could directly modulate corticosteroid receptor
transcription by acting on MR or GR gene promoters, as MR and GR gene
transcription have been demonstrated in fetal brain (Diaz et ah, 1998). Alternatively,
they may influence developing monoaminergic systems which in turn regulate brain
MR and GR expression (Kabbaj et ah, 1995; Kabbaj et ah, 1996; Maccari et al.,
1992a; Seckl et al., 1990; Takahashi and Goh, 1998; Weidenfeld and Feldman, 1991;
Yau et al., 1992; Yau and Seckl, 1992). It may be postulated that prenatal
glucocorticoids program the development of the HPA axis rather than 'hardwire' it
prenatally. This is supported by the finding that CBX rats showed a trend towards
higher hippocampal MR gene expression at 1 week of age (which reached
significance in CA2) which had disappeared completely in adult rats. At 1 week of
age, CORT is maintained at very low levels and any actions of CORT are therefore
likely to be mediated by MR. In this way, activation of increased numbers of MR
may have affected neurogenesis. However, the increased MR mRNA expression in
one week-old CBX offspring did not affect their plasma CORT levels at that stage
and the SHRP was not affected by either of the prenatal treatments.
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Taken together, data from this study suggest that prenatal CBX injections program
subtle changes in adult HPA regulation and activity and that these are associated with
reduced birthweight. Although CBX injections may have altered the in utero milieu
in various ways, the similarity to the effects of prenatal DEX injections suggest that
feto-placental 11 (3-HSD may normally function to protect the fetus from high levels
of maternal CORT. However, the efficiency of this barrier may vary between
individuals (Benediktsson et ah, 1993), rendering some fetuses more susceptible to
the programming effects of maternal CORT, such as in maternal stress.
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Chapter 4. Effects of prenatal CBX and DEX on spatial
memory
Introduction
In a population of humans or animals there are great individual variations in
cognitive performance. Genetic background, early life experiences and ageing have
all been shown to affect spatial memory as measured in a Morris watermaze (Issa et
ah, 1990; Lipp and Wolfer, 1998; Meaney et al., 1988; Zaharia et al., 1996).
Performance in this task relies on hippocampal integrity (Morris et al., 1982) and
functioning which in turn is for an important part regulated by numbers and
occupation of MR and GR. Generally, reduced corticosteroid receptor numbers in
hippocampus correlate with impaired spatial memory. However, from more direct
studies using MR and GR agonists and antagonists to manipulate hippocampal
receptor occupation, an inverted U-shaped relationship between GR occupancy (or
plasma CORT levels) and spatial memory has been proposed (Lupien and McEwen.
1997). Interestingly, a similar correlation has been used to describe the relationship
between CORT levels and LTP, the electrophysiological correlate of memory
(Diamond et al., 1992). Hippocampal MR are thought to be involved in memory
formation in a less specific way, through increased arousal and promotion of'sensory
integration'.
Prenatally stressed rats often have increased basal and stress-induced CORT levels
and reduced hippocampal corticosteroid receptor numbers (Barbazanges et al., 1996;
Henry et al., 1994; Maccari et al., 1995; Vallee et al., 1997). However, the
implications of these findings on watermaze performance are less clear cut. Of the
few investigations into cognitive performance in prenatally stressed rats, two
reported improved memory (Fride et al., 1986; Szuran et al., 1994), whereas a third
one failed to find an effect of prenatal stress on spatial memory (Vallee et al., 1997).
Effects of prenatal glucocorticoid exposure per se on watermaze performance have
thus far not been reported (although postnatal DEX administration impairs spatial
learning (Dekosky et al., 1982; Vicedomini et al., 1986)) but provide an interesting
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matter of study considering the elevated basal (in CBX and DEX rats) and post-stress
(in CBX rats) CORT levels found in the previous chapter. At the time of this
experiment, hippocampal MR and GR mRNA expression had not yet been measured
in these animals, but a previous study (Levitt et al., 1996) had shown that exposure to
DEX in the last week of pregnancy reduced both hippocampal MR and GR mRNA
levels. With this in mind, this study aimed to establish whether prenatal exposure to
glucocorticoids, by inhibiting feto-placental lip-HSD or by injections with DEX
throughout pregnancy, affects cognitive functioning measured in a watermaze task.
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Methods
As described in Chapter 2. In short, rats (n=8/group) were trained in a circular pool
to find a platform submerged under the water surface on 4 consecutive days using
visual cues (acquisition phase - the acquisition/consolidation compound of the test).
On the fifth day, the platform is removed and the amount of time spent around the
former platform location was recorded (probe test - the retention/strategy compound
of the test).
During the acquisition phase of the test, half the rats were trained to locate the
submerged platform located at the 'north-east (NE) position, and the other half was
trained to locate it at 'south-west' (SW). For each rat the platform remained in the
same position across trials. Each trial started with the rat placed into the pool facing
the wall of the pool at one of four starting positions. It was then given 2 minutes to
locate the platform. If a rat failed to find it within 120 seconds, the experimenter
placed the rat on the platform manually. The rat was left there for 30 seconds before
the next trial began. Each rat was subjected to four trials per day, on three
consecutive days. The latency to find the platform ('escape latency') was monitored
for each trial as an indicator of spatial learning.
On the fifth day of the test, the platform was removed and the animals' behaviour
was recorded during a 1-minute free-swim trial (probe test). The following
parameters were recorded: a) latency until the former platform location was reached;
b) number of crossings of the former platform location; c) percentage of time spent
swimming in the quadrant where the platform had been located; d) swim speed; e)





All animals were able to swim and improved their performance over the course of 4
days of training (Figure 4.1). The results of 4 days of training (4 sessions/day) in the
watermaze are depicted in figure 4.2. It shows the mean latency per day for control-,
CBX- and DEX1-3 offspring to find the submerged platform. Ignoring the very first
trial on the first day (trial 1, in which escape latency is determined by chance), a two-
way ANOVA reveals a prenatal treatment effect (F2,6=5.71, p<0.05), a day effect
(F3,18=39.32, pO.OOOl) and a treatment x day interaction (F6.is-5.27, p<0.01) on
escape latency. Post-hoc analysis of the treatment x day interaction showed that
CBX- and DEX1-3 rats needed more time to find the submerged platform than




Figure 4.1 Latency to find the submerged platform per group across 4 days of training.
An improvement over the course of 4 days can be seen in all three groups. Depicted are the mean









Figure 4.2 Mean latency to find the submerged platform per group across 4 days of training.
Depicted are the mean latencies of 3 sessions (day 1) or 4 sessions (day 2-4) ± SEM.** p<0.00l, ***
pO.OOOl versus control; n=8/group.
Importantly however, the position of the platform (either at NE or SW) influenced
escape latencies. In a three-way ANOVA with platform location and prenatal
treatment as independent variables and trials as a repeated factor, no platform effect
(Fi,18=0.005, p=0.94) or treatment effect (F2,is=0.16, p=0.85) on escape latency was
found, but there was a significant platform x treatment interaction (F2.i8=3.67,
p<0.05) as well as a platform x treatment x trial interaction (F28.252=l-56, p<0.05),
indicating that the three treatment groups were differentially affected by the effect of
platform location on escape latency. Therefore, normalisation of escape latencies to
correct for the effect of platform location would not be appropriate. Furthermore,
because of the low n per group per platform location (n=4), it is difficult to interpret
data from this experiment, even when data from each platform position would be
considered separately. In the probe test (next section), the possible effect of platform
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position on retention was taken into account, and platform location during the
training trials was therefore used as an independent factor in statistical analysis.
Probe test
Non-mnemonic parameters
To analyse the non-memory related parameters of the probe test on day 5, a two-way
ANOVA was performed with prenatal treatment and platform location as
independent variables, and swim speed, distance swum and thigmotaxis (time spent
along the walls) as dependent factors. There were no significant treatment or
platform effects on distance swum or swim speed, nor a treatment x platform
interaction (Table 4.1a), although there was a trend for DEX1-3 rats to swim faster
than CBX rats (Table 4.1a/b). With regard to the amount of time spent along the side
walls of the pool, there were no main effects of treatment or platform location, but a
significant interaction between the two existed (Table 4.1a), with control rats
spending more time along the side walls when trained 'NE' and DEX1-3 rats
showing more thigmotaxis when trained 'SW'.
effect Swim speed
Treatment (T) F2,is=3.20, p=0.06
Platform (PF) FU8=0.54, p=0.47
TxPF interaction F2,is=1 -38, p=0.28
Distance swum %time at side walls
F2.i8~2.34, p=0.12 F2,18=0.00, p=1.00
Fi,is=0.08, p=0.78 Fi(i8=0.06, p=0.81
F2,i8=1.92, p=0.18 F2,i8=4.65, p<0.05*
Table 4,1a Statistical analysis of effects of treatment and platform location.
n=8/group
Mean speed (m/s) Total distance (m) %time at side walls
Control 0.22 ±0.01 12.52 ± 1.00 34.5 ± 6.2
CBX 0.21 ±0.02 12.08 ±0.90 33.8 ±4.9
DEX1-3 0.25 ±0.08 14.36 ±0.39 34.3 ± 7.9




In the probe test, memory of rats was tested by observing (1) the number of times
animals crossed the position where the platform was located during the training
sessions, (2) time passed until the first crossing of that location ('latency'), and (3)
percentage of time spent in the quadrant where the platform was previously located
('correct quadrant'). Two-way ANOVAs were performed to establish the effects of
prenatal treatment and platform position during training on these parameters. Thus,
prenatal treatment and platform position acted as independent factors.
There were significant main effects of both factors on the number of crossings, but
no significant interaction (Table 4.2a). Post-hoc analysis revealed that DEX1-3
offspring have a higher number of crossings than control rats (p<0.01), and that rats
trained at NE have more crossings than rats trained at SW (p<0.01), but the number
of crossings was low in all groups (Table 4.2b; median 2, range 0-6). With respect to
the latency until the first crossing of the former platform location, there were no
effects of or interactions between prenatal treatment or platform position during
training (Table 4.2a,b).
The percentage of time rats swam in the quadrant where the platform was located
during the training sessions did not significantly differ between groups (Table 4.2a,
no significant treatment effect). Platform location during training did influence the
outcome of the probe test (Figure 4.3; Table 4.2a), with NE-trained rats performing
better than SW-trained rats (p<0.05). However, there was no treatment x platform
interaction (Table 4.2a), and raw data (Table 4.2b) were normalised to correct for the
effect of platform position during training. A one-way ANOVA performed on
normalised data (Table 4.2c) did not reveal significant differences between control
and CBX- or DEX1-3 rats with respect to number of crossings (F2,2i=2.81, p=0.08),
latency (F2.2i=0.04, p=0.96) or percentage of time swum in the 'correct' quadrant
(F2.2i=2.24, p=0.13), although there was a trend for CBX and DEX1-3 offspring
towards a higher number of crossings and greater amount of time spent in the
'correct' quadrant (Figure 4.4; Table 4.2c).
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effect Number ofcrossings Latency (s) % time in correct
quadrant
Treatment (T) F2,i8~4.45; p<0.05*
Platform (PF) Fus=9.97; p<0.01 **
TxPF interaction F2,i8=2.52; p=0.11
F2,i8=0.10; p=0.91 F2,i8=3.19; p=0.06
Fi. 18=0.18; p=0.68 FU8=8.3; p<0.05*
F2.i8=0.49; p=0.62 F2,is=2.6 1; p=0.10
Table 4.2a Effects of prenatal treatment and platform location on memory parameters in a 1-
minute probe test.
n=8/treatment group













Table 4,2b Memory parameters in a 1-minute probe test, not taking into account platform
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Figure 4.3 Percentage of time spent in former platform quadrant.
















Figure 4.4 Percentage of time spent in the 'correct' quadrant of the water maze in a 1-minute




Although all rats showed improved performance over the four days of training, they
generally performed poorly. Wistar rats are known to be worse in this task compared
to other rat strains e.g. Lister hooded rats (Yau et al., 1994). The prenatal treatments
with CBX and DEX appeared to have an impairing effect on the first day of training,
as rats from these groups had higher mean latencies to find the platform than control
rats. This difference had however disappeared by day 2, suggesting that the negative
effect of the treatments on watermaze performance is related to short-term rather
than long-term memory.
In the 1-minute probe test, both CBX and DEX1-3 rats tended to spend more time in
the quadrant where the platform had been located, although this trend did not reach
significance. Some researchers interpret this as 'good memory', because the rats
appear to remember the position of the platform during the training trials (Morris,
1984; Yau et al., 1994). However, a possibly better measure ofmemory would be the
latency until rats cross the former platform location, which was similar in the three
groups. Latency is determined by swim speed and navigation, and as swim speed was
not affected by prenatal treatments, it appears that prenatal CBX or DEX treatment
did not affect the amount of time it took rats to find the former platform position in
the probe test.
The number of crossings of the former platform location in the probe test was very
low in all groups. This does not necessarily imply poor memory. A high number of
crossings could also be interpreted as proof of a rigid search strategy, whereas a low
number of crossings might mean that the animal has discovered the platform is not
where it expected it to be, and then decides to look for it in other parts of the
watermaze. The same is true for the amount of time spent in the quadrant where the
platform was located during the training trials (perhaps confusingly called 'correct
quadrant'). The trend towards spending more time in this quadrant in CBX and DEX
rats implies an altered (more rigid) search strategy compared to control rats.
Interestingly, two studies examining the effects of prenatal stress on watermaze
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performance also failed to find an effect in the acquisition phase of the test, but in a
reversal task (in which the platform is moved to a different position) or probe test,
prenatally stressed rats spent more time in the quadrant where the platform was
previously located (Hayashi et ah, 1998; Szuran et ah, 1994). Exploratory behaviour
in this task has been associated with hippocampal MR occupation (Oitzl and de
Kloet, 1992), and decreased MR binding has been reported in prenatally stressed
adult male rats (Barbazanges et ah, 1996; Henry et ah, 1994; Maccari et ah, 1995;
Vallee et ah, 1997). Although MR (or GR) mRNA expression in this study were not
affected by the prenatal treatments, this does not rule out alterations in
posttranscriptional or -translational mechanisms resulting in a reduced number of
MR binding sites in CBX or DEX1-3 rats. However, this is only speculation and
none of the trends in the probe tests reached significance, so this interpretation
should be taken with caution.
In fact, the lack of significant effects of prenatal glucocorticoid exposure on
watermaze performance may be explained by considering the inverted U-shaped
relationship between spatial memory and hippocampal GR occupation (Conrad et al.,
1997). This relationship implies that both plasma CORT concentration and
hippocampal corticosteroid receptor levels are determinants of watermaze
performance. There were no differences in stress levels of plasma CORT between
CBX-, DEX1-3 and control rats as measured using a restraint procedure (see
previous chapter), but CORT levels were not determined in the study described here.
Water temperature in the maze has been shown to be an important factor in
acquisition and retention, probably by increasing (lower temperature) or decreasing
(higher temperature) the stressfulness of the task. Rats appear to learn better at lower
temperatures (Sandi et ah, 1997), indicating that (moderately) low temperatures are
beneficial for acquisition and retention. Interestingly, in one study differences
between prenatally stressed and unstressed rats only appeared when the watermaze
task was performed at a very low temperature. Further experiments are needed to
establish whether this could be the case for the treatments used in this study.
However, assuming that CORT levels of DEX-, CBX- and control rats were similar
during the watermaze procedure, only increased or decreased hippocampal MR or
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GR levels could account for differences in performance. However, as shown in the
previous chapter, stress-levels of plasma CORT were similar in the three groups, and
hippocampal MR and GR mRNA expression were not affected by prenatal treatment
with CBX or DEX (see chapter 3). Thus, the lack of differences in spatial memory in
this study was not completely unexpected. In fact, in one study a reduction of
approximately 25% in hippocampal MR or GR binding by i.c.v. administration of
specific antisense mRNAs did not result in impaired watermaze performance in
Brown Norway rats (Engelmann et al., 1998), indicating that only very large
alterations in receptor number may have any functional impact in this test.
The most surprising finding from this experiment was the difference in performance
between rats trained to find a platform located at 'NE' and at 'SW'. It is unclear what
may have caused this difference. Interestingly, the three treatment groups were
differentially influenced by platform positions during the training period. It appears
as though CBX and DEX1-3 rats were more attracted to the NE-side of the pool,
possibly by an unpleasant cue nearer the SW side, causing the rats to avoid this part
of the pool, even if the platform was located there. This would suggest an extremely
aversive cue, preventing them from escaping the water by staying on the platform.
One possibility is that the sound produced by the air conditioning in the testing room,
although not very loud or unpleasant to human ears, may have been perceived
(perhaps ultrasonically) as aversive by rats. Unfortunately, because of the low n per
group per platform location (n=4), it is difficult to interpret data from this experiment
when data from each platform position are considered separately.
In conclusion, this study showed that prenatal glucocorticoid exposure via CBX of
DEX administration throughout pregnancy does not significantly affect spatial
memory in a watermaze task, but may have increased the rats' sensitivity to an (as
yet unidentified) unpleasant cue in the testing room. It is possible that an increased
level of anxiety in CBX and DEX rats underlies this heightened sensitivity. Chapter
6 of this thesis will explore anxiety-like behaviour in these animals in greater detail.
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Chapter 5. Prenatal dex: a specific time window?
Introduction
The finding that exposure to DEX throughout gestation did not result in major
alterations in HPA activity or hippocampal MR or GR gene expression was
somewhat surprising considering the robust effects, peripherally as well as centrally,
of perinatal DEX administration that have been described in the literature on the one
hand (see chapter 1), and the sensitivity of hippocampal corticosteroid receptors to
early manipulations on the other (Henry et ah, 1994; Levine et al., 1994; Maccari et
ah, 1995; Meaney et ah, 1989). However, earlier studies with DEX varied greatly
with respect to timing and dosage ofDEX administration, and timing of the exposure
may be critical for effects to occur. Indeed, the existence of a critical 'time window'
in the third week of gestation for DEX effects on blood pressure (Levitt et al., 1996)
and glucose homeostasis (Nyirenda et ah, 1998) has been established.
Similarly, most studies describing the effects of prenatal DEX on brain functioning
have used late gestational or neonatal exposure. Thus, low-dose DEX administered
on gestational days 17, 18 and 19 altered 5-hydroxytryptamine turnover and
noradrenaline content in specific brain regions measured at 14 weeks of life.
Moreover, these animals had altered behaviour and elevated plasma CORT levels in
a novel environment (Muneoka et ah, 1997). Another study reported the disruption of
brain nuclear transcription factors due to late gestational DEX exposure (Slotkin et
ah, 1998), but beneficial effects of prenatal DEX administration have also been
reported (Slotkin et ah, 1993). A greater number of studies exist with regard to
neonatal DEX injections. Depending on timing (between postnatal days 1 and 7,
varying from 1 to 3 injections) and dose (0.04-100 mg/kg bodyweight), neonatal
DEX exposure resulted in behavioural suppression (Felszeghy et ah, 1993),
hyperactivity (Ferguson and Holson, 1999), spatial learning deficits (Dekosky et ah,
1982; Vicedomini et ah, 1986), decreased brain GR levels (Felszeghy et ah, 1996),
but unaltered plasma CORT concentrations (Felszeghy et ah, 1996).
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In humans, perinatal glucocorticoid therapy is usually given to accelerate lung
maturation in fetuses to prevent neonatal respiratory distress syndrome and chronic
lung disease in cases of (threatened) prematurity. The long-term effects of perinatal
glucocorticoid treatment on cognition and behaviour have received little or no
attention, but preliminary data regarding early dexamethasone exposure in cases of
suspected congenital adrenal hyperplasia show that there may be unfavourable
effects on the behavioural development (emotional and social) of children (Lajic et
al., 1998; Trautman et al., 1995). Animal models have shown that these aspects of
behaviour are modulated by corticosteroids (see chapter 1). Therefore, this chapter
aims to establish the long-term effects of late gestational DEX administration on




Pregnant females (225 g) were injected s.c. with dexamethasone (DEX, 100 pg/kg;
dissolved in 4% ethanol-0.9% saline) daily in the third week of pregnancy, and with
vehicle injections in the first two weeks. A control group received vehicle injections
throughout pregnancy. On day 20 of pregnancy a blood sample was taken from the
tail vein (see below) for determination of plasma CORT levels.
Litters
Only litters containing 8 pups or more were selected for the studies. On the day of
birth, litters were weighed, sexed and culled to 8 pups per litter. Offspring were
weighed regularly, starting 4 weeks after birth.
Blood sampling
As described in Chapter 2.
HPA axis activity
Stress-induced activation of the HPA axis was determined using a restraint
procedure, in which adult rats were restrained in Perspex cylinders for 20 minutes.
Plasma CORT levels were measured in blood samples taken from the tail vein 3 h
before (at 9:00 h), 10 minutes into and 90 minutes after the restraint.
In a separate experiment, we determined the sensitivity to the suppressive effects of
DEX on CORT secretion in the rats. Thus, rats were given a single bolus of DEX (40
ug/kg) s.c., after which the restraint procedure described above was performed.
Corticosterone assay
As described in Chapter 2.
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In situ hybridisation histochemistry
In situ hybridisation was performed as described in Chapter 2 on sections taken at the
level of the PVN (GR and CRH riboprobes) and hippocampus (MR and GR
riboprobes). Equivalent 'sense' probes were included as controls. MR, GR and CRH
mRNA expression was quantified by counting silver grains overlying identified
neurones under bright-field illumination using an automatic image-analysis system.
Results were calculated as mean number of grains/cell area for each subregion after
subtraction of background (counted over areas of white matter), which was always
low.
Statistics
Data are presented as mean value per group ± s.e.m. Data from the two treatment
groups were compared using Student's t-test or an ANOVA for repeated measures
followed by a LSD test, where appropriate. Significance was set at p< 0.05.
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Results
Effects ofDEX injections in week 3 ofpregnancy on pregnant rats
Vehicle and DEX treatment were tolerated well. Maternal plasma CORT levels on
day 20 of pregnancy were significantly lower in animals receiving DEX injections
(control 16.6 ± 2.5 pg/dl. DEX3 6.5 ± 1.6 pg/dl, pO.Ol).
Effects ofDEX injections in week 3 ofgestation on offspring
Prenatal injections with DEX in the third week of gestation had no effect on
gestation length (control 22.4 ± 0.24 days, DEX3 21.7 ± 0.29 days; p=0.12) or litter
size (control 10.8 ± 0.54, DEX3 9.8 ± 0.58; p=0.23). However, treatment with DEX
in the third week of gestation significantly reduced birth weight (Table 5.1). From
week 4 of life onwards, DEX3 and control animals had similar body weights (Table
5.1).















Table 5.1 Effect of prenatal injections on body weight.
Results are expressed as g bodyweight. **p<0.01 versus control; n=13-47/group.
Brain MR, GR and CRHmRNA expression in adult offspring
Exposure to DEX during the last week of pregnancy altered corticosteroid receptor
gene expression in specific hippocampal subfields at 6 months of age (Figure 5.1,
Figure 5.3). In DEX3 offspring MR mRNA levels were significantly reduced in
CA1 and CA2 (Figure 5.1, top panel), whereas GR mRNA expression was lower in
DG and CA1 compared to controls (Figure 5.1, bottom panel). Furthermore, DEX
exposure did not alter GR mRNA expression in PVN of 6 month-old rats (Figure 5.2
left panel; Figure 5.4), but increased CRH mRNA levels (Figure 5.2 right panel,
Figure 5.5).
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DG CA1 CA3 CA4
Figure 5.1 Hippocampal MR and GR mRNA expression.
Effect of prenatal treatments on hippocampal MR (n=8-13/group) and GR (n=8-l 1/group) mRNA
expression in 6 month-old rats. Results are expressed as mean number of grains/cell area ± s.e.m. for
each subregion after subtraction of background. *p<0.05, **p<0.01
control DEX3 control DEX3
Figure 5.2 GR and CRH mRNA expression in PVN of 6-month old rats.
Left panel GR mRNA expression, right panel CRH mRNA expression; *p<0.05; n=7/treatment group
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Figure 5.3 Photomicrographs of hippocampai MR and GR mRNA expression.
Left panels show typical sections from control rats, right panels show typical sections from DEX3
rats. A and B: MR mRNA in DG and CA1; C and D: MR mRNA in CA2: E and F: GR mRNA in DG
and CA1. Scale bar represents 100 pm.
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c
Figure 5.4 Photomicrographs of GR raRNA expression in PVN.




Figure 5.5 Photomicrographs of CRH mRNA expression in PVN.
Pictures show typical sections from control and DEX3 rats. /4-control, S-DEX3, C-sense. Scale bar
represents 200 pm.
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HPA activity in adult offspring
a. CORT response to restraint
Figure 5.6 shows the CORT response to 20 minutes of restraint. A three-way
ANOVA for repeated measures revealed a time effect (F2.2o= 17.08, p< 0.001), but no
treatment effect, (Fijo=0.007, p=0.94) or treatmentxtime interaction (F2.2o=0.10,
p=0.91) (Figure 5.6, top panel). Thus, DEX-administration in the third week of
gestation did not affect the CORT response to restraint.
b. DEX-suvoression ofstress-induced CORT levels
A single bolus of DEX (40 |ag/kg) given s.c. 3 hours before start of the restraint
procedure, suppressed the CORT response to a similar extent in the two treatment
groups. ANOVA showed no treatment effect (Fi.io=0.008, p=0.93) or treatmentxtime
interaction (F2,2o=0-64, p=0.53) (Figure 5.6, bottom panel), although there was a time
effect (F2.2o=3.60, p<0.05), showing that the dose of DEX used had not suppressed
the CORT response to restraint completely. Clearly, exposure to DEX in the last
week of gestation did not affect the sensitivity to the suppressive effects of DEX on
stress-induced CORT secretion.
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Figure 5.6 Plasma CORT response to 20 minutes restraint.
CORT concentrations measured in plasma samples taken before (pre), 5 minutes into (stress), and 90
minutes after (post) 20 minutes restraint (top graph). The bottom graph depicts the effect of a single




This study showed that DEX exposure in the last week of pregnancy reduces
hippocampal MR and GR gene expression in specific subregions and increases CRH
mRNA in the PVN. However, stress-induced activity of the HPA axis and
suppression of HPA activity by an acute DEX injection did not differ between DEX
offspring and control animals.
Earlier work from our laboratory showed that basal CORT levels in DEX3 rats are
elevated when compared to controls (Levitt et ah, 1996). This was not verified in the
present study. However, CORT levels in plasma samples taken 3 h before the start of
the restraint procedure at 9:00 h were 8.4 pg/dl for controls and 6.8 pg/dl for DEX3
rats, respectively. Unfortunately, these levels cannot be considered basal, especially
compared with basal levels shown in chapter 3, which were around 1 jag/dl (figure
3.5). The latter samples were taken in a different animal unit under slightly different
conditions, and it may be suspected that the rats used in the present experiment were
not completely unstressed under basal circumstances. Therefore, these data do not
give conclusive evidence about the effect of DEX administration in the last week of
gestation on basal CORT concentrations.
Although DEX3 rats had increased CRH mRNA expression in the PVN, their GR
mRNA levels in this region were unchanged, indicating that a reduced glucocorticoid
negative feedback action at PVN level is unlikely to account for the higher CRH
transcription rate. This suggests an increased central drive to the HPA axis that may
explain the elevated basal CORT levels found in DEX3 rats in an earlier study
(Levitt et al., 1996). DEX3 rats had reduced MR and GR gene expression in specific
regions of the hippocampus. Hippocampal MRs in particular are thought to play an
important role in the regulation of basal HPA activity. This conclusion was based on
the observation that basal ACTH levels are elevated after administration of
mineralocorticoid antagonists (Bradbury et al., 1994; Ratka et al., 1989). However,
numbers of MRs have never actually been shown to be associated with basal HPA
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activity. This is surprising considering the fact that the MR is a 'high affinity-low
capacity' receptor for which the number of receptors rather than the amount of ligand
(CORT) determines the receptor-mediated actions of CORT. In the majority of
studies, hippocampal corticosteroid receptor numbers are associated with stress-
induced rather than basal HPA activity [e.g. Henry et ah, 1994; Maccari et al., 1995;
Meaney et al., 1989], whereas MR occupation appears to determine basal ACTH and
CORT concentrations (Bradbury et al., 1994; Ratka et al., 1989). In this study
however, the reduced levels of MR mRNA in the CA1 and CA2 regions of the
hippocampus may have resulted in an increased basal transcription rate of CRH in
the PVN. Although ACTH levels were not measured in this experiment, and the
CORT levels obtained could not be considered truly basal, we may speculate that
exposure to DEX in the last week of gestation permanently alters the 'set point' of
the HPA axis at the level of the hippocampus, resulting in an increased basal HPA
activity. HPA disturbances are associated with psychiatric disorders (Barden. 1999)
and increased circulating glucocorticoid levels may impair cognition, as has been
observed in patients with Cushing's disease. Certainly in many animal studies CORT
levels and hippocampal MR and GR activity have been shown to influence learning
and memory in a watermaze. Further experiments are needed to show the
consequences of DEX-programmed alterations in hippocampus and HPA axis on
these parameters.
GR gene transcription in the hippocampus was also reduced as a consequence of
prenatal DEX exposure in the last week of gestation. As mentioned before,
hippocampal GR occupation and numbers have been correlated to stress-induced
HPA activity in many studies. In the present study however, no differences between
control and DEX3 offspring were found in stress-induced plasma CORT levels as
concentrations during as well as 90 minutes after stress were similar in both groups.
Several explanations for this lack of difference are possible. Firstly, it has been
suggested that glucocorticoid negative feedback takes place at the pituitary and
hypothalamic level rather than in the hippocampus (De Kloet et al., 1998). GR
expression in the PVN was unaltered by prenatal DEX treatment, and the same may
be the case in the pituitary. This explanation is supported by the finding that DEX-
induced suppression of HPA activity, the sensitivity to which would be determined
primarily at the level of the pituitary because DEX poorly penetrates the brain (De
Kloet, 1997), also did not differ between DEX3 and control offspring. Thus, the
impact of reduced hippocampal GR mRNA levels on HPA activity may have been
marginal in this study. Secondly, the HPA response may be stressor-specific and
differences in peak- or post-stress CORT levels may have become apparent in other
experimental paradigms. In addition, a more detailed profile of the stress response
may have been informative, as a prolonged CORT release to stress may last up to
120 minutes after exposure to the stressor. Thirdly, an increased GR gene expression
may not necessarily result in higher number of receptors. Posttranscriptional and/or -
translational mechanisms may have regulated the amount of receptor protein to a
similar level in control and DEX3 rats.
Taken together, results from this study and from chapter 3 show that the effects of
prenatal DEX administration are dependent on the timing of the exposure. A striking
effect upon adult hippocampal MR and GR gene expression is only observed in rats
exposed to DEX in the last week of gestation and may be associated with an
increased central drive to the HPA axis. It may seem surprising that DEX
administration throughout pregnancy does not have the same effect, considering that
exposure in this paradigm also contains the critical time window (week 3). It is
possible that in the three weeks of gestation several time windows for hippocampal
corticosteroid receptor development occur during which glucocorticoid exposure has
opposing effects. This is not an uncommon phenomenon: for example, prenatal stress
and neonatal stress (short daily maternal deprivations) have opposite effects on
hippocampal corticosteroid receptor binding and stress-induced HPA activity (Henry
et al., 1994; Meaney et ah, 1989). MR and GR have distinct developmental patterns
of expression (see chapter 1), and hippocampal subregions do not develop at equal
rates. Thus, the impact of high glucocorticoid levels is likely to depend on the stages
of maturity of the fetal brain areas and this may underlie the time windows for
specific effects of prenatal glucocorticoid exposure. A similar critical time window
in the last week of gestation has been observed for the programming properties of
prenatal DEX on blood pressure (Levitt et ah, 1996) and glucose metabolism
(Nyirenda et ah, 1998). Alternatively, prolonged exposure to DEX may continuously
affect growth and maturation throughout gestation without altering the relative rates
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of development. In contrast, DEX administration in the last week of gestation only
may result in disproportionate development that is persistent throughout the animal's
lifespan. Whether the subtle alterations hippocampus and pituitary resulting from
DEX exposure in the last week of pregnancy affect stress-associated behaviour will
be investigated in the next chapter.
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Chapter 6. Prenatal glucocorticoid exposure and stress-
induced behaviour.
Introduction
In humans low birth weight is a risk factor for mental disorders later in life, such as
schizophrenia (Hultman et al., 1997; Jones et al., 1998) and poor premorbid social
adjustment and cognitive ability (Cannon et al., 1997; Foerster et al., 1991; Rifkin et
al., 1994). In one study, 22% of a cohort of low birth weight children had a
psychiatric disorder at the age of 6 (Whitaker et al., 1997).
Animal models have suggested that birthweight as well as the susceptibility to
behavioural and cognitive abnormalities may be (partially) determined by early life
experiences. Indeed, prenatal stress reduces birth weight in many studies (Kinsley
and Svare, 1986; Peters, 1982; Takahashi et al., 1988; Williams et al, 1998b) and
generally induces 'behavioural inhibition' (Lambert et al., 1995), such as an
increased latency to play (Takahashi et al., 1992b), a high level of defensive freezing
(Takahashi et al., 1992a), and reduced activity in an open field (Fride et al., 1986). In
many cases prenatal stress is associated with increased anxiety later in life (Vallee et
al., 1997; Wakshlakand Weinstock, 1990; Weinstock, 1997).
Because corticosteroids modulate behaviour in many of the tests used to measure
anxiety levels, it is not unlikely that alterations in corticosteroid concentration or
action may underlie the behavioural changes observed in prenatally stressed rats.
Indeed, a hyperactive HPA axis and alterations in the hippocampus have been shown
in a number of studies (Henry et al., 1994; McCormick et al., 1995; Takahashi, 1998;
Weinstock et al., 1992). Similarly, as described in chapters 3 and 5, glucocorticoid
exposure in utero had subtle effects on HPA activity, and administration of DEX in
the last week of pregnancy reduced hippocampal corticosteroid receptor expression.
Thus, these alterations may affect stress-induced behaviour, or 'emotionality', in
these animals. Because emotionality is a complex concept, data from a single
behavioural test may not give a correct interpretation concerning the animal's
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emotionality. We therefore decided to perform multiple behavioural tests that may
measure different aspects of emotionality (Ramos and Mormede, 1998).
The behavioural expression of fear is thought to be regulated by the actions of CRH
since central administration of CRH induces anxiety-like responses [for review see
Dunn and Berridge, 1996], The amygdala is a likely site of action for CRH: it
contains CRH receptors and also produces CRH (Gray and Bingaman, 1996). Indeed,
electrical stimulation of the amygdala results in fear-associated responses [see
(Applegate et al., 1982; Davis et al., 1994)], while amygdaloid lesions attenuate fear-
related behavioural responses (Kopchia et al., 1992). Brain CRH rnRNA expression
is regulated by corticosteroids (Makino et al., 1994a; Makino et al., 1995b), possibly
via stimulation of transcription by activated corticosteroid receptors, the mRNAs of
which have been localised in several amygdaloid nuclei (Honkaniemi et al., 1992).
The aim of this experiment was firstly to establish whether prenatal glucocorticoid
exposure affects the expression of corticosteroid receptor and CRH rnRNA in
amygdaloid nuclei, and secondly to test whether these possible changes affect the
animals' behaviour in aversive environments.
Methods
Prenatal treatments
Pregnant females (n=7-8 per group in each of two separate experiments) received
daily subcutaneous injections with either 200 pi vehicle solution (control, 4% ethanol
in 0.9% saline), 12.5 mg/200 pi carbenoxolone (CBX), or 100 pg/kg dexamethasone
(DEX1-3), respectively, throughout pregnancy. An additional treatment group
received 200 pi vehicle solution during the first 2 weeks of pregnancy and 100 pg/kg
dexamethasone during the last week of pregnancy (DEX3).
Litters
On the day of birth, litters were weighed, sexed and culled to 8 pups per litter. Only
litters containing 8 pups or more were selected for the studies. Unless stated
otherwise, litters were then left undisturbed until weaning, apart from routine
maintenance. After weaning, male pups from each litter were housed in same-sex
groups of 2-4 and left undisturbed until the time of testing. Experiments were
performed on male rats selected randomly from each litter.
Blood sampling
Blood samples were taken from the tail vein, collected in Microvette tubes and stored
on ice until centrifuged at 4°C. Subsequently, plasma was stored at -20°C until
assayed. Plasma aliquots were freshly thawed for the analysis of corticosterone,
using an in-house specific radioimmunoassay as described in Chapter 2. Results are
presented as pg/dl plasma.
In situ hybridisation histochemistry
In situ hybridisation was performed as described in Chapter 2 on amygdala sections
from 6 month-old rats, using MR, GR and CRH riboprobes. Equivalent 'sense'
probes were included as controls.
MR and GR mRNA expression was quantified by counting silver grains overlying
identified neurones under bright-field illumination using an automatic image-analysis
system. Results were calculated as mean number of grains/cell area for each
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subregion and mean optical density per area, respectively, after subtraction of
background (counted over areas of white matter), which was always low. CRH
mRNA expression was determined by measuring optical density (O.D.) of the
relevant area on autoradiograms.
Open field
As described in Chapter 2.
Elevatedplus-maze
As described in Chapter 2.
Forced swim test
As described in Chapter 2.
Neophagia
As described in Chapter 2.
Statistics
Data are presented as mean value per group ± s.e.m. In most cases, data were
compared using ANOVA followed by an LSD test, where appropriate. However, a
non-parametrical statistical analysis was used on data from the forced-swim test
because of great between-group variability. Thus, between-growp differences in
immobility were analysed using Kruskal-Wallis rank-sum tests separately for the
acquisition and the retention phase, followed by Dunn's multiple-comparison test for
ranked sums. Furthermore, to compare measurements from the acquisition and the
retention phase of the forced-swim test within a treatment group, data from this test
were submitted to a Mann-Whitney rank sum test. In all cases, significance was set at
p< 0.05.
Because 'emotionality' or 'anxiety' is unlikely to be a unidimensional characteristic
and the behavioural tests described in this chapter may thus have measured different
aspects of this characteristic, the combined behavioural data were analysed by
multivariate (factor) analysis using a Statistica 5.1 package. This is a statistical
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approach that analyses the correlations between variables and tries to detect structure
in them by identifying common underlying dimensions (factors). Thus, factor
analysis aims to reduce the number of variables to a number of new indices that are
linear combinations of the original variables. These indices are then independent
from each other and represent the underlying dimensions of the data.
The principal factors were selected according to an eigenvalue > 1, which meant that
factors that accounted for only a small proportion of the total variability were
ignored. The remaining factors were then subjected to a varimax rotation (so that the
relative locations of the factors to each other remained unchanged), in order for their
significance to be interpreted more easily.
Results
Amygdala MR, GR and CRHmRNA expression in adult offspring
A low level of MR mRNA expression was found in BLA and CEA, whereas
expression in MEA was practically absent (Figure 6.1). An ANOVA revealed no
significant effects of prenatal treatment on MR mRNA in either BLA (F3,28=1.42,
p=0.26) or CEA (F3,26=L34, p=0.28), although there was a clear trend towards
increased expression in both nuclei in DEX1-3 offspring (Figure 6.3a) which became
significant in CEA when DEX1-3 rats were compared with control rats separately.
GR mRNA was moderately expressed in BLA, CEA and MEA (Figure 6.2). Prenatal
treatments significantly altered GR mRNA expression per cell in BLA (F3,24=7.23,
p<0.005) and CEA (F2,23=6.00, p<0.01), but not MEA (F3.24=6.01, p=0.07). Post-hoc
analysis revealed a significant increase in GR mRNA expression in amygdala of
CBX offspring compared to control animals (BLA and CEA: p<0.001 and p<0.01
versus control, respectively) and DEX-treated animals (BLA p<0.01 versus DEX3;
CEA p<0.01 versus DEX1-3 and DEX3). DEX1-3 animals also had significantly
higher GR mRNA expression compared to control and DEX3 animals, but only in
BLA (p<0.05) (Fig 6.3b).
CRH mRNA expression was restricted to CEA only (Figure 6.4). Analysis of total
CRH RNA expression in CEA revealed significant differences between groups
(F3,34=6.58; p<0.005). Post-hoc analysis showed that prenatal exposure to DEX,
either throughout pregnancy or in the last week only, increased CRH mRNA
expression in CEA, with a similar trend in CBX offspring (Figure 6.5).
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Figure 6.1 Typical MR mRNA expression pattern in amygdaloid nuclei.
Photomicroscopic (A, B and C) and autoradiographic (£>) images show MR mRNA expression in BLA




Figure 6.2 Typical GR mRNA expression pattern in amygdaloid nuclei.
Photomicroscopic (A and B) and autoradiographic (C) images show GR mRNA expression in BLA



























Figure 6.3a MR mRNA expression in BLA and CEA.
Effects of prenatal injections on amygdaloid GR mRNA expression. Data are expressed at
% control. Open bars control, diagonally striped bars CBX, horizontally striped bars















Figure 6.3b GR mRNA expression in amygdala.
Effects of prenatal injections on amygdaloid GR mRNA expression. Data are expressed at
% control. Open bars control, diagonally striped bars CBX, horizontally striped bars
DEX1-3, closed bars DEX3. *p<0.05, ***p<0.005; n=6-9/group
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Figure 6.4 Autoradiographic images of CRH mRNA expression in CEA.
Images show typical sections from animals in each treatment group,













control CBX DEX1-3 DEX3
Figure 6.5 CRH mRNA expression in CEA.
This graph shows the effect of prenatal treatments on total CRH mRNA expression in CEA. ♦>P=0.07;
**p<0.01 versus control.
Behavioural reactivity in adult offspring
In a 12-minute open field test, locomotion (F3,32=3.17, p<0.05) and rearing
(F3,32=4.94, p<0.01) were reduced in DEX-exposed animals, and this effect was most
pronounced in DEX3 offspring. There was also a tendency for DEX-treated rats to
avoid the centre of the open field (Figure 6.6a). Prenatal CBX treatment did not
significantly affect behaviour in this test, although the slight trend towards reduced
rearing and grooming (Figure 6.6a) was also observed in an earlier 10-minute open
field test with a different population of CBX-offspring (Figure 6.6b).
Open field
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control CBX DEX1-3 DEX3 control CBX DEX1-3 DEX3
control CBX DEX1-3 DEX3 control CBX DEX1-3 DEX3
control CBX DEX1-3 DEX3
Figure 6.6a Behaviour in a 12-minute open field test.
Shown are the effects of prenatal treatments on ambulation, approaches into the centre area,




Figure 6.6b Effect of prenatal CBX on grooming and rearing in a 10-min open field test.
** p<0.01 versus control; grey bars grooming; black bars rearing; n=19/group.
Elevated plus-maze
Analysis of variance did not reveal any significant differences between prenatally
glucocorticoid-exposed- and control offspring on the elevated plus-maze. However,
the overall picture reveals a tendency towards reduced locomotion in CBX- and
DEX3 rats (Table 6.1) and avoidance of open arms in DEX3 rats (Figure 6.4),
whereas DEX1-3 animals tended to spend more time 'decision-making' in the central
area of the plus-maze (Figure 6.7).
open closed base total
arm arm entries entries
entries entries
control 5.3 ± 1.4 25.8 ±4.2 8.0 ±2.0 39.1 ±5.6
CBX 2.9 ± 1.2 16.3 ±4.9 6.0 ± 1.8 25.1 ±6.4
DEX1-3 3.3 ± 1.0 21.6 ± 2.7 8.3 ±2.2 33.1 ±5.1
DEX3 1.1 ±0.6 14.3 ±2.8 4.0 ±0.8 19.4 ± 1.0
p=0.10 p=0.14 p=0.33 p=0.05






control CBX DEX1-3 DEX3
Figure 6.7 Percentage of time spent on different compartments of an elevated plus-maze.
Black bars closed arms; white bars open arms; grey bars base; n=8-10/group.
Forced swim test
Both the acquisition phase (day 1) and the retention phase (day 2) of the forced-swim
test showed significant differences in immobility between treatment groups (p=0.012
and p=0.017, respectively). Further analysis revealed that in both phases of the test
DEX3 rats, but not CBX or DEX1-3 rats, were significantly less immobile than
control rats (Table 6.2). In order to test whether all four groups were able to 'acquire'
immobility, data from the acquisition phase were compared with those from the
retention phase. Control rats and DEX1-3 rats spent significantly more time floating
on the second day of the test (Table 6.2). In contrast, CBX- and DEX3 rats were not
significantly more immobile in the retention test than in the acquisition test (p=0.08
and p=0.24, respectively), although there was a trend for CBX rats towards greater
immobility on the second day (Figure 6.8). Plasma CORT levels measured in
samples taken immediately after the retention test did not differ between groups
(Table 6.2).
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Floating time Floating time Difference (s) Plasma [CORT]
day I (s) day 2 (s) day 2 (jug/dl)
Control 215.6 ±2.3 250.7 ±7.9 35.1 ±8.8** 28.9 ±8.6
CBX 178.7 ± 16.3 208.3 ± 12.4 29.6 ±9.0 20.8 ±3.2
DEX1-3 203.0 ±7.4 234.6 ±8.0 31.6 ±7.7** 25.6 ±8.5
DEX3 127.8 ±28.6® 169.0± 29.7® 41.3 ± 10.7 25.8 ±4.2
Table 6.2 Immobility in a forced swim test.
Effect of prenatal glucocorticoid exposure on immobility in acquisition and retention phase of a forced
swim test and post-swimming plasma CORT levels (n=6-10/group). ® p<0.05 versus control same
day, ** p<0.01 day 1 versus day 2.
10Q
control C8X DEX1-3 DEX3
Figure 6.8 Percentage of time spent floating in a 5-minute forced-swim test.
Open bars day 1; closed bars day 2; ♦> p<0.05 compared to control same day; n=6-10/group.
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Neovhasia
Table 6.3 displays the results from the neophagia conflict test. Overall, variation was
large in all parameters measured. There were no effects of treatment (Fi.64=0.18,
p=0.67), novelty (new cage versus home cage) (F3,62=0.95, p=0.42) or treatment x
novelty interaction ^3,64=0.84, p=0.48) with regard to the latency to approach the
food pellets. The same was true for the number of approaches (treatment F3,64=0.65,
p=0.59; novelty Fi.64=0.90, p=0.35; interaction F3,64=0.13, p=0.94). In contrast, the
time it took to start eating was increased in a novel cage (novelty Fi,64=85.0,
p<0.00001), but prenatal treatment did not affect this (treatment F3,64=0.17, p=0.92;
treatment x novelty interaction F3,64=0.17, p=0.92). Similarly, the time spent eating
was less for rats in a novel cage compared to rats in their home cage (novelty
Fi.62-74.85, p<0.00001), but there was no significant treatment effect (F3.64=2.23,
p=0.09), or novelty x treatment interaction (F3.64=T.61, p=0.20). Summarising, there
were no significant effects of prenatal treatment on feeding parameters either in the
home cage or in a novel cage, although DEX3 rats appear to spend less time eating
than rats from the other groups. In general, animals in the novel cage showed a
longer latency to start eating and spent less time eating.
Group/cage Approach Number of Eating latency Time spent
latency (s) approaches (s) eating (s)
Control/home 69.6 ±35.2 4.0 ±0.9 84.8 ±31.9 175.2 ±20.4
Control/new 57.4 ± 17.0 5.0 ±0.8 268.0 ±21.1 19.5 ± 13.8
CBX/home 33.4 ± 12.1 3.5 ±0.5 87.7 ±31.1 140.8 ±25.9
CBXZnew 39.0 ±8.5 3.7 ±0.5 251.4 ± 21.2 36.8 ± 17.5
DEXl-3/home 54.5 ±25.7 3.7 ±0.7 83.6 ±31.4 168.0 ± 4.1
DEXl-3/new 87.5 ±35.2 4.0 ±0.8 267.3 ± 18.9 7.8 ±6.9
DEX3/home 111.8 ± 58.8 4.0 ± 1.1 87.8 ±43.9 85.2 ±33.6
DEX3/new 51.2 ± 14.1 4.5 ±0.6 294.0 ± 6.0 1.0 ± 1.0
Table 6.3 Food deprivation- and novelty induced feeding behaviour.
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Correlations
No correlations were found between data from the forced swim or neophagia test and
the other behavioural tests. However, when data from the open field- and elevated
plus-maze test were compared, significant correlations were found between
ambulation in the open field and the number of entries (open arms, closed arms, base
and total number of entries) on the elevated plus-maze. Borderline significance was
found for the correlation between defecation in the open field and closed-arm and
base entries on the plus-maze (Table 6.4a).
ELEVATED PLUS-MAZE
variables OA entries CA Base Total no.
entries entries entries
ambulation r=0.43 r=0.45 r=0.42 r=0.47
p=0.02* p=0.02* p=0.03* p=0.01*
centre r=0.17 r=0.32 r=0.20 r=0.29
entries p=0.39 p=0.10 p=0.31 p=0.13
grooming r=0.19 Ho £ r=0.16 r=0.09
p=0.34 p=0.50 p=0.43 p=0.64
rearing r=0.20 r=0.08 r=-0.01 r=0.60
p=0.31 p=0.68 p=0.96 p=0.76
defecation r=-l .5 r=-0.37 r=-0.36 r=-0.31
p=0.45 p=0.05« p=0.06* p=0.11
Table 6.4a Correlations between behavioural variables in open field and elevated plus-maze.
OA open arms; CA closed arms; • borderline significance.
When the percentage of time spent on the arms of the plus-maze was compared with
open field behaviour, a strong correlation was found between rearing in the open
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field and the time spent on the open arms of the elevated plus-maze. Furthermore,
there was a trend for rats, that displayed a high level of ambulation in the open field
to spend more time on the open arms and base compartment of the plus-maze (Table
6.4b).
ELEVATED PLUS-MAZE
variables % time OA % time CA % time base
ambulation r=0.35 r=-0.17 r=0.12
p=0.07* p-0.40 p=0.05*
centre r=0.26 r=-0.08 r=0.06
entries p=0.18 p=0.69 p=0.77
grooming r=0.07 i=0.21 r=-0.20
p=0.72 p=0.29 p=0.32
rearing r=0.56 r=-0.19 r=-0.01
p=0.00*** p=0.32 p-0.98
defecation r=0.01 i=0.13 r=-0.13
p=0.94 p=0.50 p=0.51
Table 6.4b Correlations between behavioural variables in open field and elevated plus-maze.
OA open arms; CA closed arms; • borderline significance.
Lastly, the level of CRH mRNA expressed in the central nucleus of the amygdala
was negatively correlated with the total number of entries made on the elevated plus-
maze and with the number of closed arm entries. Moreover, borderline significance
was found for correlations between CRH mRNA expression and the number of base
entries on the plus-maze and ambulation in the open field (Table 6.5).
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% time OA % time CA % time base
CEA CRHmRNA r=-0.20 r=0.21 r=-0.32
p=0.45 p=0.44 p=0.23
















Table 6.5 Correlations between CEA CRH mRNA expression and behaviour in elevated plus-
maze and open field.
OA open arms: CA closed arms; • borderline significance.
Characterisation ofbehavioural reactivity
Although some of the variables in the behavioural tests correlated to each other, this
does not necessarily mean that they represent the same aspect of 'emotionality' or
'anxiety'. Furthermore, a number of borderline correlations suggest that some, but
not all animals that show for example high defecation in the open field have a high
number of closed arm entries in the elevated plus-maze. In other words, there may be
a variation between rats in the 'sensitivity' to the challenges in different behavioural
tests. In order to detect structure in data from the behavioural tests by identifying
common underlying dimensions, a principal component analysis (PCA) was
performed. However, because the results from the neophagia test had large variations
and did not correlate with data from any other experiment, it was decided to exclude
this test from the factor analysis. Therefore, a PCA was performed on data from the
open field- and elevated plus-maze test. Thus, 5 factors with an eigenvalue > 1 were
retained which together accounted for 90% of the total variance (Table 6.6). These
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were then subjected to a varimax rotation (so that the relative locations of the factors
to each other remained unchanged), in order for their significance to be interpreted
more easily.
factor eigenvalue % total variance cumulative % variance
1 4.53 41.21 41.21
2 1.77 16.08 57.28
3 1.40 12.77 70.05
4 1.11 10.12 80.18
5 1.09 9.87 90.04
Table 6.6 Characteristics of each factor for PCA analysis.
% variance percentage of variation explained by each factor.
It appears that factor 1 represents variables from the elevated plus-maze test, whereas
factor 2 represents some of the variables measured in the open field. Factor 3 is
associated with avoidance of the open arms on the elevated plus-maze. Factors 4 and
5 both represent a single variable, defecation and grooming in the open field,
respectively (Table 6.7).
variables Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Ambulation .27 .88* .16 .19 -.01
Centre entries .18 .88* .02 -.24 -.05
Defecation -.28 .07 .05 -.89* .02
Rearing -.13 .64 .19 .62 .11
Grooming .09 -.02 .02 .02 .97*
CA entries .95* .08 .03 .11 .04
OA entries .50 .12 .75* .04 .17
Base entries .95* .06 .25 .10 .05
Total entries .95* .15 .24 .06 .01
% time CA -.37 .08 -.71* -.06 .36
% time OA .08 .21 .91* -.03 .07
Table 6.7 Factor loadings of each variable.
This table shows the correlation between each variable and the factors in the factor analysis. CA
closed arms; OA open arms; * loadings > 0.70.
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From table 6.7 it is clear that the elevated plus-maze and open field test paradigms
test for different aspects of 'emotionality', as variables from the two tests do not load
on the same factors. Interpretation of extracted factors is arbitrary, but in the present
analysis, factor 1 appears to be involved with the number of arm visits on the plus-
maze (with the exception of the open arms), and can be interpreted as representing
'general activity' in this particular test. Factor 2 is associated with ambulation,
entering the centre of the open field and to a lesser extent rearing. This factor
represents 'exploration', although rearing also loads on factor 4 and may have an
additional interpretation. Factor 3 comprises the number and time spent on the open
arms of the plus-maze and time spent on the closed arms (negatively related) and is
termed ' - anxiety', because a negative score on this factor suggests anxiety.
Defecation in the open field loads highly (but negatively) on factor 4, which can be
interpreted as 'fearlessness'. This factor also has moderate (positive) loading from
rearing in the open field. Finally, factor 5 is only associated with grooming, and may
represent 'relaxed' domestic activity. The location of all variables on factors 1, 2 and
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Figure 6.9 PCA of behavioural variables.
Three of the five extracted factors are plotted here. Factors 4 and 5 represent defecation and grooming,
respectively. CA closed arms; OA open arms.
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Discussion
These experiments showed that fetal exposure to DEX programmed decreased
exploration in an open field, and when administered in the last week of gestation
only, programmed decreased acquired immobility in a forced swim test and a trend
towards reduced locomotion and increased anxiety on the elevated plus-maze. CBX-
exposed offspring displayed reduced grooming and rearing in an open field, tended
to be less active on the elevated plus-maze and showed impaired (non-spatial)
learning in a forced swim test. Taken together, these data suggest that fetal
glucocorticoid exposure programmes 'behavioural inhibition' later in life.
Furthermore, neuronal GR gene transcription was increased in BLA and CEA of
CBX offspring, whereas DEX1-3, but not DEX3 offspring had higher GR mRNA
expression in BLA and a trend towards higher MR mRNA levels in BLA and CEA.
Total CRH mRNA levels were increased in CEA ofDEX-exposed rats.
Several studies have shown that corticosteroids facilitate CRH mRNA expression in
CEA (Albeck et al., 1997; Hatalski et al., 1998; Hsu et al., 1998; Makino et ah,
1994a). The CEA contains corticosteroid receptors, which are expressed in CRH-
positive neurones (Honkaniemi et al., 1992), suggesting that CORT may directly
regulate the level of CRH gene transcription in CEA through activated MR and/or
GR. Thus, increased corticosterone levels and/or increased expression of its receptors
may have contributed to the elevated levels of CRH gene transcription observed in
prenatally-glucocorticoid exposed rats in the present study: GR mRNA expression
was increased in the CEA of CBX rats and in the BLA (which projects to the CEA)
of CBX and DEX1-3 rats. DEX1-3 also tended to have higher MR mRNA levels in
both nuclei. A direct relationship between brain corticosteroid receptor levels and
anxiety-like behaviour was also shown in a recent paper by Tranche et al., who
observed reduced anxiety in mice with disrupted GR expression in the nervous
system (Tranche et al., 1999). Furthermore, both CBX and DEX1-3 offspring (and
possibly DEX3 rats, see Levitt et al., 1996) had increased basal circulating CORT.
Thus, because basal, but not stress levels of CORT were elevated by the prenatal
treatments (see chapter 3), these animals may have a higher basal CRH transcription.
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resulting in an increased amygdaloid CRH content. Considering that central or intra-
amygdaloid administration of CRH is anxiogenic [see Dunn and Berridge, 1990], it
may be postulated that high CEA CRH levels in rats exposed to glucocorticoids in
utero cause 'allostatic overload' (Schulkin et al., 1994), creating a permanent
'hyperemotional' state that is expressed behaviourally in adverse environments.
Indeed, negative correlations were found between CRH mRNA levels in CEA and
some measures of general activity and exploration in the behavioural tests.
Interestingly, upregulation of CRH (Cratty et ah, 1995) and GR mRNA (McCormick
et ah, 1995) was also found in prenatally stressed rats, which show hyperanxiety and
impaired coping behaviour (Weinstock, 1997).
CRH-containing CEA neurones project to a number of brain regions including the
BNST, hypothalamus, locus coeruleus and the nucleus of the tractus solitarius (Gray
and Bingaman, 1996). They also express CRH receptors themselves (Grigoriadis et
ah, 1993), suggesting CRH may act in a paracrine fashion to modulate behaviour.
The amygdala also modulates HPA activity (see chapter 1) and is thought to have a
tonic stimulatory influence, possibly mediated by direct and indirect projections from
the CEA to the PVN [for review see (Davis, 1992)]. Thus, activation of increased
numbers of MR and/or GR in the CEA of CBX and DEX offspring by circulating
CORT may have played a role in elevating basal CORT levels in these animals.
In the forced swim test, rats exposed to DEX throughout gestation did not behave
differently from control animals. In contrast, DEX3 and CBX rats were affected by
their respective prenatal treatments. The immobility rats acquire upon exposure to
forced swimming is regarded as a successful means of passive 'behavioural
adaptation' aimed to conserve energy in an inescapable situation. Activation of
hippocampal GR has been implicated in this coping mechanism. Interestingly, DEX3
rats had reduced GR mRNA expression in the hippocampus and spent less time
floating both in the initial and the retention test. This is in accord with a study from
Korte et al., who showed that treatment with antisense directed against GR mRNA in
the dentate gyrus of the hippocampus reduces the time spent immobile both in the
initial and the retest 24 h later (Korte et al., 1996). The same is true for mice with
disrupted GR gene expression in the nervous system (Tranche et al., 1999).
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Furthermore, DEX3- as well as CBX rats, did not improve their coping strategy upon
a second exposure to forced swimming, indicating impaired consolidation and/or
retrieval of information. Similar to initial acquisition, both consolidation and
retrieval are modulated by glucocorticoid levels (De Kloet et al., 1988; Mitchell and
Meaney, 1991). It may be postulated that in DEX3 rats, reduced hippocampal GR
levels are responsible for this impairment, whereas in CBX rats, which had normal
hippocampal corticosteroid receptor expression, increased circulating CORT levels
90 minutes post-stress (see chapter 3) interfered with the consolidation process. This
would imply an inverted U-shaped relationship between hippocampal corticosteroid
receptor occupation and memory in a forced swim test, where low GR occupation
(such as in DEX3 rats or after ADX with low-dose CORT replacement, see (De
Kloet et al., 1988; Mitchell and Meaney, 1991)) and very high GR occupation (such
as when post-testing CORT levels remained elevated) interfere with the memory
process. Importantly, the hippocampus is not the only brain region involved in the
behavioural response to forced swimming. Increased activity in the locus coeruleus
for example, also induces immobility in this test [see (West, 1990)]. The locus
coeruleus receives input from the amygdala, which had increased GR mRNA
expression in CBX rats. Thus, altered activity of locus coeruleus neurones may also
have played a role in reduced performance ofCBX rats in the forced swim test.
Adult rats exposed to DEX in utero display reduced ambulation and rearing and
appear to make less entries into the centre of an open field. In addition, DEX3 have a
tendency to defecate more. These parameters are generally assumed to represent
'anxiety' or 'emotionality'. Many studies measure only two variables in this test, and
some only use defecation as an indication of 'emotionality'. Similarly, in the
elevated plus-maze test, the amount of time spent on and the number of visits to the
open arms are used as indicators of anxiety. Indeed, administration of anxiolytics
increases the score for these parameters (Pellow and File, 1986). However, factor
analysis clearly showed that it is not correct to draw conclusions about a rat's
emotionality on the basis of one parameter or even one behavioural test. In the two
tests used in this study, no less than five factors could be extracted that underlay the
rats' behaviour.
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Although the results of the two tests were only significant for 2 of the variables
measured, DEX3 rats showed trends towards altered behaviour compared to control
rats on almost every parameter. Interpreted in the factor analysis, this implies that
DEX rats show reduced activity (factor 1), reduced exploration (factor 2) and
increased anxiety (factors 3 and 4). Taken together, this points to 'behavioural
inhibition' in aversive environments like an open field or an elevated maze.
Similarly, the reduced immobility in the forced swim test can be regarded as
behavioural inhibition, as the normal coping response would be to float and DEX3
rats are 'inhibited' from doing so. Behavioural inhibition can be regarded as an
example of reduced coping ability, as it is not necessarily beneficial for an animal to
remain passive in a challenging situation.
Rats treated with DEX throughout gestation have learning capacities similar to
control rats in a forced swim test. On the elevated plus-maze there is a tendency to
spend more time in the central area, but this was not significant. The only significant
behavioural effect of DEX exposure throughout gestation was reduced rearing in an
open field. In the factor analysis, rearing loaded moderately high on 'exploration'
(factor 1) and negatively on 'fearlessness' (factor 4), indicating that DEX1-3 rats
have a somewhat higher level of emotionality in some, but not all aspects. The
programming properties of prenatal DEX on behaviour appear to be active mainly in
the third week of gestation, similar to the critical windows observed for
programming of hippocampal corticosteroid receptor expression, hypertension and
glucose metabolism (Levitt et al., 1996; Nyirenda et al., 1998). Interestingly, this
time window also applies for the effects of gestational stress on the serotonergic
system in rats (Peters, 1988), which may be one of the systems underlying the
behavioural alterations seen in prenatally stressed, and perhaps also in prenatal
glucocorticoid-exposed rats.
Summarising, prenatal exposure to DEX, especially in the last week of gestation,
results in behaviourally inhibited offspring that display reduced coping in aversive
situations. Administration of CBX throughout pregnancy mainly impairs learning
and/or memory in a non-spatial task like the forced swim test. As discussed in
chapter 3, there are several factors that may explain why DEX and CBX offspring,
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although both prenatally exposed to glucocorticoids, are not affected by this
exposure in the same way. The patterns of 11P-HSD expression during development,
the stages of maturity of the fetal target tissues, the differential expression of
corticosteroid receptors and the stressfulness of CBX injections may underlie the
time windows for specific effects ofDEX and CBX administration in utero.
The long-term effects of fetal glucocorticoid exposure in humans have not been
investigated. A preliminary study in children showed that prenatal DEX-exposure did
not affect cognition scores, but increased scores for shyness, internalising, avoidance,
emotionality and decreased scores for sociability (Trautman et ah, 1995). Another
study reported adverse events such as failure to thrive and delayed psychomotor
development (Lajic et ah, 1998). Although it is difficult to find the rodent equivalent
of 'shyness' or 'internalising', the similarities with results from this study point to
behavioural inhibition or reduced coping possibly related to increased anxiety. In
conclusion, fetal overexposure to endogenous glucocorticoids may underlie the link
between the prenatal environment and adult behavioural disorders.
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Chapter 7. General discussion
The aim of this thesis was to establish the effects of prenatal glucocorticoid exposure
on HPA axis regulation and stress-induced behaviour, and to study the role of feto¬
placental 11(3-HSD2 in protecting the fetus from the effects of maternal
glucocorticoids on these parameters. Chapter 3 described how inhibition of the feto¬
placental barrier to glucocorticoids reduced birth weight and increased basal morning
and post-stress HPA activity, which may be associated with reduced GR mRNA
expression in the PVN. Furthermore, fetal exposure to the synthetic glucocorticoid
DEX also elevated basal morning but not stress-induced CORT concentrations. In
chapter 4 it was shown that spatial learning and memory in a watermaze were not
affected by these prenatal treatments. Chapter 5 revealed that DEX exposure in the
last week of gestation reduces hippocampal MR and GR gene expression, an effect
not seen in animals exposed to DEX throughout pregnancy. In contrast, GR mRNA
levels in the PVN remained unchanged, but CRH mRNA levels were increased.
Stress-induced CORT levels were not altered in these rats. As described in chapter 6,
prenatal DEX administration reduced exploratory behaviour and general activity in
adult offspring, especially after late-gestational exposure. CBX and DEX3 rats also
showed an impaired behavioural response in a forced swim test. Taken together, it
may be suggested that prenatal glucocorticoid exposure during specific 'critical' time




Birth weight 1 i i
Basal CORT t t n.m.
Hippocampus MR = =
Hippocampus GR = = I
Amygdala MR t =
Amygdala GR t f =
Amygdala CRH t t t
PVNGR = =
PVNCRH T t t
Coping (forced swim) •4 = I
Exploration (open field) = 4
General activity (plusmaze) 4 = 4
Anxiety (plusmaze) I = 1
Fearfulness (open field) = = t
Table 7.1 Summary of results.
Bold arrows represent significant effects; small arrows represent trends; n.m. = not measured.
An association between low birthweight and later disease has been shown in many
epidemiological as well as animal studies and has led to the concept of 'prenatal
programming'. The quest for the factors involved in prenatal programming has
resulted in two hypotheses. One hypothesis proposes that maternal undernutrition
interferes with fetal development, ultimately resulting in increased blood pressure
(Godfrey et al., 1994; Langley and Jackson, 1994; Woodall et al., 1996), obesity
(Susser and Stein, 1994), glucose intolerance (Ravelli et al., 1998) and even in the
origin of (some cases of) schizophrenia (Susser et al., 1996). The second hypothesis
is based on the importance of glucocorticoids in maintaining homeostasis and the
regulatory role they play in development. It implicates excessive glucocorticoid
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exposure in utero in fetal programming. Thus, earlier work from our lab showed that
administration of DEX in the third week of pregnancy results in hypertension and
hyperglycaemia (Levitt et ah, 1996; Nyirenda et al., 1998).
Rats exposed to DEX or to CBX during pregnancy in this study had lower food
intake than control rats. Undernutrition activates the HPA axis, as has been shown in
non-pregnant rats (Jacobson et ah, 1997), and reduces placental lip-HSD activity
(LangleyEvans et al., 1996b), suggesting that CBX injections increase in utero
exposure to CORT levels in an indirect way as well as directly via inhibiting feto¬
placental 11P-HSD activity. Unfortunately, a lack of time prevented us from testing
this by adrenalectomising CBX-injected pregnant rats. This should have been able to
reveal whether the effects of CBX injections on offspring are dependent on maternal
CORT, as is the case for hypertension and hyperglycaemia in CBX offspring
(Lindsay et al., 1996a; Lindsay et al., 1996b). Moreover, adrenalectomy of vehicle-
injected 'pair-fed' dams receiving a restricted amount of food similar to that eaten by
adrenalectomised CBX-injected dams should demonstrate whether possible effects
on offspring of undernutrition per se are dependent on maternal glucocorticoids as
well. Similarly, in order to establish whether undernutrition per se could have caused
the observed effects of DEX injections, this study would require an additional 'pair-
fed' vehicle group with a constant low amount of circulating glucocorticoids.
Thus, the effects of the daily injections on pregnant females described in this thesis
do not exclude the possibility that prenatal undernutrition may have (at least partly)
underlain the effects seen in CBX- and DEX offspring. Both undernutrition and
excessive glucocorticoid exposure may have induced fetal growth retardation by
modulation of the IGF system (Oliver et al., 1993; Price et al., 1992), which is an
important regulator of fetal and neonatal growth and development. In addition,
glucocorticoid-induced reduction in placental glucose-transporter expression (Hahn
et al., 1999) may reduce placental glucose transfer and thus contribute to fetal growth
restriction.
One of the most important findings from this study is that prenatal CBX injections
result in subtle changes in HPA axis regulation, whereas fetal DEX administration
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mainly alters behaviour in aversive environments. This suggests that prenatal CBX
and DEX are not two different versions of the same model. Other studies
investigating the effects ofDEX-injections on HPA-activity found that prenatal DEX
treatment increased basal (Levitt et al., 1996; Muneoka et al., 1997), but not stress-
induced (Holson et al., 1995) plasma CORT levels, whereas the opposite pattern is
usually found in prenatally stressed animals (Henry et al., 1994; Weinstock et al..
1992). Apparently, prenatal glucocorticoid exposure is not the only component of
maternal stress that programs offspring HPA-activity. CBX offspring had elevated
basal and post-stress circulating CORT and decreased GR gene expression in PVN.
There are several possible explanations for the differences in HPA regulation
observed in CBX and DEX offspring. Firstly, glucocorticoid exposure through
inhibition of CBX and through administration of DEX may have acted during
different time windows. Placental 11P-HSD2 is highly expressed from midgestation
onwards, but levels and activity drop in the last week of gestation (Brown et al..
1996; Waddell et al., 1998), suggesting that inhibition of this enzyme would be
effective mainly during the second trimester. In contrast, DEX is poorly metabolised
by lip-HSD and readily reaches the fetal circulation. Thus, DEX 1-3 animals were
exposed to high glucocorticoid levels from early in gestation and DEX3 animals in
the last week only. Brain GR mRNA and protein have been demonstrated from
midgestation onwards (Bohn et al., 1994; Diaz et al., 1998; Kitraki et al., 1996), and
although it is not known whether GRs are physiologically active at that time, it is
possible that in DEX1-3 rats DEX effects through activation of GR have taken place
in the second and third week of gestation. Thus, the three paradigms used in this
experiment are likely to have provided three different time windows for
glucocorticoid action: week 2 in CBX rats, week 2+3 in DEX1-3 rats, and week 3 in
DEX3 rats. The components of the HPA axis and different brain areas do not all
mature at a similar rate, and distinct development patterns in the expression of
corticosteroid receptors have been demonstrated in brain (Bohn et al., 1994;
Rosenfeld et al., 1988a; Rosenfeld et al., 1988b). Clearly, the timing of
glucocorticoid exposure is likely to be of great importance for its effects on
development. A specific prenatal time window has also been shown for
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glucocorticoid programming of hyperglycaemia (Nyirenda et al., 1998) and
hypertension in rats (Levitt et al.. 1996) and sheep (Dodic et al.. 1998).
A second explanation for the differences observed between the treatments might be
that the dose of glucocorticoids that the fetuses were exposed to was not equal in all
groups. The amount of CORT reaching the fetal circulation after inhibition of
placental 1 lp-HSD depends on maternal CORT levels, which were highly variable in
CBX-treated dams as shown in chapter 3. Thus, CBX-fetuses may have been
exposed to much higher (endogenous) levels of glucocorticoids than the relatively
low doses that DEX-fetuses were exposed to.
Thirdly, CBX and DEX may have acted through different mechanisms of
programming: CBX is not an exclusive 11P-HSD2 inhibitor and may have affected
other enzymes apart from 11P-HSD2, such as lip-HSDl, 15-hvdroxyprostaglandin
dehydrogenase and 3a-HSDs (Baker, 1994). The latter are involved in the
production of neurosteroids, which influence brain functioning via interaction with
the neurotransmitter GABAa- and NMDA receptors (Paul and Purdy, 1992; Puia et
al., 1990; Schumacher, 1990). In addition, CBX may affect differentiation by
blocking intercellular communication through gap junctions (BaniYaghoub et al.,
1999). Furthermore, CBX-induced inhibition of lip-HSD allows access of maternal
CORT to the fetus, which may activate not only GR but also MR. MR mRNA and
immunoreactivity are present from gestational day 13 onwards (Brown et al., 1996).
This contrasts with administration of DEX, which only has high affinity for GR. The
literature does not report any investigations into programming by specific MR
agonists (i.e. other than CORT), but a preliminary study shows alterations in
hippocampal 5-HTla receptor mRNA levels by prenatal aldosterone injections (Diaz,
Welberg and Holmes, unpublished observations), suggesting that MR activation may
be responsible for at least some of the programming effects observed in CBX
offspring.
In addition, CBX may have inhibited lip-HSD activity in tissues other than
placenta. 11P-HSD is expressed in many different tissues in the adult rat, such as
kidney, liver, testis, heart, aorta, colon and specific brain areas (Monder, 1991;
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Walker et al., 1992). In the mother, inhibiting 11(3-HSD may have altered the level of
circulating or local 'active" glucocorticoids, which could have effects on the
mother's physiology and may have indirectly affected fetal growth and development.
For example, CBX could have influenced glucocorticoid negative feedback on the
maternal HPA axis. Indeed, administration of glycyrrhetinic acid, a different 11P-
HSD inhibitor, decreased CRF-41 and increased AVP and oxytocin release into
hypophysial portal blood at least in male rats (Seckl et ah, 1993). Furthermore, if
CBX is capable of crossing the placenta, inhibition of fetal 11P-HSD2, which is
expressed from midgestation onwards (Brown et al., 1996), would increase the fetal
level of glucocorticoids. Thus, CBX injections may have not only increased fetal
exposure to maternal CORT. but also amplified the glucocorticoid signal locally in
the fetal brain. Since 11P-HSD1 acitivity appears to be absent from the fetal brain
(Diaz et al., 1998), reactivation of CORT (or inhibition thereof by CBX) is unlikely
to play a role in fetal glucocorticoid programming.
Lastly, it is not unlikely that the CBX-paradigm has acted not only to inhibit 11P-
HSD activity in mother, placenta and fetus, but also as a maternal stressor. CORT
levels in CBX-injected rats varied greatly and this may be related to the fact that
most pregnant rats did not tolerate CBX injections well and that some developed
sores at the site of injection. This may have been due to poor solubility of CBX in the
concentration used in this study. Other researchers (Robson, PhD thesis, Edinburgh
University) have noted similar problems in neonates. A lower concentration of CBX
(2.5 mg/day) has been tested, but did not reduce birthweight (Lindsay et al..
unpublished observations), which is why the higher dose of 12.5 mg/day was
continued in the present study. Consequently, factors released in response to
infection or stress may have (partly) underlain the alterations seen in CBX offspring.
Indeed, exposure to a prenatal immune challenge has been shown to program HPA
axis activity (Reul et al., 1994). Furthermore, as mentioned earlier, stress-induced
release of CORT in addition to inhibition of 11 p-HSD may have exposed CBX-
fetuses to much higher (endogenous) levels of glucocorticoids than the relatively low
doses that DEX-fetuses were exposed to. Moreover, other factors associated with the
possibly stressful CBX injections such as neurotransmitters or opioids may have
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played a role in programming CBX offspring. Indeed, the opioid receptor inhibitor
naltrexone prevents prenatal stress-induced alterations in rats (Keshet and
Weinstock. 1995).
Interestingly, dissociation between prenatal exposure to 'stress" and 'glucocorticoids'
has also been demonstrated in other studies. In two studies adrenalectomised rats
were injected with 21-28 mg CORT daily in the second (Lee and Rivier, 1992) or
third (Holson et ah, 1995) week of pregnancy, but in neither case was offspring HPA
activity affected. In contrast, a third study administered a much lower dose of CORT
(9 mg/day) following daily restraint procedures and observed effects identical to
those of prenatal stress (Barbazanges et ah, 1996). Prenatal stress had no effects in
offspring of adrenalectomised rats with constant low-dose CORT replacement or
with no CORT administration at all (Barbazanges et ah, 1996). Although the authors
concluded that stress-induced increases in maternal glucocorticoids may be the
mechanism by which prenatal stress impairs the development of the adult offspring's
glucocorticoid response, it appears as though the combination of stress and high
CORT levels was critical for the observed effects. Thus, an interaction between
CORT and other stress-induced factors (e.g. neurotransmitters, opioids,
neurosteroids) may be critical for inducing changes in prenatally stressed animals, as
well as in CBX offspring in the present study.
Summarising, the differential effects of prenatal DEX and CBX may be attributed to
the pattern of 11 (3-HSD expression during development and the stages of maturity of
the fetal target tissues, while the stress and possible infection caused by CBX
injections and the nonspecificity of this inhibitor may also have played a role.
The behavioural studies of this thesis were somewhat disappointing in the sense that
they revealed many trends, but few of them reached significance. Although the tests
were carefully designed and conditions kept as stable as possible, variability in the
behavioural parameters measured was high in all tests. In future, a higher number of
animals in each experimental group would be recommended to reduce the 'noise'
caused by individual variability such that differences between experimental groups
can be observed more clearly. Moreover, it might allow a clearer interpretation of the
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data, as loading on the different factors in the principal component analysis would be
greater. Furthermore, it may be interesting to test prenatally treated offspring at
different ages. It has been demonstrated that cognitive function is influenced by
perinatal manipulations, but this influence does not always become apparent until old
age. For example, the effect of neonatal handling, which increases hippocampal GR
levels, on watermaze performance can be demonstrated in 24 month-old. but not 6 or
12 month-old rats (Meaney et al., 1988), suggesting that handling interferes with the
ageing process rather than directly influencing cognitive function. Similarly,
prenatally stressed rats, which have elevated HPA axis activity in adulthood, only
show cognitive impairments at old age (Vallee et ah, 1999). Interestingly, Rowe et
al. (Rowe et ah, 1998) noted that cognitively impaired aged rats also display reduced
exploratory behaviour in a novel environment, while another group demonstrated
that reactivity to novelty in young animals predicts cognitive impairment later in life
(Dellu et ah, 1996). Thus, although the effects of prenatal injections with CBX or
DEX on behaviour, particularly cognitive function, may only be subtle (or non¬
significant) at the age the rats were tested in the present study, they may become
more apparent in old age.
An alternative mechanism that may explain the effects observed in CBX and DEX
offspring which has not been addressed in this study, is the possibility that daily
injections during pregnancy altered maternal behaviour after birth. This question may
be resolved by cross-fostering studies, whereby prenatally CBX- or DEX exposed
pups are adopted by control dams and vice versa. Adoption has been shown to
reverse the effects of prenatal stress on FIPA axis activity (Maccari et al., 1995) as
does neonatal handling (Wakshlak and Weinstock, 1990), which probably acts
through increased maternal behaviour (Liu et al., 1997). Furthermore, it would be
interesting to investigate whether the effects of prenatal glucocorticoid exposure are
transmissible across generations. Females were not tested in this study, but they
appear to be more susceptible to effects of early manipulations such as prenatal stress
(McCormick et al., 1995; Weinstock et al., 1992). Interestingly, Montano et al.
described greater transport of CORT across the placenta in female than in male
mouse fetuses, suggesting that placental 11P-HSD may be less active in female
fetuses (Montano et al., 1993). If increased prenatal glucocorticoid exposure
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permanently elevates circulating CORT levels in female offspring, then this may
affect the in utero environment of the next generation.
Both CBX and DEX3 offspring showed some alterations in HPA axis regulation.
CBX rats had elevated basal and post-stress plasma CORT levels in combination
with reduced GR gene expression and a trend towards increased CRH expression in
PVN. DEX3 rats had reduced hippocampal MR and GR and increased PVN CRH
mRNA levels, but stress-induced CORT concentrations were unaltered. These results
show that prenatal glucocorticoid exposure subtly increases HPA activity. However,
the mechanisms underlying this increase could have been more thoroughly
investigated.
For example, to state that a trend towards increased CRH mRNA expression in PVN
leads to elevated plasma CORT levels is speculative, as there are many 'steps' in
between these two parameters which have not been addressed. CRH stimulates the
release of ACTH from the pituitary into the circulation. ACTH levels can be
measured in plasma by radioimmunoassay but they rise quickly after an animal has
been disturbed or stressed. Thus, they are only informative if the plasma sample is
taken within 60 seconds from removing the rat from its cage, and unfortunately using
the sampling method described in chapter 2, we were not able to obtain enough
plasma in this short time span for measuring both CORT and ACTH.
Moreover, CRH is not the only secretagogue for ACTH but acts in concert with
AVP. The latter potentiates the stimulatory effects of CRH (for review see Aguilera,
1993), and several physiological and especially psychological stimuli increase the
median eminence AVP content (Romero and Sapolsky, 1996). Measurements of
AVP expression in the parvocellular PVN would have revealed a more complete
picture of possible alterations in the central drive of the HPA axis resulting from
prenatal glucocorticoid exposure.
Furthermore, increased gene expression does not necessarily result in higher amounts
of biologically active protein. The CRH content in the median eminence of the
experimental rats was not measured, but it is possible that posttranscriptional or -
translational mechanisms may have modified CRH protein levels. Similarly,
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decreased mRNA levels of corticosteroid receptors in PVN, hippocampus or
amygdala may not be of any influence on protein levels. The capacity and affinity of
receptors can be measured using specific binding assays, but certain disadvantages
are attached to these assays. Firstly, they require dissection of the brain region of
interest immediately after decapitation and do not allow for distinction between
separate hippocampal areas or amygdaloid nuclei as it is not possible to convincingly
dissect these subregions. Secondly, some protocols for steroid binding assays require
prior removal of endogenous ligands by adrenalectomy. Because circulating CORT
regulates MR and GR, adrenalectomy is likely to affect the result of the binding
assay. Indeed, adrenalectomy induces increased MR and GR mRNA (Herman, 1993;
Herman and Spencer, 1998; Pfeiffer et ah, 1991) and MR and GR binding (Reul et
al., 1987) in the hippocampus. Thirdly, in order to obtain enough material to perform
a binding assay, tissues from separate rats need to be pooled. As a consequence, the
data obtained cannot be correlated to behavioural measures of individual rats.
Because in situ hybridisation provides mRNA levels for each rat separately,
amygdala CRH levels could be related to behaviour in open field and elevated plus-
maze (see chapter 6). Unfortunately, MR and GR mRNA levels in amygdala and
hippocampus were measured in tissues taken from a different population of rats,
rendering correlational analysis impossible.
Results obtained from the in situ hybridisation experiments should be interpreted
with caution. In situ hybridisation is only a semi-quantitative technique, as the
number of grains expressed per neurone or the optical density on an autoradiogram
cannot be directly related to an absolute amount of mRNA. It may therefore not be
the best method available for quantifying mRNA levels. In future experiments,
competitive quantitative PCR may be a useful alternative to measure alterations in
gene expression, although this technique would not detect changes in specific
subfields of the hippocampus or amygdala.
Summarising, it would be worth-while to repeat the behavioural tests with more
animals at different ages, followed by measuring both gene transcription and protein
levels of GR, MR, CRH, and AVP in the relevant brain regions so that these can be
correlated to the behavioural measures. This would provide more direct information
151
regarding the role of these gene products in the rats' behavioural response in aversive
situations.
In conclusion, this study provides another link between low birth weight and adult
disorders, showing that prenatal glucocorticoid exposure not only increases blood
pressure and plasma glucose levels (Levitt et ah, 1996; Nyirenda et al., 1998), but
also increases HPA axis activity and impairs coping in aversive situations. This
reflects the crucial role of glucocorticoids in development and the long-term
consequences of exposure to low dose DEX administration in utero. Chronic steroid
treatment is not uncommon in cases of suspected congenital adrenal hyperplasia,
whereas short-term DEX treatment is often given to postpone delivery of- and to help
surfactant production in premature babies. From the rat model used in the present
study it may be followed that such steroid therapy may predispose to later disorders
by causing subtle alterations in brain and behaviour. A single (preliminary) follow-
up study reports increased shyness, emotionality and avoidance with less sociability
in children after early gestational exposure to DEX because of suspected congenital
adrenal hyperplasia (Trautman et al., 1995).
Furthermore, this thesis shows the importance of feto-placental 11 P-HSD in
protecting the fetus from high endogenous glucocorticoids. Considering the high
variation in placental 11(3-HSD activity observed in rats (Benediktsson et al., 1993),
low activity of this enzyme may render an individual more vulnerable to negative
effects of maternal glucocorticoids on fetal development. Indeed, 11P-HSD activity
correlates with birthweight in rats (Benediktsson et ah, 1993) and humans (Stewart et
al., 1995), and humans with defective 11P-HSD2 often have low birth weight
(Kitanaka et al., 1996; White et al., 1997). However, the reduced food intake of
CBX- and DEX treated dams and the stressfulness of CBX injections may also have
played a role in programming of offspring.
In conclusion, this study has shown that fetal overexposure to endogenous (reduced
activity of feto-placental 11 P-HSD) or exogenous (prenatal DEX therapy)
glucocorticoids may represent a common link between the prenatal environment,
fetal growth and adult neuroendocrine and affective disorders.
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